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IMMUNOLOGICAL AND HISTOLOGICAL STUDIES OF THE GUINEA PIG CONJUNCTIVA 
ABSTRACT D. P. Tuffin 
1. 'Immediate hypersensitivity in the guinea pig conjunctiva has been 
investigated as a potential animal model for human allergic 
conjunctivitis. 
2. Immediate conjunctival hypersensitivity was successfully induced to 
serum (rabbit, bovine, and sheep) and protein (ovalbumin, human 
serum albumin, horseradish peroxidase and bacterial amylase) antigens 
following immunization in buffered saline by intradermal or sub- 
cutaneous injection. 
3. Conjunctival sensitivity to ovalbumin developed between 9 and 14 days 
after immunization, and was long lasting (>116 days) with or without 
regular topical challenge. 
4. The guinea pig conjunctiva responded to topical doses of ovalbumin 
(0.025-2.5 mg), histamine (0.025-0.75 mg) and compound 48/80 
(0.75-7.5 mg) in a dose-related fashion. 
5. Responses to histamine were faster in onset (maximal at 15 minutes 
after challenge) compared with those to ovalbumin or compound 48/80 
(maximal at 30 minutes). 
6. Intradermal immunization of guinea pigs with ovalbumin (500 ug) led 
to high serum levels of IgG1 antibody in blood samples taken between 
14 and 56 days. Serum IgE antibody levels were low or undetectable 
at these times. 
r 
7. Evidence obtained using the homologous passive cutaneous anaphylaxis 
technique indicated the presence of two sub-classes of guinea pig IgG1 
anaphylactic antibody, possessing short (4-8 hours) and medium (2-4 days) 
term sensitizing passive transfer activity respectively. 
8. The conjunctival response to ovalbumin was selectively inhibited in 
dose-related fashion by topical doses of the anti-histamine triprolidine 
(0.25-250 ug), the betat-adrenoreceptor agonist salbutamol (0.25-25 Vg) 
and the anti-allergic agents disodium cromoglycate (0.25-2.5 mg) and 
doxantrazole (0.25-2.5 mg). 
9. No significant inhibition was observed following systemic doses of the 
5-hydroxytryptamine antagonists methysergide and B. W. 501C67 (both 
1-10 mg/kg), the prostaglandin synthetase inhibitor indomethacin 
(1-10 mg/kg), or the steroidal anti-inflammatory drug dexamethasone 
(10 mg/kg). 
10. Histological examination of the conjunctiva revealed an intense neutro- 
philic infiltration along the length of the bulbar and palpebral 
conjunctival epithelium between 4 and 16 hours after topical challenge 
with each'of ovalbumin, histamine and compound 48/80. 
11. Significantly increased numbers of eosinophils were only observed 8-48 
hours after topical challenge with ovalbumin. A few eosinophils resulted 
from challenge with compound 48/80, whereas these cells were rare or 
absent following histamine challenge. 
12. Immediate conjunctival hypersensitivity in the guinea pig therefore 
closely resembled human allergic conjunctivitis in a number of respects, 
and appears worthy of closer investigation as an experimental animal 
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GENERAL INTRODUCTION 
It would be neither constructive nor particularly advantageous to 
embark on an extensive historical review of the progress which has taken 
place in the field of allergy research during the last 50-70 years. 
Nevertheless, some mention should be made of those more outstanding 
experimental and clinical observations on which our current understanding 
of allergy is based. 
(i) Early studies in allergy 
The symptoms of a seasonal condition which we now recognise as hay fever 
were first described by Bostock (1819) and Elliotson (1831). Preliminary 
evidence which indicated that the symptoms of hay fever and bronchial 
asthma might be connected with exposure to specific plant pollens was 
first put forward by Blackley in 1873. Little significance appears to 
have been attached to these early observations however, for why should 
only a small percentage of the population suffer adverse reactions to such 
common airborne pollens? 
Magendie had reported as early as 1839 that if rabbits were repeatedly 
injected with serum obtained from dogs, they frequently manifested unac- 
countable reactions upon serum reinjection. Richet (1907), during a 
series of studies in which guinea pigs had been routinely inoculated with 
diptheria toxin and antitoxin as part of a horse antitoxin standardisation 
procedure, also observed the commonly fatal effects of repeated foreign 
serum injections. Clearly, a foreign substance which on first injection 
appeared harmless, became severely toxic when reinjected, provided that an 
interval of at least 14 days was allowed to elapse between the first and 
second injections. 
- 11 - 
Richet concluded from his studies that some kind of protective 
mechanism had been destroyed, and referred to the phenomenon as 'anaphy- 
laxis', in contrast to the term 1prophylaxisT or favouring protection. 
Rosenau and Anderson (1906) were also able to show that the phenomenon 
of anaphylaxis described by Richet could be induced by repeated injections 
of a variety of foreign sera and proteins. 
Auer and Lewis (1910) were the first workers to describe the symptom- 
atic and pathological picture of guinea pig systemic anaphylaxis in 
greater detail. They showed that if guinea pigs were presensitized with 
antigen, and challenged intravenously, evidence of severe irritation be- 
came apparent within 1-2 minutes. The guinea pigs emitted spasmodic 
sneezes, rubbed their noses vigorously, and suffered convulsions after 
5-10 minutes. Inspiration appeared to require violent effort, and the 
respiration rate slowed prior 
r 
to ceasing completely. On post mortem 
examination, the lungs were grossly distended, the bronchioles constricted, 
and numerous haemorrhages were clearly visible on the diaphragm. Auer and 
Lewis further postulated that the mechanism of guinea pig systemic anaphy- 
laxis might be connected in some way with human bronchial asthma. 
Most early theories presented to explain the mechanism of the anaphy- 
lactic reaction were based on the false assumption that the causative 
antigen-antibody combination occurs in the bloodstream. Both Schultz 
(1910) and Dale (1913) were subsequently able to demonstrate that the site 
of the anaphylactic reaction is actually in the tissues. They placed 
strips of guinea pig ileal and uterine smooth muscle taken from presen- 
sitized animals in contact with the appropriate antigen solution, and 
observed a contraction of the ileal and uterine smooth muscle. 
- 12 - 
The pharmacological substances responsible for the anaphylactic 
reaction in vivo remained in doubt, although Dale and Laidlaw (1910) and 
Barger and Dale (1911) had speculated on the possible physiological role 
of ß-zmidazolylethylamine, an agent which they termed 'histamin'. It was 
not until 1927 that Sir Thomas Lewis observed the formation and release 
in antigen stimulated tissues of a mediator which he called H-substance, 
and which was subsequently confirmed as histamine. With its ability to 
increase capillary permeability, and to contract ileal and uterine smooth 
muscle, the important role of histamine in anaphylactic reactions was 
soon established beyond doubt (Best et al., 1927; Code, 1939). 
(iii The allergic diseases in man 
During the fifty years which have elapsed since the early observations of 
Lewis, Dale, Schultz, and others, our knowledge and understanding of the 
causes and mechanisms which underlie an allergic reaction has increased 
substantially. The allergic diseases in man are now recognised to comprise 
a diverse range of conditions which include asthma, rhinitis, conjunctivitis, 
and urticaria. The most common causative antigens consist of a variety of 
weed and grass pollens, constituents of house dust, and animal furs or 
dander dust. The three important stages of the allergic response are 
essentially (i) the synthesis of a specific tissue bound antibody in 
response to primary antigen contact, (ii) secondary contact with antigen 
at one of the external body surfaces, and (iii) the resultant release in 
the tissues of a number of pharmacologically active substances which are 
responsible for the reaction itself. 
The-symptoms of bronchial asthma, which consist of wheezing, 
paroxysmal expiratory dyspnea, and obstructive pulmonary emphysema, are 
the result of bronchial muscle spasm in the upper airways, oedema of the 
bronchia mucosal and submucosal tissue, and excess local mucus secretion 
- 13 - 
(Dunnill, 1971). Although not universally accepted, asthma has been 
broadly classified as being of two basic types by Walker (1918) and Racke- 
mann (1940). Those asthmatics who suffer an attack following exposure to 
a specific antigen are referred to as extrinsic, while those whose 
symptoms are caused by psychological or physical stimuli such as excitement 
or exercise are classified as intrinsic. 
Allergic rhinitis and conjunctivitis, whether occurring on a seasonal 
(e. g. summer hay fever) or perennial basis, are characterized by a combina- 
tion of excessive sneezing, nasal congestion, erhthema and oedema of the 
nasal and conjunctival mucosal tissues, itching of the eyes, and 
lachrimation. 
(iii) Incidence and heredity of allergy 
A number of earll surveys quickly showed that between 10 and 15 per cent 
of the population of Europe aicd North America suffer from one or more 
allergic conditions on either a regular or occasional basis (Spain and 
Cooke, 1924; Piness and Miller, 1930; Vaughan, 1934). It also soon became 
apparent that a family history of allergy markedly increased the likele- 
hood of an individual suffering from an allergic condition, although not 
necessarily of the same type as those occurring in close relatives. In 
consequence, most investigators accepted the concept of an inherited 
allergic tendency (Spain and Cooke, 1924; Bray, 1930; Richards and Baly- 
eat, 1933; Ratner and Silberman, 1953), which has more recently been 
attributed to a specific gene (Aas, 1974). 
The inheritance of an allergic trait appeared at first to obey none 
of the known laws of genetics (Ratner and Silberman, 1953). Work with 
inbred strains of-mice has since shown, however, that the histocompatability 
linked Ir genes in this species at least may have the ability to control 
- 14 - 
the selectivity of both IgG and IgE antibody responses to specific anti- 
gens (Vaz and Levine, 1970), although they-do not affect the overall 
ability to produce an IgE antibody response. In man, it has been similarly 
proposed that the tendency to develop high serum IgE levels aginst antigens 
such as ragweed may also be controlled by genes linked to the major histo- 
compatability (HL-A) complex (Marsh et al., 1973). This inherited allergic 
tendency has futhermore been tentatively associated with a transient and 
genetically derived secretory IgA deficiency detectable during the first 
12 months of life (Kaufman and Hobbs, 1970; Taylor et al., 1973; Soothill, 
1973; Stokes, Taylor, and Turner, 1974). 
(iv) The nature-of-anaphylactic antibodies 
Nicolle (1907) was the first to show that anaphylactic hypersensitivity 
can be transferred between animals of the same species. He discovered 
that if the blood of a rabbit sensitive to horse serum is introduced into 
the bloodstream of a second non-immunized rabbit, then the recipient 
rabbit also becomes sensitive. The serum of guinea pigs and monkeys 
immunized with pollen extracts was also subsequently found to contain a 
humoral factor capable of transferring sensitivity (Harrison, 1934; 
Caulfield et al., 1937). 
In man, one early demonstration of the passive transfer of local 
anaphylactic sensitivity was provided by Prausnitz and Kustner in 1921. 
They showed that the injection of a small sample of serum taken from an 
allergic individual (Kustner himself was sensitive to fish) into the skin 
of a non-allergic person rendered the area of skin in the region of the 
injection sensitive to the particular antigen involved. 
By the early 1960's, experiments in both animals and man had there- 
fore established that synthesis of a specific humoral factor was responsible 
- 15 - 
for conferring anaphylactic or Type I (Coombs and Gel, 1975) hypersensit- 
ivity on an individual. This serum factor, widely referred to as 'reagin', 
appeared capable of transferring this type of sensitivity between animals 
of the same species for long periods of time by becoming tissue-fixed. 
Although regarded by most workers as an antibody, it was not a 7S immuno- 
globulin, and was unable to fix complement or form an immune precipitate 
when tested against antigen in vitro. 
The possibility that reaginic antibody might be a subclass of IgG or 
IgA antibody had been previously proposed. However, distinct differences 
in molecular antigenic determinants, electrophoretic mobilities, and sedi- 
mentation coefficients between reagin and IgA indicated otherwise. Reaginic 
antibody was clearly established as a unique antibody class by Ishizaka, 
Ishizaka and Hornbrook, in 1966. These authors isolated from the serum of 
an allergic patient an antibody activity with specific binding affinity 
for ragweed antigen, which lacked heavy chain antigenic determinants 
demonstrable for the other known immunoglobulin classes, and which possessed 
high activity in local passive transfer tests. 
The following year, Johansson and Bennich (1967) reported an atypical 
multiple myeloma globulin protein present in the blood of a patient (N. D. ). 
This protein, referred to as IgND, was subsequently found to be of the same 
immunoglobulin type as that described by Ishizaka et al., (1966), and both 
were quickly recognised as belonging to a new immunoglobulin class 
designated IgE (Bennich, Ishizaka, Johansson, Rowe, Stanworth, and Terry, 
1968). 
Reaginic antibodies possessing similar physicochemical and biological 
properties to human IgE have since been reported in the monkey (Ishizaka, 
Ishizaka, and Tada, 1969), rabbit (Zvaifler and Robinson, 1970), guinea 
- 16 - 
pig (Margni and Hajos, 1973a; Ovary, Kaplan, and Kojimi, 19761, rat 
(Stechschulte et al., 1970) and mouse (Provost-Danon, Binaghi, and Rochas, 
1972). 
In those widely used experimental animals such as the guinea pig and 
rat, certain IgG antibody subclasses also appear capable of conferring 
either local or systemic anaphylactic sensitivity (Parish, 1970c; Perini 
and Mota, 1973). In this connection, there has similarly been limited 
speculation concerning a role for IgG antibodies in human allergic reactions, 
particularly asthma (Parish, 1970b; Reid, 1970; Bryant, Burns and Lazarus, 
1973,1975). 
(v) The mechanism of the allergic reaction 
The close relationship which exists between immediate hypersensitivity 
reactions, reaginic (IgE) antibody, and tissue mast cells, has long been 
established. Degranulation of mast cells has been observed microscopically 
in response to either antigen-antibody combination (Mota, 1957,1958; Hog- 
berg and Uvnas, 1960), or chemical stimuli provided by substances such as 
compound 48/80, polymyxin, and the calcium ionophore A23187 (Riley and 
West, 1955; Lagunoff and Benditt, 1960; Trotter and Orr, 1974; Kagayama 
and Douglas, 1974; Cochrane and Douglas, 1974). Blood basophils have been 
shown to possess cell membrane bound IgE (Sullivan, Grimley, and Metzger, 
1971; Becker et al., 1973), and to respond to the above stimuli in an 
essentially similar manner to mast cells (Chan and Yoffey, 1960; Shelley 
and Juhlin, 1962; Friedlaender and Friedlaender, 1964). 
A number of authors have demonstrated positive correlations between 
the mast cell population and tissue content of heparin (Jorpes, 1939), 
histamine (Riley and West, 1953; Riley, 1955; Mota, 1958), and 5-hydroxy- 
tryptamine (Benditt et al., 1955). Both histamine and 5-hydroxytryptamine 
- 17 - 
are known to be stored prior to release in the granules of mast cells and 
basophils, bound to a heparin-polypeptide complex (Serafini-Francassini et 
al., 1969; Uvnas, Aborg, and Bergendorf, 1970). 
Recently, the contributory activity of at least four additional types 
of mediator has been demonstrated during immediate hypersensitivity 
reactions in different species. Two of these, slow reacting substance of 
anaphylaxis or SRS-A (Kellaway and Trethewie, 1940; Brocklehurst, 1953, 
1960) and eosinophil chemotactic factor of anaphylaxis or ECF-A (Kay and 
Austen, 1971), appear to be largely of mast cell origin. Prostaglandins of 
both the E and F series (Piper and Vane, 1969) and peptide kinins such as 
bradykinin (Brocklehurst and Lahiri, 1962; Piper, 1976) have also been 
detected in tissues undergoing an anaphylactic reaction. 
The sequence of intracellular events which lead to the release of 
histamine, 5-hydroxytryptamind', SRS-A, and ECF-A, from mast cells remains 
poorly understood. Briefly, the process is known to be initiated by the 
bridging of two adjacent, mast cell bound, IgE molecule Fab regions by an 
antigen (Austen, 1974). This crosslinking has been postulated to effect 
a rearrangement of the proteins present in the mast cell membrane to form 
a membrane calcium channel (Fewtrell and "Gomperts, 1977). It is through 
these 1protein functional units' or 'calcium channels' that the calcium 
influx known to be essential for mediator release is thought to occur 
(Foreman, Gomperts and Mongar, 1973). Further evidence that a calcium 
ion influx into the mast cell serves as the secondary stimulus for mediator 
release has been provided by the observation that the calcium ionophore 
A23187 is able to bypass the membrane calcium channels by acting as an ion 
carrier, thus directly stimulating histamine secretion (Foreman, Mongar, 
and Gomperts, 1973; Cochrane and Douglas, 1974). 
Following the influx of calcium ions, intact glycolytic and oxidative 
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phosphorylation systems are required to provide energy for the release 
process to proceed (Orange, 1973; Austen, 1974; Peterson, 1974a, '1974b). 
A rearrangement of cytoplasmic microfilaments and"microtubules within 
the mast cell is then believed to lead to the fusion of the perigranular 
and cell membranes, or to complete granular exocytosis (Orr, Hall, and 
Allison, 1972; Trotter and Orr, 1974; Tolone, Bonasera, and Parinello, 
1974). Both therefore facilitate the release of histamine by simple 
cation exchange with sodium ions'in the extracellular environment 
(Bergendorf and Uvnas, 1973; Anderson, Slorach, and Uvnas, 1983; Uvnas, 
1974). The series of events which lead to the release of histamine, a 
simplified scheme for which is summarised in Figure 1, appear to be 
accompanied by an increase in the cyclic 31,51- guanosine monophosphate 
(cGMP) content of mast cells, and a concomitant fall in the cyclic 3', 5'- 
adenosine inonophosphate (CAMP) level (Sullivan et al., 1975; Sullivan and 
Parker, 1976; Kaliner, 1977). ' 
The release of the above anaphylactic mediators from mast cells 
effectively leads to the setting up of a localized inflammatory Type I 
hypersensitivity reaction in the tissue site. A specific cellular 
infiltration of easinophils and neutrophils has been demonstrated 
following allergic reactions in human skin (Kline, Cohen, and Rudolph, 
1932), conjunctival and nasal mucosa (Loveless, 1945, Stromure, 1955), 
and bronchial epithelium (Morrow Brown, 1958). In the guinea pig, 
these cells are also characteristic of anaphylactic reactions in skin 
(Parish, 1972a) and conjunctiva (Dwyer, Turk, and Darougar, 1974). The 
mechanism and possible function of eosinophilic and neutrophilic 
infiltration into reactive tissues is more fully discussed in Chapter 
Four. 
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(vi) The purpose of the present study 
In summary, an individual probably develops an allergy due to a combina- 
tion of contributory factors. These include a possibly IgA related 
defect in the protection afforded by mucosal membrane barriers, a 
consequent increased absorption of antigen from the environment 
(depending on the immunogenic agent and the route and circumstances of 
exposure), an heieditary tendency to produce high serum levels of 
sensitizing antibodies following antigenic exposure, and an enhanced 
sensitivity to those mediators released from mast cells as a result of 
subsequent contact with antigen. 
Clinically, the treatment of allergy has traditionally consisted 
of (i) the use of either skin or direct provocation tests to identify 
causative antigens, (ii) avoidance of contact with antigen if at all 
practical, (iii) courses of desensitization injections designed to 
induce a high blood level of IgG type 'blocking antibodies' (see Devey, 
Wilson and Wheller, 1976), and (iv), the use of a wide range of anti- 
histamines, bronchodilators, and anti-inflammatory steroids in an 
attempt to alleviate the symptoms. 
However, a more intimate understanding of asthma or hay fever will 
only be achieved by careful study of the diseases themselves in man, 
coupled with the investigation of experimentally induced related 
conditions in laboratory animals. A great deal of attention has there- 
fore been focused upon the development of consistent and valid models 
of the human allergic state. It is from such in vivo (antigen induced 
bronchoconstriction and passive cutaneous anaphylaxis) and in vitro 
(release of mediators from rat peritoneal mast cells or guinea pig 
chopped lung tissue) test systems that much important information has 
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been obtained. These techniques have also allowed the synthesis and 
development of compounds possessing specific anti-allergic activity, 
such as disodium cromoglycate (Altounyan, 1967; Cox, 1967; Cox et al., 
1970), and more recently doxantrazole (Batchelor et al., 1975), ICI 
74917 (Evans et al., 1974), BRL 10833 (Spicer, Ross, and Smith, 1975), 
and M&B 22948 (Broughton et al., 1974). 
One such animal model with a seemingly direct parallel to allergic 
conjunctivitis in man is the experimentally induced condition of guinea 
pig conjunctival anaphylaxis, first described by Feinberg and Chopra 
(1966). The present investigation was undertaken in order to characterize 
more fully the guinea pig conjunctival anaphylactic response, and to 
assess its suitability as a model for human allergic conjunctivitis. The 
results obtained are presented in Chapters I-IV, which broadly comprise: 
I: A comparison of antigen immunization schedules, establishment of 
a conjunctival challenge technique, and the characterization and 
appraisal of conjunctival reaction severity. 
II: Study of the serum antibody response to primary antigen 
immunization, and subsequent topical conjunctival challenge. 
III: A description of the inhibitory activities of a number of known 
antagonists of immediate hypersensitivity reactions. 
IV: Investigation of the cellular infiltration into the conjunctiva 
which occurs in response to antigen or mediator induced 
reactions. 
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CHAPTER ONE 
THE DEVELOPMENT OF 
CONJUNCTIVAL ANAPHYLAXIS IN THE GUINEA PIG 
AS A MODEL OF 
HUMAN ALLERGIC CONJUNCTIVITIS 
r 
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INTR0D UC TION 
An experimental 1ocular manifestation' of anaphylaxis was first 
observed by Ratner, Jackson, and Gruehl (1927) during a series of 
studies using guinea pigs sensitized either in a dust laden atmosphere, 
or by parenteral injection. When challenged intravenously, or by 
exposure to dry dander dust, many of the guinea pigs suffered severe 
convulsions, and died rapidly from systemic anaphylactic shock. However, 
a thin and watery suffusion was observed in one or both eyes of a number 
of survivors, comprising some 10% of the total animals tested. This 
conjunctival suffusion frequently became thick and creamy, and lasted 
for half an hour or longer after challenge. It is possible that the 
authors observed only a low level ocular response in those poorly 
sensitive guinea pigs, which had consequently survived the systemic 
challenge. F 
Almost forty years later, Feinberg, Dewdney, and Temple (1965) 
reported a systemic erythematous and oedematous reaction which they had 
observed in the skin, ears, eyelids, muzzle, and genitalia of guinea 
pigs during a brief period between 7 and 9 days after the intradermal 
injection of small amounts of foreign serum. The symptoms of this 
response to primary immunization with a serum antigen persisted for up 
to 48 hours, and were recorded in 40-75% of the guinea pigs injected. 
Irrespective of whether they had shown a primary sensitization reaction, 
all of the guinea pigs responded with an identical secondary reaction 
within a few hours of intradermal reinjection with the same foreign 
serum. They also subsequently proved to be highly sensitive to both 
pinnal and aerosol inhalation antigen challenge. 
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A later report described the immediate conjunctival and nasal 
reactions which had been obtained as a result of topical challenge 
with whole serum antigens, in guinea pigs immunized by the same method 
(Feinberg and Chopra, 1966). The essential symptoms of the conjunctival 
response comprised immediate irritation, subsequent oedema and erythema 
of the bulbar and palpebral conjunctiva, and a watery discharge from 
the eye. In addition, the severity-of the conjunctival reaction 
appeared to be closely linked with the incidence and strength of the 
preceeding primary and/or secondary systemic immunization reactions. 
More recently, the immediate conjunctival response to rabbit serum 
in the guinea pig has been more closely investigated, and compared with 
delayed conjunctival hypersensitivity reactions in the same species of 
the classic (tuberculin) and contact (dinitro-fluorobenzene) types 
(Dwyer and Darougar, 1971; Dwyer, Turk, and Darougar, 1974). Con- 
junctival anaphylaxis elicited with ovalbumin has also been employed as 
one of three in vivo tests which comprised an extensive study of the 
anti-allergic activity of disodium cromoglycate against allergic 
reactions in the guinea pig (Taylor and Roftt, 1973). 
The experiments described in the first chapter of this thesis were 
therefore primarily directed towards the development and character- 
ization of guinea pig conjunctival anphylaxis as an animal model for 
human allergic conjunctivitis. Groups of guinea pigs were immunized 
with either whole serum or purified protein antigens, and monitored for 
resultant systemic sensitization reactions. The nature and severity of 
the conjunctival reactions which followed topical antigen challenge were 
determined for each antigen sensitive group, and possible methods of 
response assessment were investigated. The conjunctival response to 
- 25 - 
antigen was also compared with the effect of a number of topically 
applied pharmacological agents. These included histamine, 5-hydroxy- 
tryptamine, prostaglandin of the E and F series, the mast cell 
mediator releasing substance compound 48/80, and the calcium 
ionophore A23187. 
i 





Outbred albino Dunkin-Hartley strain guinea pigs weighing 300-500g 
at immunization were used. They were obtained either as offspring from 
Chelsea College breeding stock (initially a gift from the Beechmans 
Research Laboratories, Betchworth, Surrey), or from the following 
suppliers: 
Charles River U. K. Ltd., Margate, Kent. 
Porcellus Animal Breeders Ltd. 
Redfern Animal Breeders Ltd., Brenchley, Kent. 
The Animal Virus Research Institute, Pirbright, Surrey. 
Tuck & Sons, Rayleigh, Essex. 
The guinea pigs were fed a standard pellet diet supplemented with 
daily greens. 
Strain and species response variation studies were undertaken at 
Chelsea College, and at the Laboratory Animal Centre, Carshalton, Surrey 
(by kind permission of Dr. M. Festing), using the following animals: 
Rabbits: New Zealand Whites (Chelsea stock-Buxted). 
Guinea pig strains: complement (C4) deficient, R9, B, and 0M3. 
Rat strains: CFHB, WA, AGUS, PVGC, WAG, and LH. 
Mouse strains: LACA, CBA, BALB/C, C57L, A2G, and NZB. 
Serum Antigens: 
Rabbit and sheep sera were supplied by the Wellcome Research 
Laboratories, Beckenham, Kent. Bovine serum was prepared from whole 
blood at Chelsea College. The sera were stored frozen at -15°C in 2m1 
aliquots before use. 
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Protein Antigens: 
Ovalbumin (5x recrystallized) and human serum albumin were 
purchased from Koch-Light Laboratories Ltd., horseradish peroxidase 
from the Sigma Chemical Company, and bovine serum albumin and bovine 
gamma globulin from the Armour Pharmaceutical Company. 
The crystalline bacterial amylase (B. subtilis) was a gift from 
Dr. T. Yagura at the Osaka University Medical School, Osaka, Japan. 
Chemicals: 
Histamine dihydrochloride and 5-hydroxytryptamine creatinine 
sulphate were purchased from Sigma and stored dessicated at 4°C. Batches 
of compound 48/80 were kindly supplied by Dr. A. F. Green at the Well- 
come Research Laboratories. Prostaglandins El, E2, and Fla were 
purchased from Cambrian Chemicals Ltd., Croydon, Surrey, and stored in 
ethanol or buffer at -20°C. 17 
Sensitization: 
Guinea pigs were sensitized to the serum antigens either by a single, 
or two simultaneous 0.1 ml intradermal injections of serum (diluted to 
20% in buffered saline and equivalent to 0.02 or 0.04 ml whole serum 
respectively). 
Protein sensitization was by a single intradermal injection of the 
specified antigen dose in 0.1 ml buffered saline (pH 7.4). 
Conjunctival Challenge: 
Serum antigen challenge was performed by topically instilling two 
f 
drops of undiluted serum onto the cornea of the eye. The eyelids were 
then gently opened and closed to ensure uniform distribution of antigen 
in the conjunctival sac. 
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Challenge procedure was essentially similar for protein antigens 
and pharmacological agents, except that an adjustable Finn pipette 
(Jencon) with disposable tip was used to deliver accurate topical 
challenge volumes in the 5-50 pl range. The standard challenge volumes 
were for guinea pigs: 25 pl, rats: 15 il, and mice: 10 il. 
Intraconjunctival challenge was also used where specified, to deliver 
accurate antigen or mediator doses locally and directly into the sub- 
mucosal tissue of the upper bulbar conjunctiva. 0.02 ml of the 
challenge solution was injected intraconjunctivally using a 0.25 ml 
glass syringe and 30 gauge stainless steel short bevel needle. 
a 
Histamine and 5-hydroxytryptamine doses were calculated as base 
concentrations. Prostaglandin solutions were prepared by evaporating 
off the ethanol with nitrogen, and making up the required strength 
solutions in phosphate buffer '(pH 7.9). The calcium ionophore was 
dissolved initially in ethanol or dimethyl sulphoxide, and diluted in 
phosphate buffer (pH 7.4). 
Assessment of Conjunctival Reaction: 
Four methods were investigated for accuracy and ease of assessment 
of reaction severity: 
1. A0 to 4+ visually scored assessment system defined as follows: 
SCORE ERYTHEMA AND OEDEMA GROSS APPEARANCE 
0 None No symptoms detectable. 
1 Slight Reddening of the conjunctiva 
and eyelid margins. 
2 Striking Both eyelids. 
and Bulbar and palpebral 
3 111 Increasing conjunctiva. 
4 Severe Bulbar and palpebral conjunctiva 
and grossly swollen. Eye almost 
maximal clösed. Watery discharge. 
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2. Measurement of the width of upper bulbar and palpebral conjunctival 
swelling using a Vernier caliper accurate to ±. 0.05 mm. 
3. Measurement of the external surface temperature of the swollen 
conjunctiva using a thermistor temperature probe. 
4. Measurement of dye extrusion into the conjunctiva during reaction 
using the Diffusion Systems Ltd. Mark III reflectometer shown in 
Figure 2. In principle, light from the 6v lamp is directed through 
an adjustable optical filter and the apperture of an annular photo- 
cell onto the test surface. Light reflected from the test surface 
causes an output from the annular photocell which is measured on a 
galvanometer in millivolts. 
Each guinea pig was given a 20 mg/kg intravenous injection of 
Evan's Blue Dye (G. T. Gurr Ltd. ) immediately before topical or 
intraconjunctival challengt. With the red filter in position, the 
reflectometer was placed over the control (unchallenged) and then 
test (challenged) eyes of each guinea pig 30 minutes after challenge. 
The reduction in reflectance of the challenged eye over the control 
was therefore determined. 
Blood Smear Counts: 
White cell counts were performed on air dried and alcohol fixed 
guinea pig blood smears stained with Giemsa (R. A. Lamb Ltd. ). On each 
slide, 200-300 cells were counted in random microscope fields, and the 
results were expressed as percentage differential counts. 
Precipitin Testing: 
Sera from antigen sensitive guinea pigs were tested for the presence 
of specific precipitating antibody by immunodiffusion in New Zealand 
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agar gel plates (Feinberg, 1957). The plates were set up and left for 
48 hours at 4°C, stained with Coomassie Blue, and preserved as described 
by Ouchterlony (1967). 
Gel Filtration: 
A 2.0 ml sample of rabbit serum was chromatographed on a 2.5 x 100 cm 
Sephadex G-200 gel filtration column, and eluted with phosphate buffer 
pH 7.4. The protein content of the eluate was monitored by passage 
through an LKB UVICORD 4701 A Ultraviolet Absorptiometer connected to a 
pen recorder (George Washington Oscillograph Type 400 MD 2). Fractions 
were collected on an LKB 7000 A Ultrorac fraction collector, pooled, and 
reduced to the original column application volume by dialysis in visking 
tubing against carbowax. 
Statistics: 
Mean conjunctival reaction scores and standard errors were calculated 
for most experimental treatment groups. The Wilcoxon Rank Sum Test (see 
Materials and Methods section, chapter Three of this thesis) was used to 
compare treatment groups where stated, with p <0.05 being taken as 
indicating a significant result. 
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RESULT S 
1.1. Systemic Sensitization Reactions Following 
Immunization with Serum Antigens. 
Guinea pigs were immunized with three serum antigens: rabbit, 
bovine, and sheep, and observed for systemic sensitization reactions. 
Primary reaction symptoms were seen on the 8th day in 7 of 15 rabbit 
serum immunized guinea pigs, only 2 of 15 bovine serum injected guinea 
pigs, and none of the sheep serum immunized group (Table 1). Briefly, 
the reactions were characterized by extensive erythema of the ears, 
eyelids, feet, and skin, together with localized tissue oedema in the 
same areas (notably the ears). In most cases, the symptoms persisted 
for approximately 24 hours before subsiding. 
Booster intradermal injections (equivalent to 0.02 ml of serum 
r 
and given not less than 14 days later), produced strong systemic 
reactions within 2-3-hours in all 15 of the rabbit serum group, and 10 
of the 15 bovine serum group. Once again, no systemic reactions were 
seen in any of the sheep serum immunized group. 
Differential white blood cell counts were performed on a series 
of blood smears taken before, during, and after the primary sensitization 
symptoms shown by guinea pigs from the rabbit serum group (Table 2). 
Fourfold increases in blood eosinophil levels were recorded on the day 
of appearance of systemic symptoms (day S), and also on the following 
day (S+I). A 6-11 fold increase in the basophil count was noted on 
the next two days (S+II and S+III). No significant changes were seen in 
the lymphocyte or neutrophil counts on any of these four days. 
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Table 1. Guinea pig sensitivity to serum antigens. 
Positive Response (%) 
Serum antigen: 
Rabbit Bovine Sheep 
(na15) (n=15) (n=6) 
Primary systemic reactions: 47 13 0 
1st conjunctival challenge: 47 93 83* 
Secondary systemic reaction: 100 66 0 
2nd conjunctival challenge: 75 87 83* 
Charles River outbred guinea pigs were immunized with serum antigens 
as described in the text. Each guinea pig was observed for the onset 
of either primary or secondar! systemic immunization symptoms as 
appropriate, and for conjunctival sensitivity to topical challenge. 
Results are expressed as % positive responders for each treatment. 
* weak responses in all cases. 
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Table 2. White blood cell counts (. %) prior to, during, and 
following primary systemic sensitization reactions 
to rabbit serum. 
Day Lymphocytes Eosinophils Basophils Neutrophils Monocytes 
9-1 40.1 1.9 0.2 56.1 1.7 
S 36.2 4.9 0 57.2 1.7 
S+I 32.6 7.8 1.3 55.7 2.6 
S+II 38.2 3.4 2.2 54.4 1.8 
S+III 39.9 2.4 2.0 53.5 2.2 
Differential blood cell counts were performed on smears of blood 
r 
taken from 7 guinea pigs on days prior to (S-I), during (S), and 
following (S+I, S+II, S+III) primary systemic sensitization 
reactions. The results are expressed as percent differential 
counts of each cell type present. 
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1.2. Topical Conjunctival Challenge with Serum Antigens. 
Not less than 9 days after observation of either primary or secon- 
dary systemic sensitization symptoms in reacting animals, all guinea 
pigs, whether systemic responders or not, were topically challenged in 
one eye by the instillation of two drops of the appropriate serum anti- 
gen. Immediate signs of irritation such as scratching or blinking were 
frequently observed in positively responding animals. Signs of erythema 
appeared along the margins of the eyelids within 2-3 minutes, and spread 
to the bulbar and palpebral conjunctiva. Conjunctival oedema developed 
over the period 5-15 minutes after challenge. The overall severity of 
the reaction was generally maximal between 20 and 30 minutes after 
challenge. A watery discharge from the eye was also frequently observed. 
Following primary immunization, 7 of 15 rabbit serum and 14 of 15 
bovine serum injected guinea figs gave a positive conjunctival response. 
After secondary accelerated (booster) systemic reactions, a positive 
conjunctival response was recorded in 9 of 12 rabbit serum and 13 of 15 
bovine serum immunized animals. Sensitivity to conjunctival challenge 
was observed in 5 of 6 sheep serum immunized guinea pigs tested, but 
the degree of sensitivity was marginal. 
No symptoms of conjunctival reaction were seen in the contralateral 
control eye (unchallenged or saline challenged) of any guinea pig 
tested. Similarly, no reactions occurred in the eyes of unsensitized 
guinea pigs topically challenged with serum antigens. 
Conjunctival reactions in response to serum antigens were assessed 
on the basis of a visual 0 to 4+ scale as defined in Materials and 
Methods, and shown in Figure 3. 




Figure 3. The guinea pig conjunctival response to antigen at 30 minutes 
after topical challenge: (a) antigen and saline challenged 
eyes on a single animal, and (b) the stages of reaction 
severity (1-4 +) as defined in the visual assessment system. 
Note the intense erythema and oedema evident throughout the 
bulbar and palpebral conjunctival tissue. 
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1.3. The Nature of Serum Antigens. 
Immunodiffusion agar gel plates were set up to test sera from guinea 
pigs immunized with both rabbit and bovine serum for specific precipitat- 
ing antibody activity against these antigens. After incubation for 48 
hours at 4°C, multiple precipitation lines had formed between the anti- 
serum and antigen wells, as shown in Figure 4. Precipitating antibody 
activity was, therefore, clearly present against a number of serum anti- 
gen components in each guinea pig antiserum tested. Two experiments were 
subsequently performed to provide additional information about which 
foreign serum components might be antigenically active in the immediate 
conjunctival hypersensitivity reaction. 
Firstly, six actively sensitive guinea pigs were topically challenged 
in the left eye with bovine serum. The reactions were scored and the 
animals allowed two hours forrecovery. The same guinea pigs were then 
challenged in the contralateral (right) eye with two drops of bovine 
serum albumin (35 mg/ml), followed one hour later by two drops of bovine 
gamma globulin (20 mgIml). None of the six guinea pigs tested showed 
any conjunctival response to either bovine serum albumin or gamma globulin. 
Finally, whole serum challenge in the right eye produced strong con- 
junctival reactions comparable to those observed in the left eye some 
4-5 hours earlier. 
-Secondly, a sample of rabbit serum was fractionated on a 2.5 x 100 cm 
Sephadex column. Eluate from the column was monitored for protein 
content by absorption at 280 nm. Fractions from each of the resultant 
three main peaks were collected, pooled, and reduced to the original 
sample column application volume (2 ml). The pools from peaks I, II, 
and III were assumed to contain principally macroproteins, gamma globulins, 
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Figure 4. Agar gel immunodiffusion plates set up to demonstrate the 
presence of precipitating antibodies against serum antigens 
in conjunctivally sensitive guinea pigs. The antisera (centre 
wells) were obtained from four guinea pigs immunized with 
both rabbit serum (placed in outer wells 1 and 2 clockwise 
from the red marker) and bovine serum (outer wells 3 and 4). 
Outer wells 5 and 6 contained saline. Multiple precipitation 
lines were observed between all four guinea pig antisera and 
both serum antigens after incubation of the plates at 4°C 
for 48 hours, thus confirming precipitating antibody activity 
against multiple serum proteins. The plates were stained 
with Coomassie Blue, preserved, and mounted, according to 
Ouchterlony (1967). 
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Table 3. Conjunctival sensitivity to pools I, II and III 
of Sephadex G-200 fractionated rabbit serum. 
Left eye Left eye Left eye Right eye 
Animal Pool I Pool II Pool III Whole rabbit 
serum 
1 0 ++ ++ n. d. 
2 0 0 0 + 
3 0 0 0 ++ 
4 0 + + ++ 
5 0 0 0 ++ 
A sample of rabbit serum was chromatographed on a 2.5 x 100 cm Sephadex 
G-200 column. Eluate was pooled from the three main absorption peaks 
(see text), reduced to column application volume, and used to challenge 
guinea pigs sensitive to whole rabbit serum. 
n. d. : not done. 
* both eyes used to test pools II and III. This animal had given a 
4+ response to whole rabbit serum 7 days earlier. 
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and serum albumin respectively, as described for human serum by Flodin 
and Killander (1962). Five guinea pigs sensitive to rabbit serum were 
then topically challenged with two drops of each of pools I, II, and 
III. Only two of the five guinea pigs reacted to any of the three 
fraction pools (Table 3). The first animal reacted strongly to both 
pools II and III. All five guinea pigs responded with normal strength 
reactions when tested with whole rabbit serum. 
1.4. Topical Conjunctival Challenge with Protein Antigens. 
Guinea pigs were immunized with four protein antigens; ovalbumin, 
human serum albumin, bacterial amylase, and horseradish peroxidase; 
either by intradermal or subcutaneous injection. No 8th day primary 
sensitization systemic reactions were observed with any of these protein 
antigens. 
r 
Conjunctival challenge was performed 14-21 days after immunization 
by the instillation of 25 ul of protein solution on to the corneum of 
the eye. The challenge dose was 500 pg in all cases. The reactions 
which resulted from conjunctival challenge with protein antigens were 
identical in rate of onset and appearance to those previously described 
for serum antigens (Figure 3). 
Conjunctival sensitivity was subsequently routinely induced to 
ovalbumin, and on other occasions to horseradish peroxidase, human serum 
albumin, and crystalline bacterial amylase. ovalbumin immunized guinea 
pigs showed strong conjunctival sensitivity during preliminary experiments, 
and continued to do so throughout the project. The results of the pre- 
liminary experiments with protein antigens are sinmarised in Table 4. 
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Table 4. Conjunctival sensitivity to protein antigens. 
Immunization Conjunctival sensitivity 
Antigen Dose Route n% response Reaction 
mean t s. e. m. 
OVA 250 ug i. d. 11 100 2.6 t 0.2 
OVA 500 ug i. d. 10 100 1.9 ± 0.2 
OVA 500 ug s. c. 10 90 2.0 ± 0.3 
HSA 500 jig i. d. 3 100 2.0 ± 0.6 
BA 500 ug i. d. 7 100 2.2 ± 0.3 
HP 1.0 mg i. d 7 0 0 
HP (boost) 1.0 mg i. p. 7 43 1.0 1 0.3 
Guinea pigs were immunized with ovalbumin (OVA), human serum albumin 
(HSA), bacterial amylase extracted from B. subtilis (BA), and horse- 
radish peroxidase (HP) by intradermal (i. d. ), subcutaneous (s. c. ), 
or intraperitoneal (i. p. ) injection at the doses stated. All were 
topically challenged not less than 14 days after immunization. 
Conjunctival reactions were visually assessed at 30 minutes, and 
results expressed as group mean scores ± standard error of the 
mean (s. e. m. ). 
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1.5. The Effect of Conjunctival Challenge with Anaphylactic 
Mediators and Mast Cell Mediator Releasing Agents. 
Guinea pigs were challenged topically and by intraconjunctival 
injection with a series of doses of histamine, 5-hydroxytryptamine, 
prostaglandins E1, E2, and Fla, compound 48/80, and the calcium 
ionophore A23187. 
Slight irritation and minor reddening of the eyelid margins was 
observed in response to topical challenge with low doses of histamine 
(2.5 and 25 ug). Higher doses (250 and 750 Vg) resulted in the extensive 
conjunctival oedema and erythema characteristic of antigen induced 
reaction. Intraconjunctival challenge with histamine elicited discrete 
reactions in the upper bulbar conjunctiva at low doses (1-10 pg), and 
severe whole conjunctiva reactions at high doses (30-100 Vg). 
r 
At similar topical dose levels to those used for histamine, 
5-hydroxytryptamine caused no observable oedema or erythema. A ten fold 
increase in dose (2.5 mg) produced weak () responses, as did intra- 
conjunctival doses in the 100-300 pg range. 
The three prostaglandins were tested at topical doses up to 25 pg$ 
and intraconjunctival doses over the range 1-10 pg. No conjunctival 
oedema or erythema was observed with any of the three prostaglandins 
at any of the doses tested. Some individual guinea pigs showed evidence 
of local irritation (scratching, watering of the eyel at the highest 
doses of prostaglandin E1. 
At topical doses of 500 vg and 1.25 mg, compound 48/80 also produced 
evidence of irritation including blinking, lachrymation, and scratching, 
but no oedema. Following increased doses (2.5 and 5.0 mg) these signs 
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were observed prior to the development of conjunctival oedema and 
erythema as previously described. Intraconjunctival doses of compound 
48/80 at 0.1 and 1.0 mg levels also produced clear reactions within 5-10 
minutes of challenge. 
The calcium ionophore A23187 elicited conjunctival reactions only 
at comparatively high topical (250 ug-1.0 mg) and intraconjunctival 
(30-100 ug) doses. 
1.6. Dose-Response Relationship of the Conjunctival Reactions. 
Dose-response data was obtained in guinea pigs topically challenged 
with a range of doses of ovalbumin, histamine, or compound 48/80. 
Challenge and assessment were both performed blind, and reactions were 
visually scored 30 minutes after challenge. Resultant typical raw data 
dose-response curves are shown for ovalbumin (Figure 5), histamine 
(Figure 6), and compound 48/80 (Figure 7). All three types of con- 
junctival reaction proved to be highly dose dependant. 
Ovalbumin dose-response curves were of similar slope, but showed 
slight variation according to guinea pig batch sensitivity. Topical 
ovalbumin doses between 250 ug and 2.5 mg regularly produced severe con- 
junctival oedema and erythema. 
Conjunctival dose-response curves to topical histamine challenge 
remained remarkably consistent in all experiments (Figure 61. Severe 
reactions (3-4 +) were always recorded with 250 and 750 ug doses. High 
doses of compound 48/80 were required to elicit strong (2 +) conjunctival 
oedema and erythema. The three separate batches of compound 48/80 tested 
(K4023, K7755, and K9308) showed little variation in activity (Figure 71. 
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FIQJRE 5. The dose-related conjunctival response to topical 
ovalbinin challenge. 
Guinea pigs were immunized with ovalbumin (500 vg) by intradermal injection, 
and topically challenged not less than 14 days later. The conjunctival 
reactions were visually assessed at 30 minutes after challenge. Results 
are shown for two batches of guinea pigs with 9 (0-0) and 8 (  -0 ) 
animals per treatment group. In the latter case, a lower degree of 
sensitivity is demonstrated by a lateral shift in the dose-response 
curve to the right. 
















FIGURE 6. The dose-related conjunctival response to topical 
histamine challenge. 
The results shown are taken from two separate batches of guinea pigs with 
15 (0 - 0) and 8 (  - 0) animals per treatment group. Conjunctival 
reactions were visually assessed at 30 minutes after challenge. There was 
no statistically significant difference between the data obtained on each 
occasion. 
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FIGUM 7. The dose-related conjunctival response to topical oa ourxi 
48/80 challenge. 
Three samples of compound 48/80 numbered K4023 (I -") , K7755 
(  -  ) and 
K9308 (A -A, ) were tested, using 15,15 and 10 guinea pigs per treatment 
group respectively. The reactions were visually assessed at 30 minutes 
after challenge. There was no statistically significant difference between 
the data obtained on each occasion. 
0.25 0.75 2.5 7.5 
TOPICAL COMPOUND 48/80 DOSE (Mg) 
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Dose-response curves were also determined for intraconjunctival 
challenge with ovalbumin. histamine, compound 48/80, and 5-hydroxytryp- 
tamine. The results largely confirmed the information obtained with 
topical challenge. Both ovalbumin and histamine gave positive con- 
junctival responses with injection doses as low as 1-2 ug (Figure 8). 
Dose-related weak responses were observed with 5-hydroxytryptamine over 
the 30-300 ug range. Histamine therefore proved approximately 300 
times as active as 5-hydroxytryptamine in inducing local erythema and 
oedema in the guinea pig conjunctiva. 
The possible effect of challenge volume on the conjunctival response 
was also investigated. A range of four challenge volumes (5,10,25 
and 50 microlitres) were tested with set doses of avalbumin (500 Vg), 
histamine (250 vg) and compound 48/80 (7.5 mg). The responses at dif- 
ferent challenge volumes showed little variation for ovalbumin (1.2 ± 0.3 
- 1.7 ± 0.3), histamine (1.9 ± 0.2 - 2.4 ± 0.2) or compound 48/80 
(0.8 ± 0.2 - 1.3 ± 0.2). No significant difference was observed between 
any challenge volume for any of the three reagents. In accordance with 
these results, 25microlitres was routinely used as the standard volume 
for topical challenge in all studies. 
1.7. Time Courses of the Different Conjunctival Reactions. 
Three groups of ten guinea pigs were topically challenged with 
ovalbumin, histamine, and compound 48/80 (500 ug, 250 ug, and 7.5 mg 
doses respectively). They were scored for severity of conjunctival 
reaction by visual assessment at 5,10,15 and 30 minutes after 
challenge, and at 30 minute intervals thereafter. The reaction time 
courses for the three types of challenge are shown in Figure 9. 
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The most striking observation was the speed of onset of the 
histamine response. Irritation was immediately evident, and the margins 
of the eyelids began reddening within 2-3 minutes of challenge. 
Erythema and oedema of the bulbar and palpebral conjunctiva appeared 
after 3-5 minutes, wero maximal by 15 minutes, and unchanged at 30 
minutes. Antigen (ovalbumin) and compound 48/80 reactions showed a 
similar but rather slower onset of symptoms, and reached their peak at 
30 minutes after challenge. 
The recovery curves for all three types of reaction were essentially 
parallel in nature. The symptoms had usually receded and the eyes were 
normal in appearance between 120-180 minutes after challenge. Severe 
(4+) reactions frequently required up to 4 hours for complete recovery. 
1.8. Onset and Duration of Antigen Sensitivity. 
Three groups of guinea pigs received standard 500 ug doses of 
ovalbumin in 0.1 ml phosphate buffered saline given by intradermal 
(groups I and II) or subcutaneous (group III) injection. The onset of 
detectable conjunctival sensitivity was studied by topically challenging 
selected animals from each group over the period 8-14 days after 
immunization. All three groups were then left for a further 14-21 days 
and monitored for sensitivity to regular antigen challenge during the 
subsequent 5-13 weeks. 
The first detectable conjunctival sensitivity was recorded in 
guinea pigs from all three groups at 9 days after immunization. 
Sensitivity increased in those animals tested on days 10 and 11, and 
was maximal by the 14th day (Figure 10). 
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No significant decline in sensitivity was observed in any of the 
three groups as a result of regular topical challenge during the period 
5-13 weeks after immunization. Furthermore, there was no significant 
difference in conjunctival sensitivity between the intradermal and 
subcutaneous injection groups. 
1.9. Assessment of Conjunctival Reaction. 
Four potential methods of conjunctival reaction assessment were 
compared; visual scoring, reflectometer readings, width of upper con- 
junctival swelling, and external conjunctival temperature. On each 
occasion, conjunctival reactions of increasing severity were elicited 
by intraconjunctival injection into the upper bulbar conjunctiva of a 
range of doses of histamine (1,2,5, and 10 ug). The reactions were 
routinely assessed 30 minutes after intraconjunctival challenge. The 
highly consistent nature of the histamine conjunctival response on dif- 
ferent occasions allowed a meaningful comparison of data obtained over 
a series of experiments (Table 5). 
Although appreciation and experience of the main symptoms of 
conjunctival reaction are required, visual appraisal of reaction severity 
within the 0 to 4+ system proved the quickest to perform, gave a clear 
increase of group mean score with dose, and resulted in small treatment 
standard errors. Both intraconjunctival challenge and reaction assess- 
ment were routinely performed 'blind' when using the visual scoring 
system, to eliminate any possibility of personal bias. 
Measurement of conjunctival reaction intensity using reflectometer 
values was unsatisfactory. The guinea pigs required Evans Blue dye 
(20 mg/kg) by intravenous injection immediately prior to conjunctival 
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challenge. Readings took considerably longer to complete as both 
control and reacted eyes required testing to obtain a difference value 
for each experimental animal. The readings were also less consistent, 
giving larger group standard errors (Table 5) and a poor correlation 
with increased histamine dose (Table 6). 
Measurement of the upper bulbar/palpebral conjunctival oedema 
using Vernier calipers resulted in consistent reaction scores except 
at the highest histamine dose level (10 vg). Oedema is sufficiently 
intense at this dose to begin to close the eye (Figure 3: 4+ reaction) 
making measurement difficult. 
No improved correlation with histamine dose was obtained by 
calculating the value of the product of reflectometer difference and 
conjunctival oedema width for each guinea pig, when both methods were 
used in the same experiment. P, 
In the experiment designed to test for variation in external con- 
junctival temperature using a thermistor temperature probe, no 
significant differences were observed between any treatment groups. 
1.10 Repeated Conjunctival Challenge at Differing Time Intervals. 
Three types of experiment were performed to investigate the effect 
of repetitive topical conjunctival challenge in guinea pigs with 
standard doses of ovalbumin (500 ug), histamine (250 ug), and compound 
48/80 (7.5 mg). Groups of guinea pigs were challenged in the same eye 
at short, medium, and long time intervals of two, four, and twenty four 
hours respectively. Each eye was assessed immediately prior to 
challenge for residual symptoms, and at 30 minutes after the subsequent 
challenge. 
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Table 6: Correlation of reaction assessment with increasing 
intraconjunctival histamine dose. 
Assessment Method R D. F. Significance 
Visual score 0.74 30 p40.001 
Reflectometer 0.38 18 0.1>p>0.05 
difference (R. D. ) 
Conjunctival 0.17 18 n. s. 
width (C. W. ) 
R. D. x C. W. 0.46 18 0.1>p>0.05 
Conjunctival -0.24 22 n"s" 
temperature 
Correlation coefficient values (R) were derived from 
the data obtained for each conjunctival reaction 
assessment method presented in Table S. 
D. F.: Degrees of Freedom. 
n. s.: Not significant. 
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In the first two experiments, guinea pigs were challenged four 
times between 10 a. m. and 4 p. m. at two hour intervals (Figure 11). 
A progressive increase in reaction severity with each successive 
challenge occurred in the ovalbumin challenged groups. Recovery was 
never complete between successive challenges which indicated that this 
might be an additive effect. There was therefore a highly significant 
difference between the first and fourth ovalbumin challenge responses 
(0.005>p>0.001). The histamine and compound 48/80 induced conjunctival 
reactions remained of similar strength with each challenge, and recovery 
from symptoms between challenges was almost complete. 
Conjunctival challenge every four hours over a period of twenty 
hours produced a different picture (Figure 12). Compound 48/80 
sensitivity was initially poor (1 + reactions), but remained constant 
with each successive challengg. Ovalbumin and histamine both elicited 
strong responses at the first challenge, but showed a gradual decline 
in reaction severity thereafter. Activity was therefore significantly 
reduced in both cases by the fifth and sixth challenges after 16 and 
20 hours (p<0.05). Topical challenge with the same agents was performed 
in the contralateral eye of each animal four hours after the end of the 
experiment. The responses were slightly depressed, but not significantly 
different from those recorded in the first challenge. 
Long term challenge was repeated every 24 hours for five days. A 
progressive decline in conjunctival response to all three types of 
challenge was observed (Figure 13). Ovalbumin and compound 48/80 
reactions showed the sharper decline, being poor or absent as early as 
the second and third days. The histamine response decreased progress- 
ively to a1+ response by the fifth day. Contralateral eye challenges 
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FIGURE 11. Repeated conjunctival 
p. m. 
TIME OF CHALLENGE 
(b) 
Challenge at two hour intervals. 
In a series of experiments, four groups of guinea pigs were topically challenged 
with (a) ovalbumin (" -0: n-6;  - : n- 8) in two cases, and (b) with 
either histamine (0-0: n- 8) or compound 48/80 (0 -0 :n- 8). Topical 
doses of ovalbumin, histamine and compound 48/80 were 500 vg, 250 ug and 
7.5 mg respectively. In each experiment, the guinea pigs were topically 
challenged four times with one of these agents at intervals of 2 hours. 
Reactions were visually assessed, and residual symptoms from the preceding 
challenge were monitored in each case before the subsequent challenge. 
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DAY OF CHALLENGE 
FIGURE 13. Repeated conjunctival challenge at twenty four hour intervals. 
Three groups of guinea pigs were topically challenged with ovalbumin 
(" -": n= 8), histamine (  - : n- 9) and compound 48/80 (A -A 
:n= 8) five times at twenty four hour intervals. Topical doses of 
ovalbumin, histamine and compound 48/80 were 500 ug, 250 ug and 7.5 mg 
respectively. Reactions were visually assessed. On the fifth day, 
guinea pigs in each group were also challenged in the contralateral eye 
with ovalbumin (0 ), histamine (O) and compound 48/80 (A) as 
appropriate. 
.ý 
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on the fifth day produced conjunctival reactions of similar strength. 
to those observed on the first day. 
1.11. Variation in Antigen Sensitivity amongst 
different batches of guinea pigs. 
Although all guinea pigs tested responded strongly to topical 
histamine challenge (250 Vg), considerable variation was observed in 
the degree of antigen sensitivity shown by batches of animals obtained 
from different sources. 
Only Charles River guinea pigs regularly showed strong primary 
(8th day) and secondary (accelerated) systemic reactions to serum 
antigens (see Table 1). Conjunctival sensitivity to topical rabbit 
serum challenge also proved strongest in guinea pigs obtained from 
Charles River (Table 7), and subsequent batches responded consistently 
to ovalbumin. 
Redfern and Chelsea (Beecham) guinea pigs became strongly sensitive 
to ovalbumin following standard intradermal immunization, but responded 
poorly to serum antigens. Neither group showed systemic or topical 
reactions of any note. A single group of Tuck guinea pigs showed 
appreciable conjunctival sensitivity to rabbit serum in three of seven 
animals immunized, but only weak systemic reactions were observed. 
Porcellus guinea pigs responded well to ovalbumin immunization, 
but only weakly to rabbit serum, while those obtained from Pirbright 
gave weak conjunctival reactions following ovalbumin immunization, but 
were not tested with serum antigens. 
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Table 7: Variation in antigen sensitivity amongst different 
batches of guinea pigs. 
Conjunctival response 
Challenge Guinea Pigs n% positive sensitivity (mean): 
N. R. S.: 
(2 drops). Charles River 15 40.6 2.0 
Charles River 12 75.0 1.7 
('boosted) 
Redferns 5 0 0 
Chelsea Stock 7 57.1 0.5 
Tuck 7 42.8 1.7 
Porcellus 5 60.0 1.0 
OVA.: 
(500 Vg) Charles River 20 100.0 2.8 
Redferns 9 88.8 2.1 
Chelsea Stock 11 100.0 2.4 
Pirbright 40 87.5 1.3 
Porcellus 5 100.0 2.6 
Op 
HIS.: 
(250 jig) Charles River 9 100.0 2.1 
Redferns 9 100.0 2.2 




Male guinea pigs obtained from the above suppliers were immunized with 
rabbit serum (N. R. S. ) or ovalbumin (OVA. ) by intradermal injection, and 
challenged with these antigens or histamine (HIS. ) as stated. Positive 
responders (%) and conjunctival sensitivity (mean) are shown for each 
batch of guinea pigs and type of challenge. 
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1.12. Species Variability of Conjunctival Reaction. 
The effect of topical conjunctival challenge with antigen, hista- 
mine, 5-hydroxytryptamine, and compound 48/80 was investigated in six 
strains of mice, six strains of rats, four additional inbred strains 
of guinea pigs, and Chelsea stock rabbits. The results are summarised 
in Table 8. 
Three strains of mice (LACA, CBA, and BALB/c) were immunized with 
rabbit serum (0.1-ml of a 5% solution) or ovalbumin (250 Vg) by sub- 
cutaneous injection. No reaction was observed following topical con- 
junctival challenge with one drop of either rabbit serum or ovalbumin 
solution (10 mg/ml) in any of the mice tested, although the same mice 
proved strongly sensitive to pinnal antigen challenge performed as a 
positive control (Feinberg, 1961; Feinberg and Hill, 1968). The same 
mice, and also a further threl strains (C57L, A2G, and NZB), failed to 
respond to topical challenge with histamine (100 pg) and 5-hydroxytryp- 
tamine (150 ug). Mice of the LACA, CBA, and BALB/c strains also showed 
no evidence of conjunctival oedema or erythema following instillation 
of compound 48/80 (2.0 mg). 
Rats from only one strain (CFHB-Wistar) were immunized with antigen 
(0.02 ml rabbit serum or 250 ug ovalbumin by intradermal injection) and 
challenged after 2-3 weeks. No symptoms of conjunctival reaction 
resulted. Subsequent topical challenge of these same rats with a high. 
dose of compound 48/80 (2.0 mg) produced some irritation, watering of 
the eye, and a little swelling of the eyelids. No intense erythema and 
oedema characteristic of the guinea pig conjunctival response was 
observed. These and five additional strains of rats (WA, AGUS, PVGC, 
WAG, and LH) were tested for conjunctival sensitivity to histamine 
- 63 - 
(150 ug) and 5-hydroxytryptamine (225 Vg). No response was observed 
in any of the strains following histamine challenge. In two of the six - 
strains (WAG and LH) distinct swelling of the eyelids and conjunctiva 
developed between 5 and 15 minutes after challenge with 5-hydroxytryp- 
tamine. 
The variation in antigen sensitivity observed in outbred Hartley 
strain guinea pigs obtained from different outside suppliers has already 
been described. A limited amount of work with four additional strains 
of guinea pigs (R9. B, 0M3, and complement C4 deficient) indicated 
that all were ovalbumin, histamine, and compound 48/80 sensitive where 
tested. 
No conjunctival reactions were observed in New Zealand White rabbits 
following conjunctival challenge with antigen (ovalbumin), histamine, 
or 5-hydroxytryptamine. Sensitivity to compound 48/80 was not tested 
in the rabbit. 
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Table 8: Species Variability of the Conjunctival Response. 
Conjunctival challenge 
Species Strain Antigen Histamine 5-HT Comp. 48/80 
Mouse: LACA - - - - 
CBA - - - - 
BALB/c - - - - 
C57L nd. - - nd. 
A2G nd. - - nd. 
NZB nd. - - nd. 
Rat: CFHB - - - t 
WA " nd. - - nd. 
AGUS nd. - - nd. 
PVGC nd. - - nd. 
WAG nd. - + nd. 
LH nd. - + nd. 
Guinea pig: Hartley + + ± + 
R9 nd. + ± nd. 
0M3 nd. + ± nd. 
.B nd. + ± nd. 
C4 def. + + nd. + 
Rabbit: N. Z. White --- nd. 
Animals of the above species and strains were immunized and topically 
challenged with antigen (ovalbumin), histamine, 5-HT, or compound 48/80 
as stated. Challenge volumes were: guinea pigs 25 ul; rats 15 ul; and 
mice 10 il. Results were expressed as strong positive (+), weak 
positive (±) and nil (-) responders respectively. 
nd. '= not done 
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DISCUSSION 
The systemic erythematous and oedematous reactions which were 
observed following primary or secondary immunization with serum 
antigens closely resembled those previously described by Feinberg, 
Dewdney, and Temple (1965). Primary reactions were recorded in 47% and 
13% of rabbit and bovine serum immunized guinea pigs respectively 
(Table 1), compared with a 40-70% incidence reported by the above 
authors. Secondary (accelerated) systemic reactions were observed in 
100% and 67% of rabbit and bovine serum sensitive animals. No systemic 
reactions (primary or secondary) were seen at any time during experiments 
with sheep serum. Similar systemic reactions have also been reported 
in guinea pigs presensitized with aqueous extract and challenged with 
alum-precipitated pyridine-extracted preparations of timothy pollen 
(Chopra, Feinberg, and Chopra o 1968) and house dust mite (Chopra and 
Vincent, 1974). 
Examination of blood smears taken prior to, during, and following 
systemic reactions to rabbit serum confirmed the presence of sequential 
rises in eosinophil (days: S, S+I) and basophil (days: S+II, S+III) 
counts (Table 2), although these increases were less extreme than those 
previously described (Feinberg, Dewdney, and Temple, 1965). 
The severity of the conjunctival response to topical serum 
challenge appeared to be closely linked with the incidence of primary 
and secondary systemic reactions (Table 1). Absence of a systemic 
sensitization reaction did not preclude conjunctival reaction, but in 
such cases the conjunctival response was invariably weak, particularly 
in the sheep serum immunized group. The symptoms of immediate con- 
junctival hypersensitivity in guinea pigs have been previously described 
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(Feinberg and Chopra, 1966; Dwyer and Darougar, 1971; Dwyer, Turk, and 
Darougar, 1974). 
Sensitization of guinea pigs to protein antigens proved straight- 
forward and successful. Guinea pigs immunized with ovalbumin by intra- 
dermal injection generally responded with 2-3+ conjunctival reactions 
at first challenge, and there were few poor or nil responding animals 
in each batch. The route of injection used for protein antigen im- 
munization may also not be important. For example, immunization by 
either intradermal or subcutaneous injection resulted in strong con- 
junctival sensitivity in the present study. Larger ovalbumin doses 
(60 mg) given intraperitoneally and subcutaneously have previously 
proved equally successful (Taylor and Roitt, 1973). The lyophilized 
bacterial amylase protein (purified from B. subtilis) had been original- 
ly employed for aerosol sensitization and inhalation challenge in guinea 
pigs by Yamamura, Yagura, and Miyuke (1973). In the present investigation, 
notably strong conjunctival responses were obtained following immunization 
with this protein. 
Comparison of the conjunctival sensitivity which resulted from im- 
munization with either serum or protein antigens suggested several 
important advantages in the use of the latter. Conjunctival sensitivity 
to ovalbumin was initially strong, long lasting, and required no booster 
injections (Figure 10). In contrast, the response following immunization 
with serum antigens was less consistent, required routine secondary 
injections, and appeared to be guinea pig batch dependent (Tables 1 and 
7). 
The incidence and severity of an allergic response in man is now 
known to be predominantly governed by genetic considerations (see 
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General Introduction). The possibility that genetic variation between 
strains of guinea pigs-might affect the strength of the conjunctival 
response, (as implied by the data in Table 8), is further supported by 
the observations of Ovary, Kaplan, and Kojima (1976). These authors 
studied the anti-dinitrophenyl (DNP) IgE antibody response to immunization 
with DNP-Ascaris extract in guinea pigs. Of those strains tested, 
Hartley strain gave the lowest titres, while substantially higher serum 
IgE levels were recorded in English Short Hair strain guinea pigs. 
Unfortunately, the latter strain was not tested during the present 
,. investigation. 
The importance of ensuring a consistent and accurate topical antigen 
dose was strongly emphasised by the dose-response relationship observed 
with ovalbumin challenge (Figure 5); an effect more difficult to control 
but presumably equally important for serum antigens. The identification 
r 
of the specific serum components antigenically active in the conjunctival 
response was therefore felt to be a first step towards purification of 
antigenic material. However, little evidence was obtained to indicate 
that the major serum proteins are active antigenic constituents of serum 
antigens with regard to immediate conjunctival hypersensitivity. None 
of the bovine serum sensitive guinea pigs showed a positive conjunctival 
response when tested with bovine serum albumin or gamma globulin. 
Furthermore, only 2 of 5 rabbit serum sensitive animals reacted when 
challenged with pooled fractions of rabbit serum separated by gel dif- 
fusion chromatography which corresponded to the main protein elution 
peaks, although additional antigenic material may have been present in 
the untested fractions eluted between these peaks. 
Histamine is an established anaphylactic mediator in the guinea pig. 
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Its ability to reproduce anaphylactic type symptoms, and the effective- 
ness of specific histamine antagonists in preventing them, has been 
demonstrated in guinea pig lung (Auer and Lewis, 1910; Armitage, 
Herxheimer, and Rosa, 1952; Brocklehurst, 1960; Popa, Douglas, and 
Bouhuys, 1973; Drazen and Austen, 1974), trachea (Constantine, 1965; 
Coleman and Farmer, 1971; Weiss, Anderson and O'Brien, 1975), skin (Miles 
and Miles, 1952; Yeoh, Tay, and Greaves, 1972), and ileum (Joiner, Wall, 
Davis, and Hahn, 1974). 
The effect of topical histamine instillation onto the guinea pig 
conjunctiva, previously unreported, was both dramatic and pronounced. 
The conjunctival reactions became evident as early as 2-3 minutes after 
challenge, and were frequently of equal or greater severity than those 
resulting from antigen challenge. 
In contrast, the response to topical or intraconjunctival challenge 
with 5-hydroxytryptamine was poor, even at dose levels up to 300 times 
greater than those at which histamine was active. This result is 
consistent with previous reports that guinea pig tissues including skin 
and ileum, although not lung, are substantially less sensitive to 
5-hydroxytryptamine than those of the rat (Herxheimer, 1955; West, 1957; 
Sanyal and West, 1958; Mongar and Schild, 1962; Collier and James, 
1967; Maling et al., 1974). 
The ability of compound 48/80 to release histamine from tissue 
mast cells has been extensively investigated in dogs (Feldberg and 
Talesnik, 1953), cats (Paton, 1951; Westerholm, 1960), guinea pigs 
(Mongar and Schild, 1952; Mota and Vugman, 1956a, 1956b; Feinberg and 
Sternberger, 1955), and rats (Moran et al., 1962; Horsefield, 1965; 
Ranadive and Ruben, 1973). ' 
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Many workers have compared the mechanisms by which antigen and 
compound 48/80 induce release of histamine from isolated rat peritoneal 
mast cells. In common with antigen challenge, compound 48/80 release 
requires energy supplied by glycolysis and oxidative phosphorylation 
(Diamant and Uvnas, 1961; Thon and Uvnas, 1967; Peterson, 1974b), and 
can be inhibited by agents such as isoprenaline which are known to 
increase intracellular levels of cAMP (Hogberg and Uvnas, 1960; Loeffler, 
Lovenberg, and Sjoerdsma, 1971; Johnson, Moran, and Mayer, 1974; 
Fredholm et al., 1976). Unlike antigen release however, compound 
48/80-induced secretion of histamine from rat mast cells is still able 
to proceed in a calcium free medium (Uvnas, 1968). This latter release 
is inhibited by preincubation with EDTA, and is thought to indicate the 
use of tightly bound intracellular calcium (Dahlqvist, Diamant, and 
Elwin, 1973; Kagayama and Douglas, 1974; Cochrane and Douglas, 1974; 
Kruger, 1976). 
There is some evidence available to suggest that the in vivo 
activity of compound 48/80 in the guinea pig may not be entirely due 
to release of histamine from mast cells, as is thought to be the case 
in the rat or dog. Feinberg and Sternberger (1955), despite finding 
variation in potency between batches, reported that all samples of 
compound 48/80 tested produced severe symptoms of itching, sneezing, 
retching, and prostration in guinea pigs given intraperitoneal injections 
of 3 mg/kg. However, both injection and inhalation of compound 48/80 
failed to produce the severe broncho-constriction characteristic of 
systemic guinea pig anaphylaxis. The view of the above authors that 
compound 48/80 may have additional toxic side effects in the guinea pig 
supported the earlier conclusions of Miles and Miles (1952). These 
authors showed that although 2-4 pg intradermal injections of compound 
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48/80 cause visible cutaneous permeability reactions in pontamine blued 
guinea pigs, extensive thrombotic damage to blood vessels is also 
apparent. Furthermore, there is no change in the microscopic appearance 
of guinea pig lung, skin, or mesenteric mast cells following intra- 
peritoneal injection of compound 48/80 (Mota and Vugman, 1956a, 
1956b). 
Clearly therefore, the conjunctival reactions observed in response 
to high topical and intraconjunctival doses of compound 48/80 during 
the present investigation may have resulted from other local non- 
specific toxic or inflammatory effects, in addition to mast cell amine 
release. 
The divalent cation ionophore A23187 (Chaney, Demarco, Jones and 
Occolowitz, 1974) has been shown to induce granule exocytosis and 
histamine release from rat mast cells (Foreman, Mongar, and Gomperts, 
1973) and human basophil leucocytes (Lichtenstein, 1975) in vitro. 
These and other studies have demonstrated that this release is dependent 
on an ionophore facilitated transmembrane flux of calcium ions into the 
mast cell or basophil (Foreman and Mongar, 1972; Foreman, Gomperts, and 
Mongar, 1973). 
There have been few reports of experiments designed to test the 
activity of A23187 in vivo, although its ability to release both 
histamine and SRS-A from rat peritoneal mast cells following intra- 
peritoneal injection has been described (Bach and Brashler, 1974). 
Intraconjunctival doses of A23187 (30-100 pg) elicited typical 
oedamatous and erythematous conjunctival reactions in the present study. 
However, the precise in Vivo effects of an agent which is unable to 
descriminate between different divalent cations or cell types must be 
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subject to further investigation. 
No response was obtained in guinea pigs to intraconjunctival doses 
of prostaglandins E1 and E2 (100 ng - 10 Vg) during the present 
investigation, although some evidence of minor irritation was apparent 
following injection of the higher PGE1 doses. While it has been shown 
that PGts are released from antigen challenged guinea pig lung (Bakhle 
and Smith, 1972; Piper and Vane, 1969,1971; Yen, Maths, and Dugan, 
1976) and trachea superfused with histamine (Orehek et al., 1973; 
Grodzinska et al., 1975), this species appears less sensitive in some 
respects to the effects of E series PGts than the'rat. For example, 
PGE1 and PGE2 both cause increased vascular permeability when injected 
intradermally into rats (Crunkhorn and Willis, 1969; Freeman and West, 
1972; Thomas and West, 1974). This effect is probably mediated via 
mast cells, in view of the inhibitory activity of mepyramine, methy- 
sergide, and PGF2a against the response (Crunkhorn and Willis, 1971a, 
1971b). In contrast, only weak cutaneous responses are observed 
following PGE1 injection in the guinea pig (Horton, 1963; Williams and 
Morley, 1973). 
The results obtained during study of the effect of repetitive 
topical conjunctival challenge in guinea pigs raised several quite 
interesting questions, while at the same time offering few solutions. 
The short term (two hour interval) challenge responses were found to 
be of either constant (histamine and compound 48/80) or increased (oval- 
bumin) strength. In contrast, when challenge was performed at four or 
twenty four hour intervals, conjunctival responses to both ovalbumin 
and histamine exhibited a sequential decline. In the case of repeated 
challenge at the two longer time intervals, loss of sensitivity occurred 
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only in the conjunctiva subjected to repeated challenge. Testing of 
the contralateral eye at the conclusion of each experiment invariably 
resulted in normal strength conjunctival responses. 
The short term interval challenge data shown in Figure 11 
demonstrated the useful and important possibility of sustaining a 
conjunctival response to antigen or histamine over a period of several 
hours. This type of response may be of more direct relevance to the 
clinical situation in man than a single dose acute reaction. The gradual 
decline in antigen sensitivity observed with longer interval antigen 
challenge might be due to depleted mast cell amine stores, although a 
reduction in histamine sensitivity also occurred. Agonist receptor 
saturation may also contribute to the loss of sensitivity to both agents. 
Most important of all might be the infiltration into the conjunctival 
tissue of substantial numbers of neutrophils and eosinophils (as described 
in Chapter Four of this thesis) if these cells are involved in the 
inactivation of anaphylactic mediators and phagocytosis of immune 
complexes. The fact that these considerations do not appear to apply 
to the short term interval challenge experiment could perhaps be due 
to partially excited tissues remaining sensitive to additional challenge, 
whereas recovered tissues may go through a refractory phase. Further 
work is clearly required to elucidate these points more fully. 
The conjunctival sensitivity demonstrated in two strains of rats 
(Wistar albino and Liverpool hooded) to 5-hydroxytryptamine but not 
histamine is in agreement with previous work emphasising that the former 
agent is an important anaphylactic mediator in this species (Sanyal 
and West, 1958; Maling et al., 1974). The greater sensitivity of rats 
to intradermal PGE1 reported by Crunkhorn and Willis (1969,1971a, 
- 73 - 
1971b) also suggests that the conjunctiva of the rat might be more 
responsive to PGE1 than that of the guinea pig. 
The only previous report to the knowledge of the author of an 
immediate hypersensitivity reaction in the conjunctiva of a species 
other than the guinea pig or man, is that in the rabbit described by 
Abdel-Maguid, Nofal, and Hennawi (1973). In contrast to the present 
study, in which no reactions were seen following topical challenge 
with antigen, histamine, or 5-hydroxytryptamine in the rabbit, the 
above authors obtained positive responses to intraconjunctival 
injection of ovalbumin (immunized animals) and histamine. The 
discrepancy between the two studies remains to be resolved, but might 
be explained by the difference in route of challenge employed. 
f 
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CHAPTER TWO 
SERUM ANTIBODY STUDIES 
IN SENSITIZED GUINEA PIGS 
- 75 - 
INTR0DUCT10N 
The observations of Yagi, Maier, and Pressman (1962), White, 
Jenkins, and Wilkinson (1963), and Benacerraf, Ovary, Bloch, and 
Franklin (1963), led to the recognition of two distinct 7S IgG antibody 
populations in sensitized guinea pigs. These antibody populations were 
shown to possess different electrophoretic mobilities in agar gel and 
starch block systems, could be cleanly separated by ion exchange chroma- 
tography on DEAE cellulose, and were appropriately designated as 
electrophoretically fast IgG1 (gamma-1) and slow IgG2 (gamma-2). 
While IgG1 antibodies appeared capable of mediating passive local 
or systemic anaphylactic reactions, IgG2 antibodies did not (Ovary, 
Benacerraf, and Bloch, 1963; Baker, Bloch, and Austen, 1964; Stechschulte, 
Austen, and Bloch, 1967). In contrast, IgG2 but not IgG1 antibodies 
fixed complement by the classical nine component pathway, demonstrated 
by lysis of tanned antigen-coated sheep red blood cells (Bloch, 
Kourilsky, Ovary, and Benacerraf, 1963). Although a later report has 
shown that pre-prepared, washed, specific IgG1 antibody-antigen 
precipitates are able to fix complement and generate anaphylatoxin by a 
third component (C'3) bypass mechanism (Osler, Oliveira, Shin, and 
Sandberg, 1969), the involvement of complement in guinea pig anaphylactic 
reactions is doubtful. For example, IgG1 mediated passive cutaneous 
anaphylaxis (PCA) in this species is not inhibited by an anti-complement- 
ary factor isolated from cobra venom (Cochrane, Muller-Eberhard, and 
Aikin, 1970). 
Homocytropic anaphylactic antibody activity in the guinea pig was 
therefore primarily associated in the early 1960's with the 7S IgG1 
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(gamma-1) class of antibody. The characterization of reaginic antibody 
activity in man as belonging to a new homocytotropic immunoglobulin 
class termed IgE (Ishizaka, Ishizaka, and Hornbrook. 1966; Ishizaka and 
Ishizaka, 1967) coincided with preliminary evidence for the existance 
of IgE-like antibodies in rats and mice subjected to helminth infection 
(Mota 1964; Ogilvie 1967; Revoltella and Ovary, 1969). The presence 
of homocytotropic reaginic antibodies was subsequently demonstrated in 
the mouse (Levine and Vaz, 1970), rat (Stechschulte, Orange, and Austen, 
1970 ), guinea pig (Catty, 1969), and rabbit (Zvaifler and Robinson, 1970). 
In the guinea pig, as in these other experimental animals, reaginic 
(IgE) antibody was principally identified by its ability to passively 
sensitize skin sites following local serum transfer for long periods 
of time (> 8 days). This activity could be destroyed by heat (56-60°C) 
and 2-mercaptoethanol treatment as in man, and was thus easily 
distinguished from the short term sensitizing, heat and 2-mercaptoethanol 
stable 7S IgG1 antibodies previously described(Catty, 1969; Mota and 
Perini, 1970; Levine, Chang, and Vaz, 1971). Despite these early 
observations, the chromatographic isolation, purification, and subsequent 
description of the physicochemical and biological properties of guinea 
pig IgE has only recently been achieved (Margni and Hajos, 1973a, 
1973b). 
In addition, other reports have proposed the existence of a third 
homocytotropic antibody in the guinea pig. This is thought to be a 
second type, or sub-population, of IgG1 type antibody, and is heat 
stable, but sensitive to 2-mercaptoethanol treatment. It is reported 
to be partially separable from the 2-mercaptoethanol stable IgG1 using 
DEAE cellulose ion exchange chromatography, and shows maximal mast cell 
sensitizing activity in PCA tests at 2-4 day latent periods (Parish, 
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1970c; Ovary and Warner, 1972; Perini and Mota, 1972). Active or pas- 
sire anaphylactic reactions in the guinea pig may therefore be attribut- 
able to one or more of three types of homocytotropic antibody, two Igel 
sub-populations and IgE, possessing short, medium, and long term mast 
cell sensitizing activity respectively. 
The nature of the anaphylactic antibodies active in animal models 
of allergic conditions is especially important in view of the finding 
that the inhibitory activity of known anti-allergic agents such as 
disodium cromoglycate may depend on the class of homocytotropic antibody 
(I&G1 or IgE) actively or passively sensitizing mast cells for mediator 
release (Goose and Blair, 1969; Orr, Gwilliam, and Cox, 1970,1971; 
Taylor and Roitt, 1973). 
The object of the present work was therefore firstly, to characterize 
the serum antibodies produced Rn response to antigen immunization for 
conjunctival anaphylaxis, and secondly, to monitor the effect of regular 
conjunctival challenge on those antibody activities detected. Antibody 
activity was investigated in four types of test comprising (i) PCA at 
increasing latent periods of sensitization with selective heat and 
2-mercaptoethanol serum treatment, (ii) haemagglutination of antigen 
coated sheep red blood cells, (iii) haemolysis of antigen coated sheep 
red blood cells, and (iv) precipitin formation in agar gel plates. 
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MATERIAL S_ANDMETHOD S 
Animals: 
Outbred albino Dunkin-Hartley strain guinea pigs obtained from 
Charles River U. K. Ltd., or Redfern Animal Breeders Ltd., were used 
for both immunization and PCA studies. 
Antigens: 
Ovalbumin, 5x recrystallized (Koch-Light Laboratories Ltd). 
Rabbit serum (Wellcome Research Laboratories). 
Immunization/Topical Challenge/Reaction Assessment: 
All methods as described-in Chapter One of this thesis. 
Sera: 
Blood was collected from guinea pigs either by cardiac puncture or 
at sacrifice, at various time intervals after immunization. After being 
allowed to clot (6-18 hours at 4°C), serum was taken off by centrifugation 
(200 g for 15 minutes) and stored frozen at -15°C until use. The serum 
samples used in the haemagglutination and haemolytic antibody tests 
were complement inactivated by heating at 56°C for 30 minutes. 
Preparation of normal and ovalbumin-coated sheep erythrocytes: 
Normal sheep red blood cells were obtained preserved in Alsever's 
solution (Wellcome Reagents or Oxoid) and washed three times with 
Dulbecco phosphate buffered saline (PBS) pH 7.4, before being packed 
by centrifugation (250 g for 15 minutes at 4°C). 0.3 ml aliquots of 
packed red cells were resuspended in 5 ml PBS, to which 5 ml of freshly 
made up tannic acid solution (0.1 mg/ml) was added. The cells were then 
incubated at 37°C for 15 minutes, centrifuged (200 g for 5 minutes at 
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4°C), and the supernatant taken'off. A proportion of the cells were 
then put aside as tannic acid treated uncoated controls, while oval- 
bumin (5 ml of a2 mg/ml solution) was added to the remainder, which 
were gently resuspended and incubated for a further 30 minutes at 37°C. 
All the cells (coated and uncoated) were then separately washed three 
times and resuspended in PBS containing 1% inactivated and absorbed 
rabbit serum. 
Haemagglutinating antibody tests: 
Control (tanned uncoated) and antigen (ovalbumin) coated sheep red 
cells (1% suspensions) were added to serial doubling dilutions of each 
serum prepared in MRC pattern agglutination plates (0.1 ml volumes of 
each). The contents of the wells were mixed by gently agitating the 
plates, and the agglutination reactions were scored on a visual 0 to 4+ 
basis after incubation for 18 hours at 4°C. The titre of each serum 
F 
was taken as the highest dilution showing a 1+ result (i. e. the 
dilution at which first detectable positive agglutination of red cells 
occurred). Positive, negative, nil-serum, and uncoated tanned cell 
controls were included in all experiments. 
Haemolytic 'antibody tests: 
Tanned uncoated and ovalbumin coated sheep red cells were taken 
and serum dilutions prepared in MRC plates as in the haemagglutination 
test, using haemolytic diluent (Dulbecco A+B solutions). Freshly 
reconstituted preserved guinea pig serum diluted 1: 30 was added to each 
well as a source of complement (0.1 ml per well). The plates were then 
incubated for one hour at 37°C, and visually assessed for lysis on a 
0 to 4+ scale. Titres were quoted as the reciprocal of the serum 
dilution giving 50% (2+) lysis. Positive, negative, nil serum, and nil 
complement controls were included in each test. 
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Titres for both haemagglutinating and haemolytic antibody tests 
were expressed in log 2 units. 
Immunodiffusion: 
Sera were tested for the presence of precipitating antibody 
activity by diffusion against antigen in New Zealand agar gel plates 
(Feinberg, 1957). The agar was prepared at 1% dilution, and poured in 
petri dishes to a depth of 3mm. Well patterns were cut using Shandon- 
Feinberg gel cutters. The sera were diffused against a range of oval- 
bumin solutions (10,1,0.1, and 0.01 mg/ml) and observed for the 
presence of precipitin lines after incubation for 48 hours at 4°C. 
Passive Cutaneous Anaphylaxis (PCA): 
PCA tests were performed essentially following the method of Ovary 
(1952,1964). Sensitization of shaved guinea pigs was accomplished by 
0.1 ml intradermal injectionsrof serial dilutions. of serum from oval- 
bumin sensitive guinea pigs spaced equally on either flank. No guinea 
pig received more than twelve injections in all, or more than six on 
either flank. 
Various sensitization time intervals were used where stated to 
distinguish between different types of homocytotropic antibody. For 
the time course experiment, in which six latent periods of sensitization 
were used (4,8, and 24 hours, 2,4, and 8 days), the complete time 
course for any one serum sample was performed on the same guinea pig 
by sequential injections on one or other flank at the specified times. 
Control injections of normal diluted guinea pig serum were incorporated 
in all experiments. 
Challenge was effected by a1 ml/kg intravenous injection (ear 
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vein) of a solution 20 mg/ml in Evan's Blue, and 1.0 mg/ml in ovalbumin. 
The guinea pigs were sacrificed, skinned, and the reactions assessed 
at 30 minutes after challenge. The score for each reaction consisted of 
the arithmetic mean of two diameters measured at right angles. Although 
assessment of the intensity of blueing was also routinely recorded 
(visually 0 to 4+ scale, or with the reflectometer (see Chapter One)), 
statistical analysis of the results indicated that no additional inform- 
ation was provided by including a measure of blueing intensity. - 
Separation of 7S IgG1 and IgG2 guinea pig antibodies: 
A sample of pooled guinea pig serum (see text) was chromatographed 
on Whatman DE-52 pre-swollen ion exchange cellulose following the method 
outlined by Fahey, McCoy, and Goulian (1958). A 2.0 ml sample was 
equilibrated with the starting buffer by overnight dialysis at 4°C, and 
the resultant faint precipitate was removed by centrifugation (2500 rpm 
for 15 minutes at 4°C). The sample was then loaded onto a 1.5 x 15 cm 
DE-52 column, and a potassium phosphate buffer molarity gradient of 
0.01M (0.009M K2HPO4,0.01M KH2PO4 pH 7.9) to 0.30M (0.282M K2HPO4, 
0.018H KH2P04 pH 7.9) passed across the column.. A constant flow pump 
maintained a flow rate through the column of 0.5 ml per minute. 2.0 ml 
fractions were collected on an LKB 7000A Ultrorac fraction collector, 
and monitored for protein content by ultraviolet absorption on a Perkin- 
Elmer spectrophotometer at 280 nm. 
Phosphate'determination: 
Phosphate ion concentration and thus buffer molarity was determined 
in selected fractions from the DE-52 separation using the following micro- 
determination method. 
20 ul samples from every tenth fraction were made up to 1.0 ml with 
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distilled water in test tubes. 1.0 ml of 2% L-ascorbic acid solution 
in 10% trichloroacetic acid (w/v) was added to each tube, followed by 
0.5 ml of a 1% ammonium molybdate solution. After two minutes, 1.0 ml 
of citrate-arsenfite solution (2. Og sodium citrate. 2H20 + 2. Og anhydrous 
sodium arsenite + 2.0 ml glacial acetic acid made up to 100 ml with 
distilled water) was added, and the tubes were allowed to stand at 
room temperature for 15 minutes while the colour reaction developed. 
A standard curve for phosphate ion concentration was determined 
using known standards (0,1,2,5, and 10 ug phosphate per ml). From 
their absorbance at 780 nm, the phosphate ion concentrations in each 
of the ten fractions were read off on the standard curve. The phosphate 
ion gradient across the DE-52 column was then calculated in terms of 
molarity. 
Heat treatment of sera: º 
The pooled serum samples were placed in sealed tubes and heated 
in a water bath at 56°C for four hours (Perini and Mota, 1972). 
2-mercaptoethanol treatment of sera: 
Either pooled or DE-52 fractionated serum samples were dialysed 
against the same two litre volumes of O. 1M 2-mercaptoethanol (3 hours), 
and then 0.02M iodoacetamide (4 hours), at room temperature with stir- 
ring (Mota and Perini, 1970). The samples were then dialysed against 
four changes of PBS pH 7.4 over 24 hours at 4°C. Control samples were 
dialysed against PBS in place of 2-mercaptoethanol, and treated in the 
same way as test samples with iodoacetamide and four further PBS 
changes. 
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Statistics: 
Conjunctival response scores were analysed using the Wilcoxon 
Rank Sum Test. All other results (PCA scores, antibody titres etc. ) 
were analysed using Student's t-test. p<0.05 was taken as indicating 
a significant result in both cases. 
r 
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RESULT 
-S 
2.1. Preliminary Studies on the Nature of Serum Antibodies in 
Conjunctivally Sensitive Guinea Pigs. 
2.1.1. Initial PCA experiments: 
A series of experiments were performed to investigate the homologous 
PCA activities of sera from guinea pigs actively sensitive in conjunct- 
ival challenge to rabbit serum or ovalbumin. Sera from five rabbit 
serum sensitive guinea pigs, and three groups of ovalbumin sensitive 
guinea pigs (6,8, and 19 animals respectively) were tested over a range 
of fourfold serum dilutions (1: 4,1: 16,1: 64 and 1: 256), at two passive 
sensitization latent periods of 4 hours (short term) and 7 days (long 
term). All five of the rabbit serum sensitive guinea pigs had shown 
strong (3+) conjunctival reactions, while responses in the ovalbumin 
group had varied between 1+ and 4+. 
The sera from all the guinea pigs showed strong short term (4 hour) 
PCA reactions at 1: 4 and 1: 16 dilutions, and weaker activity at 1: 64 
and 1: 256 (Table 9). Although 7 day PCA activity was again strong in 
the sera from rabbit serum sensitive guinea pigs, it was weak or absent 
in the sera from ovalbumin immunized groups. 
2.1.2. Correlation between serum PCA activity and conjunctival response: 
To test for correlation between PCA reaction scores and conjunct- 
ival reaction severity, ten guinea pigs were immunized with ovalbumin 
in the normal way. Blood samples (approximately 2 ml) were taken from 
each animal by cardiac puncture at 14 and 28 days after immunization 
and sera prepared. PCA activity was determined for each serum sample 
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with conjunctival reaction severity following topical antigen challenge 
at 18,25, and 34 days after immunization. The results are shown in 
Table 10. 
Short term PCA activity'proved poor in the sera obtained at 14 days, 
but significantly stronger at 28 days (0.01>p>0.005). Long term (7 day) 
PCA activity was nil in all of the samples. There was no significant 
difference between the conjunctival responses recorded on days 18,25, 
or 34 (group mean scores ± s. e. m.: 2.3 ± 0.3,1.7 ± 0.2, and 2.0 ± 0.3 
respectively). There was no significant positive correlation between 
4 hour PCA scores and conjunctival reaction severity, although a 
significant inverse (negative) correlation resulted between 25 day 
conjunctival challenge and 28 day PCA activity (Table 11). 
2.1.3. Placental transfer of conjunctival sensitivity: 
An experiment was designSd to study the placental transfer (if 
any) of conjunctival sensitivity from parent guinea pigs to offspring. 
Eight pregnant guinea pigs were immunized approximately six weeks before 
term with either ovalbumin (5 animals) or rabbit serum (3 animals). 
After a further 14 days all eight showed positive conjunctival responses 
to their respective antigens, although none greater than 2+. Within 
24 hours of the birth of each litter, both mother and young were topic- 
ally challenged with either ovalbumin or rabbit serum as appropriate. 
In two of the five litters from ovalbumin immunized mother guinea pigs 
(7 young in all), weak but unmistakeable conjunctival responses were 
observed. The transfer of ovalbumin sensitivity to offspring appeared 
to follow an inverse relationship, with the least sensitive guinea 
pigs giving birth to responding litters (Table 12). No reactions were 
recorded in any of the litters born to rabbit serum immunized guinea 
pigs, although the mothers responded normally to challenge. 
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Table 10. Comparison of conjunctival response severity and serum 
PCA activity (fourfold dilution at four hours) in 













1. 3.5 2.0 1.5 17.5 2.0 
2. n. d. 2.5 2.0 15.3 2.0 
3. 0 2.5 1.5 n. d. 2.0 
4. 11.0 3.0 0.5 18.0 n. d. 
5. 2.3 0 2.5 14.3 2.0 
6. 5.8 2.0 1.0 18.8 1.0 
7. 14.3 2.5 1.0 16.5 0.5 
8. 17.5 2.0 1.5 17.5 2.5 
9. 11.8 3.5 3.0 14.3 3.0 
10. 0 3.0 2.0 17.0 3.0 
F 
Passive cutaneous anaphylaxis (PCA) scores for*sera obtained by 
cardiac puncture at 14 and 28 days after intradermal immunization with 
ovalbumin are expressed as the mean reaction diameter in mm. for 
each serum sample determined in duplicate. The conjunctival response 
(C. R. ) was scored visually (0 to 4+ scale). Correlation coefficients 
between variables are shown in Table 11. 
n. d.: not done 
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Table 11. Correlation coefficient analysis between the severity 
of conjunctival response and short term (4 hour) 
serum PCA activity. 
Correlation test R D. F. P 
Variable 1 Variable 2 
14 day PCA 18 day C. R. 0.25 7 n. s. 
14 day PCA 25 day C. R. 0.21 7 n. s. 
28 day PCA 25 day C. R. -0.84 7 0.01>P>0.005 
28 day PCA 34 day C. R. -0.35 7 n. s. 
r 
The correlation coefficient values (R) were derived from the 
conjunctival response (C. R. ) and four hour PCA data described 
in Table 10. 
D. F. : Degrees of freedom 
n. s. : not significant 
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Table 12. Placental tansfer of conjunctival sensitivity 
Guinea Immunization Maternal Litter Offspring: 
pig C. R. size positive C. R. 
1. Ovalbumin 2.0 2 
0/2 
2. Ovalbumin 0.5 4 
4/4 
3. Ovalbumin 2.0 3 
0/3 
4. Ovalbumin 1.0 4 
3/4 
5. Ovalbumin 2.0 4 
0/4 
6. N. R. S. 0.5 4 
0/4 
7. N. R. S. 2.0 2 
0/4 
8. N. R. S. 1.0 3 0/4 
p 
500 g guinea pigs were immunized approximately six weeks before term 
with ovalbumin (500 vg intradermally) or normal rabbit serum (N. R. S.: 
2x0.1 ml 20% dilution). Offspring were topically challenged within 
24 hours of birth. 
Maternal conjunctival challenge dose: 500 ug ovalbumin in 25 ul, or 
2 drops N. R. S. 
Offspring conjunctival challenge dose: 200 ug ovalbumin in 10 pl, or 
1 drop N. R. S. 
Conjunctival responses (C. R. ) were scored visually, 30 minutes after 
challenge, in both cases. . 
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2.1.4. Topical immunization with rabbit serum: 
The fact that conjunctival challenge with an antigen can act as a 
stimulus to the immune system was demonstrated in an experiment in which 
8 normal (unimmunized)guinea pigs were topically challenged with rabbit 
serum on a twice weekly basis in one eye only. At the sixth challenge 
after three weeks, two of the eight animals showed a positive conjunctival 
response, increasing to four of the eight guinea pigs after five weeks. 
In addition, positive contralateral eye challenge proved that systemic 
rather than local sensitivity had developed. 
2.2. Serum antibodies in ovalbumin immunized guinea pigs. 
A series of experiments were designed to further investigate the nature 
of the serum antibodies which result from intradermal ovalbumin im- 
munization, and the effect of regular topical challenge thereon. A batch 
of 36 guinea pigs was divided into six groups and immunized with ovalbumin 
in the usual way. Groups I, I; I, and V were kept for 14,28, and 56 days 
respectively without conjunctival challenge. Groups II, IV, and VI were 
kept for 28,56 and 103 days, and topically challenged with ovalbumin 2, 
5, and 8 times respectively. In addition, all 36 guinea pigs from the six 
groups were topically challenged immediately (30 minutes) prior to 
sacrifice, to establish final conjunctival sensitivity at death. Blood 
was collected from each guinea pig and sera prepared. 
The 36 sera from groups I to VI were then examined for anti-ovalbumin 
antibody activity in the following tests: (1) haemagglutination, (2) haemo- 
lysis, (3) immunodiffusion, and (4) passive cutaneous anaphylaxis. The 
experimental design and overall results are summarised in Table 13. 
No significant variation was recorded in conjunctival sensitivity 
between occasions in any of the regularly challenged groups (II, IV, and 
VI), or between conjunctival reaction scores in all six groups 
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2.2.1. Haemagglutination: 
The ability of doubling dilutions of each serum to agglutinate 
tanned sheep red blood cells coated with ovalbumin was assessed in MRC 
pattern agglutination plates. All titres were determined in duplicate with 
controls as specified in Materials and Methods. 
The agglutination titres of sera in groups I, III, and V (guinea pigs 
unchallenged except immediately prior to sacrifice) showed a progressive 
increase (mean titres: 3.2,5.3, and 9.4 respectively). This implied that 
the activity present at 14 and 28 days is part of an ongoing antibody 
synthesis possibly persisting for at least 56 days after immunization 
(Table 13). The mean titres for sera in groups II, IV, and VI (9.8,10.5, 
and 12.5 respectively), were all higher than those for groups I, III, and 
V, and increased progressively with both time, and regular topical 
antigen challenge. 
There was a statistically significant difference (0.05>p>0.025) between 
titres for groups II and III (challenged vs unchallenged at 28 days), but 
not between those for groups IV and V (challenged vs unchallenged at 56 
days). Agglutination titres in group VI (multichallenged guinea pigs) were 
significantly higher than those observed in any other group (p<0.001). The 
mean titre for this group of 12.5 (log2 units) represented positive 
agglutination reactions at 1: 8192 or 1: 16384 serum dilutions. 
Control treatments using tanned uncoated sheep red cells, nil serum 
(saline), and normal guinea pig serum (unimmunized animals) were all 
negative, ruling out the possibility of non-specific agglutination. 
Therefore, guinea pigs immunized intradermally with ovalbumin for 
conjunctival challenge produced serum antibodies capable of agglutinating 
coated sheep red cells. Topical antigen challenge in the period 14-21 
days after immunization significantly increased 28 day but not 56 day 
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titres. Regular challenge between 4 and 10 weeks after immunization 
further increased the antibody titres to higher levels than those found 
either at 28 or 56 days in groups II to V. 
2.2.2. Haemolysis: 
Sera from each group were tested for haemolytic activity against 
ovalbumin coated sheep red cells in MRC plates. In contrast to the high 
agglutination titres recorded earlier for many of the sera, all 36 sera 
failed to show any haemolytic activity, even at the lowest dilution 
tested (1: 8). The test system itself was not at fault, as positive 
control sera used on each occasion gave high lytic antibody titres as 
expected. 
2.2.3. Imnunod if f us ion: 
Sera were tested for the presence of precipitating antibodies 
using double diffusion in agaf gel plates. Each serum sample was placed 
in the centre well and diffused against a range of ovalbumin solutions 
(10 ug, 100 ug, 1.0 mg, and 10 mg per ml), to ensure adequate but not 
excess of antigen, as the latter resolubilizes precipitin complexes. 
The results were recorded non-quantitatively as a positive or negative 
precipitin reaction after incubation for 48 hours at 4°C. 
With the sera from groups I. III, and V, only one serum sample from 
group III (animal 17) gave a positive precipitin result. In contrast, 
3 of the six sera in each of groups II and IV, and all in group VI were 
positive (Table 13). It was therefore concluded that regular conjunct- 
ival antigen challenge induced the formation of precipitating serum anti- 
bodies to ovalbumin, which were either absent or undetectable in im- 
munized unchallenged guinea pigs. 
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2.2.4. Passive cutaneous anaphylaxis: 
Three fourfold dilutions of each serum sample-were tested in 
duplicate for activity at 4 hour and $ day latent periods of sensitization. 
The group mean reaction diameters (mm) shown in Table 13 and Figure 14 
were calculated from the duplicate means for each individual serum 
sample. 
Long term (8 day) activity of the test sera was either poor or 
zero. The short term (4 hour) activity was strong however, especially 
in those sera from regularly challenged guinea pigs. There were no 
significant differences between PCA scores for groups I, III, and V 
(unchallenged at 14,28, and 56 days). The three challenged groups II, 
IV, and VI again showed a progressive increase in 4 hour PCA activity 
(group mean reaction diameters of 10.8,11.7, and 17.4 respectively at 
1: 16 dilution). 
F 
The difference in 4 hour PCA activity between groups II and III 
(challenged vs unchallenged at 28 days) and groups IV and V 
(challenged vs unchallenged at 56 days) was statistically significant 
in both cases (0.05>p>0.025). The PCA scores in group VI (regularly 
challenged) were significantly higher than those for any other group 
(p<0.001). Two samples of normal guinea pig serum at 1: 4 dilution 
used as zero controls both gave negative reactions. 
2.2.5. Correlation coefficient analysis: 
In addition to the previously mentioned statistically significant 
differences observed between sera from groups I to VI in the haemag- 
glutination and PCA experiments, correlation coefficient analysis was 
performed on the data to check for positive correlation between individual 
serum antibody activities in each test and conjunctival sensitivity 
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(Table 14). 
No positive correlation was observed between either PCA or haem- 
agglutination scores and conjunctival sensitivity. However, there 
proved to be a highly significant correlation between the 4 hour PCA 
and haemagglutination activities themselves (Table 14). 
2.2.6. Summary: 
The results from three of the four tests employed (PCA, haem- 
agglutination and immunodiffusion) re-emphasised the fact that regular 
conjunctival challenge is a continuing antigenic stimulus to the immune 
system. It results in increased short term PCA and haemagglutinating 
activity, and the appearance of precipitating antibodies. No complement 
fixing lytic antibody activity was detected in any of the sera from 
either immunized alone or regularly challenged guinea pigs. The positive 
correlation observed between schort term PCA and agglutinating antibody 
activities indicated that these might be due either to the same serum 
antibody, or to different antibody populations (e. g. IgG antibody sub- 
classes) synthesised quantitatively in parallel. 
2.3. PCA time course studies with pooled sera from guinea pig groups 
I to VI : The*Effect of Heat and 2-mercaptoethanol Treatment. 
In view of the contrasting strong short term and poor long term 
mast cell sensitizing antibody activities observed in PCA experiments 
with sera from ovalbumin sensitive guinea pigs, it was considered 
essential to study the PCA activities 
of these sera over a range of 
sensitization latent periods between 4 hours and 8 days. In addition, 
the effect of heat and 2-mercaptoethanol on PCA activity was determined 
at each of the six chosen latent periods: 4,8, and 24 hours, 2,4, 
and 8 days. 
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Table 14. Correlation coefficient analysis between the 
severity of conjunctival response and serum 
antibody activities. 
Correlation test. 
Variable 1. Variable 2. R D. F. P 
C. R. 4 hour PCA 0.03 34 n. s. 
C. R. HA. 0.21 34 n. s. 
H. A. 4 hour PCA 0.67 34 p<0.001 
The data used for the correlation coefficient analysis shown in 
this table was obtained from guinea pigs 1-36 in groups I to VI. 
These guinea pigs were immunized with ovalbumin and topically 
challenged as described in the text (2.2.1-4). Conjunctival 
response (C. R. ), 4 hour passive cutaneous anaphylaxis(PCA) 
and haemagglutination (HA. ) data is summarised in Table 13. 
n. s. : not significant 
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Serum pools were prepared by combining 1.0 ml volumes of individual 
sera from within each of the guinea pig groups I to VI. The serum 
pools I to VI used in the PCA time course study therefore corresponded 
directly to the guinea pig groups I to VI described previously (Table 13). 
The serum pools I to VI were then diluted (1: 4,1: 4,1: 4,1: 16,1: 4, 
and 1: 64 respectively), according to the known short term PCA 
activities of their constituent sera (Figure 14). 
Each serum pool dilution was divided into four equal aliquots and 
treated as follows: 
(a) : normal pool as untreated control, 
(b) : heat treated pool (56°C for 4 hours), 
(c) : 2-mercaptoethanol treated pool (dialysed sequentially 
against 2-mercaptoethanol, iodoacetamide, and 4 
changes of PBS), P 
(d) : 2-mercaptoethanol control pool (dialysed sequentially 
against saline, iodoacetamide, and 4 changes of PBS). 
The PCA activities were determined in quadruplicate for each of 
the four treatments of the six serum pools, at the six specified 
sensitization latent periods. Each sample was coded and randomised so 
that the PCA test was performed blind. The PCA test guinea pigs 
received 6 sequential intradermal injections at the appropriate times 
comprising one complete pool time course on each flank. The results 
for each of the six serum pools are shown in Figures 15 and 16. 
The same characteristic PCA activity time courses were observed 
for each of the six serum pools over the six sensitization latent 
periods. The previously determined strong 4 hour activities increased 
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FIGURE 15. The effect of heat and 2-mercapto ethanol on pooled sera 
from groups I, II, and III. 
Pools of serum from guinea pig groups I, II, and III (see Table 13) were 
tested for PCA activity at six latent periods of sensitization. Each serum 
pool was divided into four aliquots and tested as (i) untreated control 
(S - "), (ii) heated at 56°C for 4 hours (0 - 0), (iii) iodoacetamide 
treated 2-mercaptoethanol control (  -  ), and (iv) 2-mercaptoethanol 
dialysed (13-13). PCA lesions were scored using the mean of two diameters 
measured at right angles. Each point is the mean of four determinations. 
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FIGURE 16. The effect of heat and 2-3nercaptoethanol on pooled sera f=m 
groups IV, V, and VI. 
Pools of serum from guinea pig groups IV, V, and VI (see Table 13) were tested 
for PCA activity at six latent periods of sensitization. Each serum pool was 
divided into four aliquots and tested as (i) untreated control (" - 0), (ii) 
heated at 56°C for 4 hours (0 - 0), (iii) iodaacetamide treated 2-mercapto- 
ethanol control (i - i) , and 
(iv) 2-mercaptoethanol dialyzed ([3-[3). PCA 
lesions were scored using the mean of two diameters measured at right angles. 
Each point is the mean of four determinations. 
4.8 24 48 96 192 
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GROUP V 
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at 8 hours, and were maximal at 24 hours in each pool. Thereafter, 
activity declined at 2 days (48 hours) and 4 days (96 hours), and was 
poor or absent after 8 days (192 hours). The PCA response curves for 
untreated and iodoacetamide alone treated (2-mercaptoethanol control) 
serum groups agreed closely in each case. In addition, no inhibition 
of PCA activity was evident following heat treatment in any of the 
serum pools. 
A reduction in PCA activity occurred following 2-mercaptoethanol 
treatment in all six serum pools. PCA scores were generally similar 
to control values at 4 and 8 hour latent periods, but reduced at 24 and 
48 hours. The inhibition was most marked with pools I, III, and V 
(pools of sera from unchallenged guinea pigs sacrificed at 14,28, and 
56 days respectively), but was also present in serum pools II, IV, and 
VI (sera from regularly challenged animals). Despite the small PCA 
treatment group sizes (4 determinations in each case), the inhibitory 
effect of 2-mercaptoethanol proved either marginally or highly significant 
(StudentIs t-test) with several of the serum pools at 24 and 48 hour 
sensitization latent periods (Table 15). 
2.4. Separation of guinea pig 7S 1gG1 and 1gG2 antibodies. 
A sample of pool VI guinea pig serum, known to contain high PCA 
and haemagglutinating activity, was chromatographed on Whatman DE-52 
preswollen ion exchange cellulose and eluted on a continuous potassium 
phosphate buffer (pH 7.9) molarity gradient from 0.01 M to 0.3 M. The 
eluate protein absorption curve at 280 um and the buffer molarity 
gradient across the column are shown in Figure 17. Four discrete elution 
peaks (three major and one minor) were observed before minimal protein 
elution was established after the passage of approximately 200 ml of 
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Table 15.2-mercaptoethanol inhibition of serum pool PCA 
activities: statistical analysis. 
Latent period of sensitization 
Serum Pool 24 hours 48 hours 
I 0.005>p>0.001 0.01>p>0.005 
II p>0.1 0.05>p>0.025 
III p>O. 1 0.1>p>0.05 
IV 0.1>p>0.05 0.05>p>0.025 
V p>O. 1 0.05>p>0.025 
VI 0.1>p>0.05 p>0.1 
Serum pools I to VI correspond directly to guinea pig groups I to VI 
as shown in Table 13. Statistical analysis of results was by 
Student's t-test between control and 2-mercaptoethanol dialysed 
serum PCA activities at 24 and 48 hours. The results for 
2-mercaptoethanol inhibition of pools III and V at 24 hours were not 
significant, due to small treatment group sizes and wide scatter of 
results. 
p>O. l : not significant. 
0.1>p>0.05 : marginal significance. 
P<0.05 : activity significantly different from control score. 
- 103 - 
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buffer. The bulk of the serum proteins therefore eluted over the 
phosphate buffer molarity range 0.03 M to 0.1 M. 
Individual 2.0 ml elution fractions were pooled into twelve major 
protein fractions and the volumes of each adjusted to 8.0 ml (equivalent 
to a 1: 4 dilution of the column sample application volume). The twelve 
fractions were then tested for short term (4 hour) PCA and sheep red 
cell agglutinating activity by the previously described methods. The 
composition of the twelve major DE-52 fractions together with the test 
results are shown in Figure 18. 
2.4.1. Haemagglutination: 
Agglutinating activity was widely distributed over all twelve of 
the fractions. Fractions 2 to 6 proved the most active, with a gradual 
decline over fractions 7 to 12. 
r 
2.4.2.4 hour PCA: 
Fraction 1 (predominantly 7S IgG2) showed minimal 4 hour PCA 
activity, as did fractions 9 to 12. The low activity observed in 
fraction 1 might have been due to slight contamination with IgGI anti- 
body. Strong 4 hour PCA activity was present in fractions 2 to 6 (as 
for haemagglutination), being maximal in fraction 3. 
These results collectively indicated at least a partial separation 
of 7S IgG1 (gamma-1) and IgG2 antibodies, with the former clearly 
exhibiting the bulk of the 4 hour PCA and haemagglutinating activity 
present (fractions 2 to 6). 
2.4'. 3. The effect of 2-+mercaptoethanol treatments 
The effect of dialysis against 2-mercaptoethanol on the PCA 
activities of the individual pool VI DE-52 
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FIGURE 18. Agglutinating and PCA activity in W' atman DE-52 ion exchange 
chranatographed guinea pig senu. 
A sample of pooled guinea pig serum 
(Group VI) was pooled and chromatographed on 
Whatman DE-52 ion exchange cellulose (see Figure 17). The eluate was pooled into 
12 fractions as shown (a). Each fraction was tested in duplicate for agglutinating 
activity against ovalbumin coated sheep red blood cells 
(b), and for PCA activity 
using a4 hour latent period of sensitization 
(c) where the result is the mean of 
four determinations. 
, 50 100 150 200 
ELUTION VOLUME (ml) 
(a) WHATMAN DE-52 ION EXCHANGE FRACTIONS 
123456789 10 11 12 
FRACTIONS . (b) OVALBUMIN COATED SHEEP RED BLOOD CELL AGGLUTINATION 
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was investigated in order to ascertain which of these fractions contained 
the 2-mercaptoethanol sensitive PCA antibody activity previously 
demonstrated in each of pools I to VI. The PCA activities of the result- 
ing 24 DE-52 fraction-treatments (either 2-mercaptoethanol or saline 
dialysed) were determined in quadruplicate at the three sensitization 
time intervals (8,24, and 48 hours), at which 2-mercaptoethanol in- 
hibition had been previously observed (Figures 15 and 16). The results 
are shown in Figure 19. 
Although short term (4 hour) PCA activity had been strongest in 
fraction 3 (Figure 1$), control PCA activity at 8 hours was maximal in 
fraction 4, while 24 and 48 hours activities peaked in fraction 7. 
There was therefore a distinct shift in maximal PCA activity through 
'fractions 3 to 7 at increasing latent periods of sensitization. 
Significant 2-mercaptoetlanol inhibition of this activity at 8 and 
24 hours was only apparent in fractions 7 and 11 (Table 16). In 
contrast, marginal or highly significant inhibition was observed at the 
48 hour latent period-. infractions 2,6, and 9-11. A decrease in 
PCA score was also recorded for fractions 7 and 8 which proved 
insignificant when analysed (Student's t-test), due to small treatment 
group-sizes and large standard errors. -Nevertheless, the overall 
picture suggested that the 2-mercaptoethanol stable PCA activity was 
largely present in fractions 2 to 5, while the 2-mercaptoethanol 
labile antibody activity occurred predominantly in the later fractions 
6 to 11. 
a 
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(c) 48 HOURS 
FIGURE 19. The effect of 2-ir rcaptoethanol on the PCA activities of DE-52 
ion exchange chranatographed guinea pig serun. 
Guinea pig serum (Group VI pool) was chromatographed on Whatman DE-52 ion 
exchange cellulose (shown in Figure 17). The eluate was pooled into 12 
main fractions (see Figure 18). A sample of each fraction was then 
divided and treated by dialysis with 2-mercaptoethanol (O - 0) or 
iodoacetamide alone (! - 0). The PCA activities of the 12 control 
(iodoacetamide) and 2-mercaptoethanol treated fraction samples were 
determined at 8 (a), 24 (b) and 48 (c) hour latent periods of 
sensitization. 
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Table 16.2-mercaptoethanol inhibition of ion exchange fraction 
411 PCA activities from pool VI: statistical analysis. 
DE-52 Latent period of sensitization 
Fraction 8 hours 24 hours 48 hours 
1 n. s. n. s. n. s. 
2 n. s. n. s 0.1>p>0.05 
3 n. s. n. s. n. s. 
4 n. s. n. s. n. s. 
5 n. s. U. S. U. S. 
6 n. s. n. s. 0.005>p>0.001 
7 0.01>p>0.005 0.05>p>0.025 n. s. 
8 U. S. U. S. U. S. 
9 n. s. n. s. 0.025>p>0.02 
10 n. s. n. s. 0.05>p>0.025 
11 0.025>p>0.01 0.005>p>0.001 0.05>p>0.025 
12 n. s. U. S. U. S. 
Fractions 1-12 correspond to the DE-52 fractions described in the text 
and Figure 18. Statistical analysis was by Student's t-test on PCA reaction 
scores determined in quadruplicate for each fraction at the three 
sensitization periods. 
n. s. : not significant (p>0.1)... 
0.1>p>0.05 : marginal significance. 
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DISCUSS10N 
The production of serum antibodies in the guinea pig, which are 
known to include IgM (macroglobulin), IgG1 (gamma-1), IgG2 (gamma-2), 
IgA, and IgE (Nussenzweig and Benacerraf, 1964; Nelson and Mildenhall, 
1968; Pondman, Den Harink, and Van Es, 1969; Dobson, Rockey, and Soulsby, 
1971; Dobson, Morseth, and Soulsby, 1971; Margni and Hajos, 1973a), 
will clearly be influenced by the type and dose of antigen used, the 
route of injection, and the adjuvant employed, if any (Parish, 1970c; 
Wong and Barbaro, 1976). 
The electrophoretically slow IgG2 antibody is formed in largest 
amounts when guinea pigs are immunized with antigens emulsified in 
complete adjuvant, whereas immunization with protein antigens in saline, 
as in the present study, results in a predominantly IgG1 antibody 
r 
response (Bencerraf, Ovary, Bloch, and Franklin, 1963). Serum IgE 
levels appear to be enhanced by the use of alumina gel adjuvants, 
infection with parasitic organisms, or simultaneous injection of 
antigen with Bordetella pertussis (Catty, 1969; Mota and Perini, 1970; 
Levine, Chang, and Vaz, 1971; Perini and Mota, 1972; Catty and Fraser, 
1972; Ovary and Warner, 1972). Hicks, Opako, and Leach (1968) have 
observed the importance not only of the antigen immunization dose, but 
the period between immunization and challenge, finding that low antigen 
doses resulted in earlier maximal immediate hypersensitivity responses. 
When investigating actively induced immediate hypersensitivity 
states in the guinea pig, most workers adopt and adhere to their own 
successsful immunization schedules, frequently making difficult a 
direct comparison of results. Nevertheless, evidence has accumulated 
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from the present and other studies to suggest the existence of three 
homocytotropic antibodies in the guinea pig, comprising (1) a short 
term sensitizing heat and 2-mercaptoethanol stable IgGl, (2) a medium 
term sensitizing heat stable, 2-mercaptoethanol labile IgG1, and (3) 
a reaginic (IgEZ heat and 2-mercaptoethanol labile long term sensitizing 
antibody. The in vivo and in vitro activities of these homocytotropic 
antibodies are summarised and compared with those of the electro- 
phoretically slow IgG2 antibody in Table 17. 
The partial separability of the two IgG1 antibody populations on 
DE. AE cellulose ion exchange resin observed in the present experiments 
has been previously reported by Perini and Mota (1972). Partial separ- 
ability has also been reported using electrophoresis, where the 2-4 day 
sensitizing IgG1 possessed slightly faster mobility in the most anodal 
region (Ovary and Warner, 197; ). A clean separation of the two IgG1 
antibody populations by these or other methods has therefore yet to be 
achieved. 
Successful purification of guinea pig IgE using ion exchange 
chromatography was first reported by Margni and Hajos (1973a, 1973b). 
These authors pointed out that the failure to isolate IgE by this method 
during previous investigations might be due to the use of stepwise 
rather than continuous molarity gradient techniques, at only 0.01 to 
O. lM buffer strengths, whereas IgE eluted at 0.13M in their experiments. 
Ovary, Kaplan, and Kojima (1976) however, claim to have eluted heat- 
labile PCA activity from guinea pig serum between 0.035 and 0.05M using 
DEAE cellulose chromatography. In the present study, weak short and 
medium term sensitizing IgG1 homocytotropic antibody activity was 
detected in the 0.12-0.15M. eluate (Figure 19, fraction 11), but no 
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IgE was present. 
Although a PCA test will detect very low serum levels of homocyto- 
tropic antibody, and has been widely employed for this purpose, its 
inherent weaknesses must be recognised. These include stress induced 
by poor animal handling and bad injection technique, both of which can 
cause poor or diffuse cutaneous reactions. Dye recovery experiments 
have also shown discrepancies between the amount of antibody injected 
intradermally, and the quantity of dye subsequently recovered from skin 
reaction sites (Blum and Ovary, 1974). The use of precise methods for 
measuring tissue dye extrusion has therefore been reported to provide 
little additional information (Ovary, 1964; Blum and Ovary, 1974), and 
the measurement at specified serum dilutions of either antibody titres 
or comparative reaction diameters appears sufficient in practice. 
The PCA experiments described in the text indicated the presence. 
of both short and medium term sensitizing IgGl antibody populations in 
sera taken from guinea pigs immunized with ovalbumin for conjunctival 
challenge. PCA activity was 2-mercaptoethanol stable at 4 and 8 hours, 
but significantly inhibited at 24 and 48 hour latent periods. Activity 
at all these latent periods increased markedly in those sera from 
regularly challenged guinea pigs. PCA scores for sera from both 
challenged and unchallenged guinea pigs were low or nil at 4 and 8 day 
sensitization latent periods, indicating low or undetectable serum IgE 
levels at 14,28, or 56 days after ovalbumin immunization, with or with- 
out conjunctival challenge. In contrast, strong 7 day PCA activity was 
recorded in sera from rabbit serum sensitive guinea pigs during 
preliminary experiments (see Table 9), suggesting that higher serum IgE 
levels are obtained following whole serum antigen administration. 
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No positive correlation occurred in any experiment between serum 
PCA activity and conjunctival response, for either ovalbumin or rabbit 
serum antigens. However, the serum levels of homocytotropic antibody 
detected in PCA experiments, be they IgG1 or IgE, can serve as little 
more than a tentative guide to the amount and type of tissue mast cell 
fixed antibody, on which the conjunctival sensitivity of actively 
immunized guinea pigs must ultimately depend. Although IgE antibody 
activity was weak or absent in sera 14,28, or 56 days after ovalbumin 
immunization, recent reports have shown that guinea pig serum IgE levels 
are frequently high very early in the antibody response to antigen (11- 
13 days), and subsequently low or undetectable after 3-4 weeks (Mota 
and Perini, 1970; Taylor and Roitt, 1973; Margni and Hajos, 1973a). 
Two other investigations using guinea pigs immunized with rabbit 
serum (Dwyer, Turk, and Darougar, 1974) and ovalbumin (Taylor and 
r 
Roitt, 1973) for conjunctival anaphylaxis have also indicated the 
presence of up to three homocytotropic antibodies in sera from reactive 
animals. The work of Dwyer et al. (1974) further suggested that the 
heat and 2-mercaptoethanol stable IgG1 antibody may also persist in PCA 
skin sites rather longer (up to 10 days) than found in the present and 
other studies. 
The agglutinating, precipitating, and short term PCA activities 
of the 2-mercaptoethanol stable IgG1 antibody are well documented 
(Table 17), and a high positive correlation was obtained (p<0.001) 
between haemagglutination and 4 hour PCA results in this investigation. 
The probability that both of the IgG1 antibody sub-populations possess 
haemagglutinating activity was reinforced by the high titres recorded 
in this test for the DEAE fractions containing the 2-mercaptoethanol 
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labile IgG1 (fractions 9-11), in addition to those which contained 
predominantly 2-mercaptoethanol stable IgG1 (fractions 2-5) as shown 
in Figure 18. 
The absence of haemolytic antibody activity in any of the sera 
tested agrees with previous reports that saline immunization with low 
doses of protein antigens produces little detectable IgG2 and IgM serum 
antibody. It further demonstrated that haemolytic antibody activity 
does not arise as a result of regular topical conjunctival antigen 
challenge. The initially strong and subsequently increasing haem- 
agglutination antibody titres recorded in each of guinea pig groups I 
to VI showed that the IgG1 antibody response is ongoing either up to 
or beyond 56 days after immunization, and confirmed that regular antigen 
conjunctival challenge serves as a continuing stimulus to the antibody 
producing system. 
i 
Whichever of the homocytotropic antibodies are responsible, there 
is no question that guinea pigs, once immunized, remain conjunctivally 
sensitive to antigen with or without regular topical challenge for at 
least 3-4 months. Long term persistence of non-serum detectable tissue 
mast cell fixed IgE is one plausible explanation. However, for either 
of the IgG1 homocytotropic antibodies to be at least in part responsible, 
the serum levels of each must presumably remain sufficiently high to 
maintain tissue bound levels over an extended period. In fact, two 
pieces of evidence actually contraindicate IgG1 involvement. Firstly, 
although regular conjunctival challenge significantly increases IgG1 
serum PCA activity, overall conjunctival sensitivity remains unaltered. 
Secondly, the serum half life of guinea pig IgG1 antibody is reported 
as being only 7.1 days (LeFever and Ishizaka, 1972), which would 
- 115 - 
presumably necessitate high initial serum levels and continuing 
antibody synthesis over an extended period to maintain sensitivity. 
In conclusion, (1) no positive correlation was observed in any 
experiment between serum PCA activity and conjunctival sensitivity, 
(2) PCA activity increased in sera taken from regularly challenged 
guinea pigs, whereas conjunctival sensitivity did not, and (3) serum 
detectable homocytotropic antibodies may not in any case accurately 
reflect the situation at tissue mast cell level. No definite conclusions 
can therefore be drawn concerning the precise nature of the anaphylactic 
antibodies responsible for immediate conjunctival hypersensitivity 
without further investigation. 
r 
- 116 - 
CHAPTER THREE 
PHARMACOLOGICAL CONTROL 
OF THE GUINEA PIG CONJUNCTIVAL RESPONSE 
TO ANTIGEN AND HISTAMINE 
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INTR0DUCT10N 
The diverse pharmacological effects of histamine are now recognised 
as being mediated through two types of tissue receptor recently 
designated Hl and H2 (Ash and Schild, 1966). H1 receptors have been 
shown to control peripheral vasodilation and the contraction of smooth 
muscle, and are antagonised by anti-histamines such as mepyramine or 
promethazine. In contrast, H2 receptors stimulate gastric acid secretion, 
effect inotropic and chronotropic cardiac regulation, and are antagonised 
only by burimamide or metiamide (Black et al., 1972). 
The potency of H1 receptor antagonists in protecting guinea pigs 
against antigen induced bronchoconstriction is well documented 
(Armitage, Herxheimer, and Rosa, 1952; Collier and James, 1967; 
Bernauer, Hahn, and Giertz, 1969), although higher mepyramine doses 
are required to inhibit antigen induced bronchoconstriction than that 
due to histamine (Friebel, 1953; Bernauer, Hahn, and Giertz, 1969). 
H1 receptor anti-histamines are also potent inhibitors of guinea pig 
PCA (Goose and Blair, 1969; Mielens, Ferguson, and Rosenberg, 1974), 
cutaneous inflammatory responses to thermal injury (Wilhelm and 
Mason, 1960), and antigen induced contraction of sensitized ileal and 
tracheal preparations in vitro (Joiner et al., 1974). 
The H1 receptor antagonist tested against the conjunctival 
response in the present study, triprolidine hydrochloride, is one of 
a series of phenylpyridlallylamines first noted for their anti- 
histamine activity by Adamson and Billinghurst in 1950. Its activity 
has subsequently been confirmed as equal to or greater than that of 
mepyramine in lung (Armitage, Herxheimer, and Rosa, 1952), skin (Movat 
et al., 1967), and ileum (Green, 1953). 
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Conjunctival sensitivity to 5-hydroxytryptamine (5-HT) in the 
guinea pig is poor, even at high topical or intraconjunctival doses 
(see Chapter One). In addition, other workers have suggested that 
5-HT is probably not an important anaphylactic mediator in this species 
(Sanyal and West, 1958; Collier and James, 1967). Two 5-HT receptor 
antagonists, methysergide and B. W. 501C67, were used to further 
investigate the possible contribution of this agent to guinea pig 
conjunctival anaphylaxis. Both inhibit 5-HT induced rat paw oedema, 
and 5-HT stimulated contraction of rat uterus and guinea pig trachea 
(Green, unpb. obs.; Mawson and Whittington, 1970; Maling et al., 1974). 
Similarly, both inhibit reagin mediated PCA in the rat, but not guinea 
pig (Mielens, Ferguson, and Rosenberg, 1974; Follenfant and Follenfant, 
unpub. obs. ). As a control for non-specific histamine receptor 
antagonism at high doses, the two compounds were also tested for 
activity against the histamine Conjunctival response. 
Sympathomimetic amines such as adrenaline and isoprenaline possess 
a recognised beneficial bronchodilator action in the treatment of 
asthma. However, a considerable weight of evidence has accumulated 
indicating an important additional effect of these agents at tissue 
mast cell level. Schild (1936) was the first to demonstrate that high 
concentrations of adenaline inhibit the antigen induced release of 
histamine from guinea pig lung. More recent investigations have shown 
that drugs capable of increasing intracellular levels of adenosine 3', 
5'-cyclic phosphate (cAMP), either by adenyl cyclase stimulation (e. g. 
ß-adrenergic agents), or cAMP phosphodiesterase inhibition (e. g. methyl- 
xanthines), are effective inhibitors of histamine release from passively 
sensitized human lung (Assem and Schild, 1969; Kaliner et al., 1971), 
human leucocytes (Lichtenstein and Margolis, 1968), guinea pig lung 
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(Assem, Pickup, and Schild, 1970), and rat peritoneal mast cells 
(Koopman, Orange, and Austen, 1970; Assem and Richter, 1971; Johnson, 
Moran, and Mayer, 1974). 
Inhibition of mast cell mediator release by ß-adrenergic agents 
can be prevented by ß-adrenoreceptor blockade (propranolol) but not 
a-adrenoreceptor blockade (phentolamine). In contrast, a-adrenoreceptor 
agonists have been shown to increase intracellular levels of guanosine 
3', 5'-cyclic phosphate (cGMP), and thus to enhance mediator release 
(Lichtenstein and De Bernado, 1971; Kaliner, Orange, and Austen, 1972; 
Tauber et al., 1973). Sympathomimetic amines also appear to reduce the 
histamine formation capacity via histidine decarboxylase of mast cells 
in vitro (Assem and Feigenbaum, 1972). 
Salbutamol, the $-adrenergic agent chosen in the present study, is 
an active inhibitor of both IgGI and IgE mediated PCA reactions in 
guinea pigs (Martin, 1971; Mielens, Ferguson, and Rosenburg, 1974), and 
of histamine release from either passively sensitized human lung (Assen 
and Schild, 1969) or leucocytes (Perper, Sanda, and Lichtenstein, 1972). 
Although less potent than isoprenaline in most test systems, salbutamol 
is also reported to possess greater resistance to degradation by 
catechol-0-methyl transferase in vivo (Assem and Schild, 1969; Perper, 
Sanda, and Lichtenstein, 1972). 
Clinical trials have conclusively proved the efficacy of disodium 
cromoglycate (DSCG) in the prophylaxis of bronchial asthma, allergic 
rhinitis, and allergic conjunctivitis-(Howell and Altounyan, 1967; 
Morrison-Smith, 1968; Pepys et al., 1968; Robertson et al., 1969; Cohan 
et al., 1976). DSCG has no intrinsic bronchodilator, anti-histamine, 
or anti-inflammatory activity (Cox, 1967; Cox et al., 1970; Brogden, 
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Speight, and Avery, 1974), and is thought to act via an inhibitory 
effect on anaphylactic mediator release at mast cell level (Cox, 1971). 
Inhibition of immediate hypersensitivity reactions by DSCG has recently 
been reviewed by Cox (1976). This compound has shown high inhibitory 
activity in most reagin mediated systems, including rat and monkey PCA, 
and monkey or human bronchoconstriction (Altounyan, 1967; Goose and 
Blair, 1969; Orr, Gwilliam, and Cox, 1971). 
Taylor and Roitt (1973) have previously investigated the effect of 
DSCG on conjunctival anaphylaxis in guinea pigs. DSCG was applied 
topically, simultaneously with antigen, over a specific period between 
9 and 16 days after ovalbumin immunization. Inhibition of the conjunct- 
ival response was observed on days 9,10, and 11. No inhibition was 
recorded on days 12 and 16, while slight but significant potentiation 
occurred on days 13 and 14. 
The discovery of DSCG was unquestionably an important advance in 
the treatment of bronchial asthma and hay fever. However, being 
ineffective orally, it must be regularly applied topically, or be 
inhaled in a micronised powder form. A number of investigations have 
been undertaken in an attempt to develop a similarly active but orally 
effective agent. Doxantrazole is the result of one such investigation. 
This drug inhibits IgE mediated PCA and lung bronchoconstriction in 
rats, antigen induced histamine release from human chopped lung, and 
histamine release from passively sensitized rat peritoneal mast cells 
(Batchelor et al., 1975). Single oral doses also increase forced 
expiratory volume and peak expiratory flow rate in bronchial asthmatics 
(Haydu, Bradley, and Hughes, 1975). 
Inhibition of intracellular CAMP specific phosphodiesterase (PDE) 
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has been proposed as a potential mechanism of action for anti-allergic 
drugs including DSCG and doxantrazole (Roy and Warren, 1974; Taylor et 
al., 1974a, 1974b; Tateson and Trist, 1976; Foreman and Garland, 1976). 
However, inhibition of cAMP PDE by anti-allergic drugs does not 
correlate with relative potency against mast cell histamine release in 
vitro for either DSCG, AH 7725, or theophylline (Varley and Skidmore, 
1976). Furthermore, these and other anti-allergic agents of potential 
therapeutic value such as M&B 22948, ICI 74917, and BRL 10833, are more 
potent inhibitors of cGMP than cAMP hydrolysis in vitro (Bergstrand et 
al., 1977; Coulson et al., 1977). Considering that the KI cAMP/KI 
cGMP ratios for these compounds correlate with anti-allergic activity 
in vivo (rat PCA) and in vitro (human chopped lung), effects on intra- 
cellular mast cell cGMP levels, or on the cAMP/cGMP ratio, may be of 
equal or greater significance than effects on cAMP levels alone 
(Coulson et al., 1977). In tice present study, DSCG and doxantrazole 
were compared as potential inhibitors of the antigen induced guinea 
pig conjunctival response when administered either topically, or by 
intravenous injection. 
The view that prostaglandins (PG's) may function as chemical 
modulators of anaphylactic and inflammatory tissue reactions has gained 
considerable support in recent years. For example, PGF2o has broncho- 
constrictor activity in man (Mathe et al., 1973), while PGE's are 
bronchodilators (Cuthbert, 1969; Herxheimer and Roetscher, 1971; Smith 
and Cuthbert, 1972). Aspirin, an inhibitor of PG biosynthesis, has 
also been found to precipitate attacks of broncospasm in some asthmatics 
(Smith, 1972; Szczeklik et al., 1975). E and F series PG's may there- 
fore be important in the maintenance of bronchial smooth muscle tone 
in vivo. 
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Histamine, SRS-A, and PG's are released from passively sensitized 
human and guinea pig chopped lung tissue following incubation with 
antigen (Piper and Vane, 1969; Piper and Walker, 1973). In addition, 
guinea pig lung releases a rabbit aorta contracting substance (RCS) 
originally believed to be a PG precursor (Piper and Vane, 1969; 
Palmer, Piper, and Vane, 1973; Gryglewski and Vane, 1971). RCS is now 
known to be a mixture of PG biosynthesis intermediates (the endo- 
peroxides PGG2 and PGH2) and new mediators (thromboxanes A2 and B2), 
possessing short in vivo half lives (Kolata, 1975; Hamberg et al., 
1976). 
PG's are also released from guinea pig lung perfused with hista- 
mine, 5-HT, or SRS-A (Bakhle and Smith, 1972; Yen, Mathe, and Dugan, 
1976; Engineer, Piper, and Sirois, 1977), and from guinea pig tracheal 
preparations superfused with histamine (Grodzinska, Panczenko, and 
r 
Gryglewski, 1975). Furthermore, PG's themselves release histamine 
from human and guinea pig lung tissue, and from human or rat skin 
(Crunkhorn and Willis, 1971a, 1971b; Tauber et al., 1973; Hitchcock, 
1974). PG's have been shown to inhibit in vitro histamine release from 
passively sensitized human lung (Tauber et al., 1973) and leucocytes 
(Lichtenstein et al., 1972), although only at concentrations sufficient 
to increase intracellular cAMP levels. Lower doses are reported to 
reduce tissue cAMP levels and enhance release (Tauber et al., 1973), 
while in human lung, indomethacin (a PG synthetase inhibitor) inhibits 
histamine release, and potentiates SRS-A release (Walker, 1973). 
It is therefore unclear whether PG biosynthesis in vivo is a 
direct result. of target mast cell activation, or a secondary effect 
following mediator release. Nevertheless, endogenous PG production 
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appears capable of regulating both the release and in vivo activity of 
other anaphylactic mediators (Walker, 1973). The effect of PG's E1, E2, 
and Fla on the guinea pig conjunctival response was investigated by 
incorporating low PG doses into antigen and histamine intraconjunctival 
challenge solutions. The possible contribution of endogenous PG bio- 
synthesis to the conjunctival response was studied by treating guinea 
pigs with the prostaglandin synthetase (cyclo-oxygenase) inhibitor 
indomethacin prior to challenge. 
Experiments were also included in the present study to investigate 
the effects on guinea pig anaphylaxis of the anti-inflammatory steroid 
dexamethasone (Hicks, 1965; Kovacs, 1965), previously shown to be 
active in guinea pig tissues (Kurihara and Shibata, 1975), and the 
topically applied local aneasthetic lignocaine. 
The latter agent was initrially employed to alleviate any discomfort 
during and immediately following an intraconjunctival injection. 
Lignocaine was therefore tested for effects against the conjunctival 
response itself. 
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MATERIALSANDMETH0DS 
Animals: 
Outbred albino Dunkin-Hartley strain guinea pigs, approximately 
300g at immunization, were purchased from Charles River U. K. Ltd., 
or from the Redfern Animal Breeders Ltd. 
Immunization: 
Ovalbumin (Koch-Light; 5x recrystallised) was given by intradermal 
injection (500 vg in buffered saline) as described in Chapter One. 
Challenge: 
Topical and intraconjunctival challenge was performed as described 
in Chapter One. Standard topical doses of ovalbumin (500 pg), hista- 
mine (250 jig), and compound 48/80 (7.5 mg) were used except where 
stated. op 
Reaction Assessment: 
The visual (0 to 4+) scoring system was routinely employed, except 
following intraconjunctival injection challenge in guinea pigs pre- 
treated with intravenous Evans Blue. In the latter case, either 
reflectometer values alone, or reflectometer difference value x upper 
bulbar/palpebral conjunctival width was used (see Chapter One). 
Chemicals: 
B. W. 501C67 (a-anilino-N-2 m-chlorophenoxypropylacetamidine: 
Wellcome Research Labs. ). 
Compound 48/80 (Wellcome Research Laboratories). 
Dexamethasone (Decadron: Merck, Sharp and Dohme Ltd. ). 
Disodium cromoglycate (Intal: Fisons Ltd. ). 
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Doxantrazole (Wellcome Research Laboratories). 
Histamine dihydrochloride (Sigma Chemical Co. ). 
Indomethacin (Sigma Chemical Co. ). 
Methysergide hydrogen maleate (Sandoz). 
Pentabarbitone sodium (Nembutal). 
Prostaglandins E1, E2, and F 2a 
(Cambrian Chemicals Ltd. ). 
a 
Salbutamol sulphate (Ventolin: Allen and Hanbury Ltd. ). 
Triprolidine hydrochloride (Actidil: Wellcome Research Labs. ). 
Lignocaine hydrochloride (Xylocaine: Astra Chemical Co. ). 
Experimental design: 
Two alternative experimental designs may be used to obtain pharma- 
cological control and test data during the investigation of conjunctival 
reaction antagonist activities. Both methods possess inherent 
advantages and disadvantages: 
r 
(1) Control and test conjunctival responses may be determined by using 
both eyes of the same individual guinea pigs. This type of 
experiment allows improved sensitivity control, and the use of 
smaller treatment group sizes. However, Home Office guidelines 
stipulate the avoidance of subjecting guinea pigs to simultaneous 
conjunctival reaction in both eyes if possible. This method there- 
fore requires a 2-3 hour delay between challenges, to allow complete 
control reaction recovery before drug testing in the contralateral 
eye. However, it does also facilitate the removal from the 
experiment of poor or zero antigen responders at the control 
challenge stage. 
(2) Challenge in one eye only of different guinea pigs assigned to 
either control or drug treatment test groups removes the problem of 
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a delay between challenges. One disadvantage of this method is 
that larger treatment groups are required to compensate for the 
variation in individual antigen sensitivity present in all batches 
of similarly immunized guinea pigs. 
The second type of experimental design was most often used, with 
separate control and test groups of animals challenged in a random 
treatment order. All experiments were performed 'blind' at both the 
challenge and scoring stages, in order to eliminate any possible personal 
bias when using the visual reaction assessment system. 
Statistical analysis of results: 
The method of pharmacological data analysis chosen when using an 
arbitrary visual reaction scoring system, as in the present study, 
requires careful consideration. Principally, the choice lies between 
using either a parametric or non-parametric type of statistical test. 
The decision made may initially affect the significance of the results 
obtained, and accordingly the validity of any conclusions to be drawn. 
Briefly, a parametric test, of which Student's t-test is probably 
the most widely used example, makes a number of important assumptions 
about the data to be analysed. Data sets are assumed to be derived 
from a normally distributed population, and consequently to possess 
similar variances. In addition, the results are generally derived from 
a clearly defined ordinal scale of known linearity (e. g. PCA reaction 
diameters, antibody titres, voltage electrode potentials, etc. ). In 
contrast, a non-parametric test makes no such assumptions about the 
population to be analysed. The results are therefore valid for data 
populations of possibly differing variances, measured using either 
ordinal or nominal scales. 
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Clearly, the choice of test for the analysis of conjunctival 
response data must wholly depend on the type of reaction assessment 
employed. Measurement of dye extrusion into the conjunctiva with the 
reflectometer would permit the use of a parametric test. On the other 
hand, the visual scoring method, although on a numerical scale, is only 
a more sophisticated form of 'ranking' reaction severity. There is no 
clear evidence to suggest that the visual 0 to 4+ scoring scale is linear, 
and it may rather be logarithmic. Furthermore, it is also a scale 
possessing an artificially predefined upper limit (4+), the level of 
which may not be totally valid. 
For these reasons, the visually scored results described in the 
text have been analysed using the non-parametric Wilcoxon Rank Sum Test 
rather than by parametric methods. In this test, both control and drug 
test scores are placed in overall rank order. The rankings of the test 
sample (N1) are summed and compared with the value for the controls (N2). 
By reference to the appropriate statistical tables the significance (p 
value) of the test group data is obtained for the appropriate treatment 
group sizes N1, N2. As in the Student's t-test, p<0.05 is taken as 
indicating a significant result (see Siegal, 1956). 
For the same reasons as those which led to the adoption of the 
Wilcoxon Rank Sum Test (WRST), the visually scored conjunctival response 
data presented graphically in the text is expressed in terms of absolute 
reaction scores, rather than by Z inhibition values. 
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RE_SULT_S 
3.1. Inhibition of the Conjunctival Response by Triprolidine. 
The inhibitory activity of the H1 receptor antagonist triprolidine 
against topical ovalbumin, histamine, and compound 48/80 induced 
conjunctival responses was investigated. The drug was administered 
either systemically (by intraperitoneal injection 30 minutes prior to 
challenge), or topically (incorporated into the respective challenge 
solutions). 
Conjunctival responses obtained following systemic triprolidine 
pre-treatment doses are shown in Figure 20. Compound 48/80 reactions 
were significantly inhibited at all three dose levels tested (p<0.01). 
Histamine induced responses were also potently inhibited in a dose- 
related fashion (p<0.01). To; al inhibition of the histamine conjunct- 
ival response was observed following a 3.0 mg/kg triprolidine dose in 
most guinea pigs. In contrast, inhibition of the antigen reaction was 
only partial, although significant at doses between 1 and 10 mg/kg. 
Inhibition was maximal at the 3.0 mg/kg dose level as in the case of 
histamine, but no additional suppression of the antigen response was 
observed at the higher 10 mg/kg dose. 
Topical application of triprolidine simultaneously with challenge 
also resulted in a dose-related inhibition of both antigen and histamine 
induced conjunctival erythema and oedema (Figure 21). This effect was 
significant (p<0.01) at triprolidine doses between 2.5 and 250 pg. As 
when administered systemically, topical triprolidine was able to 
completely abolish the conjunctival response to histamine. However, 
the antigen reaction was again only partially inhibited, even with a 
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FIGURE 20. Inhibition of the guinea pig conjunctival response to ovalbunin 
(s - ") , histamine (R - n) and canpound 48/80 (A - A) by 
systemic doses of triprolidine. 
Triprolidine was given in saline by intraperitoneal injection 30 minutes 
prior to topical challenge. Control or drug treated guinea pigs were 
challenged in one eye only. Not less than 10 guinea pigs were challenged 
at each dose level in all three cases. 
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FIGURE 21. Inhibition of the conjunctival response to topical ovalbtnin 
(. - ") and histamine (  -U) by topically applied triprolidine. 
Triprolidine at the doses stated was incorporated into the ovalbumin and 
histamine topical challenge solutions. Group sizes used were not less 
than 8 guinea pigs per treatment dose. Each guinea pig (control or drug 
treated) was challenged in one eye only. 
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tenfold increase in drug dose. 
The evidence indicating a sequential release of anaphylactic 
mediators in immediate hypersensitivity reactions is now substantial 
(Brocklehurst, 1960; Kaliner, Wasserman, and Austen, 1973; Jones and 
Kay, 1974). An explosive release of histamine appears to be followed 
by a slower formation and progressive release of other active substances 
such as SRS-A and PG's. If this holds true for the guinea pig conjunct- 
ival response to antigen, then the effect of triprolidine might be 
expected to be greater during the histamine release phase in the early 
stages of the reactions. 
To test the above hypothesis, conjunctival reactions were assessed 
in control and triprolidine treated (3.0 mg/kg) guinea pigs at 5 minute 
intervals from 5 to 30 minutes after ovalbumin challenge. The results 
(Figure 22) did not show incrgased triprolidine inhibitory activity in 
the early stages of the response (5-15 minutes), but rather a continuing 
and highly significant (p<0.01) suppression of reaction severity over 
the entire reaction time course. Accelerated recovery from the resultant 
milder responses was observed in the drug treated group. 
3.2. The Effect of 5-KT Antagonists on the Conjunctival Reaction. 
In order to investigate the contribution, if any, of 5-HT to 
guinea pig conjunctival anaphylaxis, the effects of two recognised 5-HT 
antagonists (. B. W. 501C67 and methysergide) were studied. Both drugs 
were administered by intraperitoneal injection 30 minutes prior to 
challenge, and were tested against both ovalbumin and histamine responses 
(the latter to act as inhibition specificity controls). 

















FIGURE 22. Inhibition of the conjunctival response to topical ovalbunin 
challenge by triprolidine at varying intervals after challenge. 
Two groups of 12 guinea pigs were treated with saline (40 - ") or triprolidine 
(  - ; 3.0 mg/kg) by intraperitoneal injection 30 minutes prior to topical 
challenge with ovalbumin. Conjunctival responses were scored at 5 minute 
intervals up to 30 minutes after challenge, and again at 1 hour after 
challenge. 
5 10 15 20 25 30 60 
TIME AFTER CHALLENGE (MINUTES) 
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In two separate experiments, 3.0 mg/kg but not 0.3 mg/kg doses of 
B. W. 501C67 effected significant (p<0.01) inhibition of the ovalbumin 
challenge response (Table 18). Methysergide also produced a significant 
reduction in ovalbumin reaction severity (p<0.05) at both dose levels 
tested (1.0 and 10.0 mg/kg). However, the specificity of receptor anta- 
gonism for both drugs at the dose levels employed must remain in question. 
B. W. 501C67 (3.0 mg/kg) in one experiment, and methysergide (10.0 mg/kg) 
in another, also significantly inhibited the conjunctival response to 
histamine (Table 18). 
3.3. Inhibitory Activities of two Anti-Allergic Agents: 
Disodium cromoglycate (DSCG) and Doxantrazole. 
These two drugs were tested for inhibitory activity against the 
antigen conjunctival response by (1), topical application of drug 
simultaneously with antigen by incorporation into challenge solutions, 
and (2), intravenous (ear vein) injection of drug immediately prior to 
ovalbumin challenge. Guinea pigs were initially challenged at 
approximately 14 days after immunization, and were used for subsequent 
experiments at weekly intervals. 
(1) The data which resulted from topical DSCG and doxantrazole 
administration is shown in Figure 23. Each inhibition curve was 
built up over a series of experiments using three separate batches 
of animals. Both drugs proved to be ineffective at the lowest 
topical dose tested (75 pg). However, a progressive dose-related 
inhibition was observed in each case for the three higher dose 
levels. This effect was significant for DSCG and doxantrazole (both 
p<0.01) following doses of 750 ug and 2.5 mg. Determination of 
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Table 18. Inhibition of the antigen and histamine induced conjunctival 
response with 5-hydroxytryptamine antagonists. 
Challenge Drug Dose C. R. (mean i s. e. m. ) WRST 
mg/kg Control Test 
OVA B. W. 501C67 0.3 2.3 ± 0.2 2.2 ± 0.3 n. s. 
OVA if 501C67 0.3 2.3 ± 0.3 1.8 ± 0.4 n. s. 
OVA of 501C67 3.0 2.3 ± 0.2 1.3 ± 0.2 p<0.01 
OVA it 501C67 3.0 2.3 ± 0.3 0.9 ± 0.2 p<0.01 
OVA METH. 1.0 2.3 ± 0.3 1.3 ± 0.3 p<0.05 
OVA METH. 10.0 2.3 ± 0.3 1.4 ± 0.2 p<0.05 
HIS B. W. 501C67 3.0 2.2 ± 0.2 2.0 ± 03 n. s. 
HIS it 501C67 3.0p 2.5 ± 0.3 1.4 ± 0.2 p<0.05 
HIS METH. 10.0 2.5 ± 0.3 1.3 ± 0.3 p<0.05 
Methysergide (METH. ) and B. W. 501C67 were given by intraperitoneal 
injection 30 minutes prior to topical challenge with ovalbumin (OVA) 
or histamine (HIS). The results are expressed as mean ± s. e. m. for 
visually scored conjunctival responses (C. R. ), and were analysed using 
the Wilcoxon Rank Sum Test (WRST). All treatment group sizes were 
6 guinea pigs. 
n. s. : not significant 
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FICA 23. Inhibitory activity of disodiun crcmoglycate and doxantrazole 
against the conjunctival response to topical ovalbu in. 
Disodium cromoglycate (  -0) and doxantrazole (A -A Iwere administered 
topically, incorporated in the ovalbumin challenge solution. The inhibition 
curves shown are comprised of data obtained from a series of six experiments 
with three separate batches of guinea pigs. Each guinea pig was challenged 
in one eye only. Total group sizes were > 20 guinea pigs for each treatment 
dose. 
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relative potency by performing linear regression analysis on the 
data showed that there was no significant difference between the 
topical inhibitory activities of the two compounds. In some 
experiments, evidence of minor occular irritation (blinking) was 
noted immediately after instillation of the highest topical doxan- 
trazole doses. 
(2) Intravenous pretreatment with DSCG (30 mg/kg)immediately prior to 
challenge produced no significant inhibition of the ovalbumin 
conjunctival response. In contrast, doxantrazole was again able to 
inhibit the ovalbumin response in dose-related fashion when given 
by this route (Figure 24). The effect was significant at the two 
highest doses (p<0.01). 
Taylor and Roit (1973) have previously described the variable 
effects of DSCG on antigen induced conjunctival anaphylaxis in 
guinea pigs challenged over a specific period from 9 to 16 days 
after immunization. In an attempt to repeat these findings, separate 
groups of guinea pigs immunized and challenged according to my own 
protocols were used to investigate the inhibitory activity of DSCG 
at similar dose levels between 8 and 15 days after immunization. At 
the chosen dose of DSCG (250 jig) no significant inhibition or 
potentiation of the ovalbumin conjunctival response was observed on 
any of the days in this period (Figure 25). 
As high doses of DSCG and doxantrazole were required to inhibit the 
antigen conjunctival reaction, a series of inhibition specificity 
control experiments were also performed by testing both of these 
drugs against the histamine conjunctival response. Three types of 
challenge system were used: 















FIGURE 24. Inhibition of the conjunctival response to topical ovalbunin 
challenge by systemically administered doxantrazole. 
Doxantrazole was given by intravenous injection immediately (2 minutes) 
prior to challenge. Group sizes were >8 animals for each treatment 
dose. Disodium cromoglycate (30 mg/kg i. v. ) was inactive in this test. 
I 
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FIGURE 25. The effect of topical disoditan cram glycate on the 
conjunctival response to topical ovalbunin challenge 
between 8 and 14 days after immunization. 
A batch of 120 guinea pigs was immunized with ovalbumin and divided into 
groups of 8 animals. Each group was topically challenged in one eye only, 
on one occasion between 8 and 14 days after immunization, with ovalbumin 
(0 - 0), or ovalbumin plus disodium cromoglycate (0 - 0). No significant 
inhibition or potentiation of the conjunctival response was observed on 
any of these days at the dose of disodium cromoglycate tested (250 ug). 
89 10 11 12 13 14 
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1. Topical drug vs topical histamine (visual assessment). 
2. Intravenous drug vs topical histamine (visual assessment). 
3. Topical drug vs intraconjunctival histamine (guinea pigs pre- 
treated with Evans Blue and reactions assessed by reflectometer 
difference value x upper conjunctival width). 
The topical and intraconjunctival doses of histamine employed were 
chosen where possible to give conjunctival reactions of equivalent 
severity to those obtained with ovalbumin challenge (i. e. 
approximately 2+). The results for all three challenge systems are 
shown in Table 19. 
Topical DSCG at 250 ug and 2.5 mg doses did not inhibit either 
topical or intraconjunctival histamine responses. In contrast, 
doxantrazole caused a significant reduction of responses to both 
topically and intraconjutcctivally applied histamine at the highest 
topical (2.5 mg) and i. v. (100 mg/kg) doses tested. These results 
indicated that although DSCG and doxantrazole were found to be 
equally active inhibitors of the antigen conjunctival response, non- 
specific anti-histamine activity may possibly have contributed to the 
efficacy of doxantrazole at the highest topical and intravenous 
doses employed. 
3.4. -The Inhibitory Effect of a ß-adrenoreceptor stimulant: 
Cn11m»t. Omnl _ 
The inhibitory activity of the specific 02-adrenergic agent sal- 
butamol against both antigen and histamine conjunctival responses was 
determined. The salbutamol was administered topically, incorporated in 
the respective challenge solutions. 
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This drug proved to be a highly effective inhibitor of the 
conjunctival response which follows either antigen or histamine topical 
challenge. A marked and dose-related inhibition of both types of 
challenge was observed with salbutamol doses between 0.25 and 250 Vg 
(Figure 26). This effect was highly significant for both antigen and 
histamine challenge at the highest dose levels in each case (p<0.01). 
3.5. The Activity of Prostaglandins in the Antigen Conjunctival Response. 
The potential contribution of PG's to the conjunctival immediate 
hypersensitivity reaction was investigated by two methods. Firstly, 
groups of guinea pigs were pretreated with doses of the non-steroidal 
anti-inflammatory agent indomethacin, a recognised PG synthetase (cyclo- 
oxygenase) inhibitor. Secondly, PG's themselves were incorporated into 
intraconjunctival (i. c. ) challenge solutions of ovalbumin or histamine. 
01 
(1) Indomethacin was administered either intravenously immediately prior 
to topical challenge (3.0 and 10.0 mg/kg), or topically simultaneous- 
ly with challenge (75 vg). These doses reduced the severity of the 
antigen reaction in both experiments performed (Table 20), but only 
to a marginally significant degree (0.1>p>0.05) in one case. 
(2) Low doses of PG's E1, E2, and F2a, previously established as 
possessing no conjunctival inflammatory effects when given alone 
(Chapter One of this thesis), were incorporated into histamine (1 Vg) 
and ovalbumin (3 ug) i. c. challenge doses. PG's E2 and Fla (both 
500 ng doses) were found to have no significant effect on either 
type of conjunctival challenge. Doses of PGE1 however, in the 30 to 
300 ng range, were observed to actively potentiate the conjunctival 
response to both ovalbumin (Figure 27) and histamine (Figure 28). 














FIGURE 26. Inhibition of the conjunctival response to ovalbunin and 
histamine by salbutaanol. 
Guinea pigs were topically challenged in one eye only with ovalbumin 
(  -  ) and histamine (0 - 0) solutions also containing increasing doses 
of salbutamol (a B2 adrenergic stimulant). Not less than 8 guinea pigs 
were challenged in any one treatment group. 
a 0.25 2.5 25 250 
TOPICAL SALBUTAMOL DOSE (ug) 
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Table 20. The effect of indomethacin on the antigen conjunctival 
response. 
Indomethacin C. R. (mean ± s. e. m. ) WRST 
Dose Route Control Test 
75 pg Topical 1.7 ± 0.2 1.5 ± 0.3 p>0.1 
3.0 mg/kg i. v. 1.7 ± 0.2 1.2 ± 0.3 p>0.1 
3.0 mg/kg i. v. 1.6 ± 0.2 1.0 ± 0.2 p>O. 1 
10.0 mg/kg i. v. 1.6 1 0.2 0.9 1 0.3 0.1>p>0.05 
The indomethacin was administered intravenously (i. v. ) via an ear vein 
immediately prior to challenge. All treatment groups contained not 
less than 10 guinea pigs. The results are expressed as mean ± s. e. m. 
for visually scored conjuntival responses (C. R. ), and analysed using 
the Wilcoxon Rank Sum Test (WRST). 
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FIGURE 27. The effect of prostaglandin. E on the response to intra- 
conjunctival injection of avaThumin. 
In the two experiments (0 -" and  -  ) shown above, increasing doses of 
PGE1 were incorporated into ovalbumin solutions given by intraconjunctival 
injection. Five guinea pigs were challenged in each treatment group. 
Doses of PGE1 between 30 and 300 ng caused no discernable conjunctival 
response alone (see Chapter One). 
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PROSTAGLANDIN E1 DOSE (ng) 
FIGURE 28. The effect of prostaglarxdin E on the response to intra- 
conjunctival injection of hi. tamine. 
In two experiments (0 -0 and  - 0) increasing doses of PGE1 were 
incorporated into histamine challenge solution given by intraconjunctival 
injection. Between 5 and 8 guinea pigs were challenged in each 
treatment group. Doses of PGE1 between 30 ng and 190 ug caused no 
discernable conjunctival response alone (see Chapter One). 
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The effect was dose-related in both cases, and was significant at 
the 100 and 300 ng PGE1 doses (p<0.05). 
3.6. The Effect of Anaesthetics On the Conjunctival Response. 
During the development of the intraconjunctival injection challenge 
technique, the topically applied local anaesthetic lignocaine was 
initially employed to alleviate any local pain or discomfort which might 
result. Although subsequent experiments demonstrated that pretreatment 
with a local anaesthetic is unnecessary in the use of this technique, a 
series of control experiments designed to investigate any effect of 
lignocaine on the conjunctival response itself produced some interesting 
results. 
A topical 5 minute pretreatment with lignocaine (1.0 mg) was found 
to cause a significant reduction in the antigen conjunctival response 
(Table 21). In contrast, no effect was observed on the histamine response, 
whereas significant potentiation of the compound 48/80 response was 
obtained on two occasions (Table 21). 
In a single experiment, it was confirmed that systemic anaesthesia 
induced with pentabarbitone (60 mg/kg) has no effect on the conjunctival 
response to topically instilled antigen. 
3.7. The effect of Dexamethasone on the Conjunctival Response 
An experiment was performed to investigate the inhibitory effect of a 
representative anti-inflammatory steroid, dexamethasone, on the antigen 
an histamine conjunctival responses. Groups of guinea pigs were pre- 
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injection at 4 or 24 hours prior to topical challenge with either 
histamine or ovalbumin. No significant inhibition of either type of 
conjunctival reaction was observed in those guinea pigs given 
dexamethasone 24 hours before challenge (Table 22). At 4 hours however, 
dexamethasone at this dose was effective aginst the histamine but not 
the ovalbumin response (Table 22). 
a 
r 
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Table 22. The effect of dexamethasone on the conjunctival response. 
Challenge Pretreatment C. R. (mean ± s. e. m. ) WRST 
(hours) Control Test 
Ovalbumin 4 1.8 t 0.2 1.7 ± 0.3 n. s. 
Ovalbumin 24 2.1 ± 0.3 1.9 ± 0.3 n. s. 
Histamine 4 2.5 ± 0.3 1.1 t 0.2 p<0.01 
Histamine 24 2.6 ± 0.3 2.3 t 0.3 n. s. 
Guinea pigs were pretreated with dexamethasone (10 mg/kg) in celacol, 
or saline (controls), given by intraperitoneal injection at 4 or 24 
hours before topical challenge. Conjunctival responses (C. R. ) were 
scored visually and analysed using the Wilcoxon Rank Sum Test (WRST). 
Each treatment group contained not less than 10 guinea pigs. 
n. s. : not significant 
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DISCUSSION 
Triprolidine proved to be a potent inhibitor of antigen, histamine, 
and compound 48/80 induced conjunctival reactions when given either 
topically (25 ug), or intraperitoneally (1-3 mg/kg). These results are 
broadly in agreement with previous reports that systemic triprolidine 
doses between 0.1 and 10 mg/kg protect guinea pigs from antigen induced 
anaphylactic shock (Armitage, Herxheimer, and Rosa, 1952; Green, 1953), 
and inhibit both IgG1 and IgE mediated guinea pig PCA reactions (Movat 
et al., 1967; Follenfant, unpub. obs. ). In addition, Dwyer, Darougar, 
and Jones (1976) have reported complete inhibition of guinea pig 
conjunctival anaphylaxis with systemic (2.0 mg/kg) and topical (one drop 
of a 10 mg/ml solution) doses of triprolidine. 
The total inhibition of the histamine conjunctival response by 
triprolidine (Figures 20 and 21) strongly indicated that this response 
is mediated exclusively via H1 histamine receptors. As only partial 
inhibition of the antigen conjunctival response was recorded in the 
present study (Figure 20), even at the highest triprolidine doses tested, 
the results implied that additional anaphylactic mediators apart from 
histamine are released. These may include SRS-A (Brocklehurst, 1960; 
Stechschulte, Orange, and Austen, 1973), eosinophil chemotactic factor 
of anaphylaxis (Kay and Austen, 1971), E and F series PG's (Horton, 1969; 
Piper and Vane, 1969), and thromboxane A2 (Vane, 1976). 
Experiments designed to test (1) the conjunctival response to 
topical challenge with purified SRS-A preparations, and (2) the inhibitory 
activity of the recently reported specific SRS-A receptor antagonist 
FPL 55712 (Augstein et al., 1973), would provide important information 
concerning a possible role for SRS-A in guinea pig conjunctival anaphylaxis. 
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Partial inhibition of the conjunctival response to ovalbumin was 
observed with the 5-HT receptor competitive antagonists B. W. 501C67 and 
methysergide. However, since significant inhibition of the histamine 
response also occurred at the effective doses of these drugs (Table 18), 
the specificity of receptor antagonism at the doses employed remains open 
to question. 
Significant potentiation of the conjunctival response to both antigen 
and histamine was obtained when low PGE1 doses (30-300 ng) were incorporated 
into intraconjunctivel challenge solutions. PGE's have been previously 
observed to potentiate histamine and bradykinin induced increases in 
guinea pig cutaneous permeability (Williams and Morley, 1973), and 
carrageenin induced paw oedema in the rat (Moncada, Ferreira, and Vane, 
1973). Vane (1976) proposed that rather than contributing directly to 
local erythema or oedema formation, PG's may act by increasing the 
r 
inflammatory effects of other known mediators. 
Conjunctival PG synthetase activity in the rabbit has been found to 
be high compared to that of retina, anterior uvea, spleen, and kidney 
medulla in the same species (Bhattacherjee and Eakins, 1974). The 
authors concluded that in the rabbit, PG's may be active in external 
conjunctival inflammation, in addition to uveitis as previously reported 
(Eakins et al., 1972). 
In the guinea pig conjunctiva, although the response potentiating 
effects of PGE1 were clearly apparent, PG's alone produced no response 
(Chapter One of this thesis). The inhibitory effects of systemic indo- 
methacin pretreatment were also only marginal (Table 20). No conclusive 
evidence was therefore obtained for a significant PG contribution to 
conjunctival anaphylaxis in the guinea pig. 
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The contradictory results obtained during DSCG inhibition studies 
reported in the literature have emphasised that at least three important 
criteria must be considered when comparing the activity of this drug in 
various test systems. Firstly, the target tissue chosen is important, 
e. g. skin, lung, or leucocytes. Secondly, the experimental method 
employed may affect the results, i. e. actively vs. passively sensitized 
tissues, challenged in vivo or in vitro. Thirdly, the nature of the 
homocytotropic anaphylactic antibody responsible appears critical, as 
reagin (IgE) mediated systems appear more sensitive to DSCG than those 
mediated by IgG1 (guinea pig) or IgGa (rat). 
Previously reported results in the guinea pig have emphasised the 
importance of the above mentioned considerations. For example, DSCG is 
'inactive against IgG1 mediated guinea pig PCA (Cox, 1967; Lopez and Bloch, 




Greaves, 1972). In contrast, IgE mediated PCA in the guinea 
pig is highly sensitive to DSCG (Taylor, 1973; Taylor and Roitt, 1973). 
In lung, Cox (1967) observed no inhibition of histamine from actively or 
passively sensitized tissue by DSCG, whereas Assem and Richter (1971) 
found this drug to be active against histamine release mediated by a 
purified antidinitrophenol IgG1 antibody. Furthermore, DSCG has also 
been shown to inhibit histamine release from blood basophils in this 
species (Greaves, 1969). 
Resolution of the results described in my own and previous studies 
has been further complicated by the recognition of two distinct guinea 
pig IgG1 homocytotropic antibody populations, in addition to IgE (Parish, 
1970c; Ovary and Warner, 1972; Perini and Mota, 1972). Anaphylactic 
reactions mediated by each of these homocytotropic antibodies could 
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conceivably possess widely differing sensitivities to DSCG. Furthermore, 
a combination of all three may contribute to immediate hypersensitivity 
reactions in the guinea pig conjunctiva (see Chapter Two). 
In the experiments described here (Figure 23), both DSCG and doxan- 
trazole significantly inhibited the ovalbumin conjunctival response when 
applied topically (750 ug and 2.5 mg doses). On the other hand, doxan- 
trazole was also inhibitory when given intravenously (30 and 100 mg/kg), 
whereas DSCG was not. However, doxantrazole was also shown to possess 
non-specific anti-histamine activity at the highest doses tested, which 
presumably contributed to its slightly greater potency in each test. 
Taylor and Roitt (1973) have previously reported DSCG inhibition of 
guinea pig conjunctival anaphylaxis at 9,10, and 11 days after oval- 
bumin immunization, and slight potentiation on days 13 and 14. Using my 
own immunization and challenge protocols, I have been unable to confirm 
either the inhibition or potentiation observed by the above authors. 
This may be due': to a number of important differences in the experimental 
designs, which include dose and route of antigen immunization, and the 
topical antigen and drug doses employed. 
In the present study, the ß2-adrenoreceptor stimulant salbutamol 
proved to be a highly effective inhibitor of both antigen and histamine 
induced conjunctival reactions. The activity of salbutamol against the 
antigen response can at least in part be explained by the recognised 
inhibitory effects of ß-adrenergic agents on mast cell mediator release. 
However, since highly significant inhibition of the histamine conjunctival 
response was also observed, this cannot be the complete explanation. Two 
recent reports describing the effects of $-adrenergic agents on skin 
wheal and flare (Shereff et al., 1975) and skin histamine (Jorde and 
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Schata, 1976) responses in man have both concluded that these drugs may 
also affect small blood vessels directly, probably via cAMP. A direct 
effect on the local conjunctival vasculature might therefore be the 
mechanism by which salbutamol antagonised the histamine response in my 
own work. Some additional experiments incorporating ß-receptor blockade 
(e. g. propranolol) would at least elucidate whether this is a specific 
$-receptor effect. 
The series of experiments designed to investigate the effects of the 
local anaesthetic lignocaine on the conjunctival response were initially 
undertaken on the basis that challenge by intraconjunctival injection 
might require induction of temporary local anaesthesia. In the event, 
guinea pigs were found to tolerate this technique satisfactorily, with- 
out requiring pretreatment with lignocaine. Nevertheless, the contrast- 
ing effects of lignocaine on the conjunctival response, causing inhibition 
r 
of the antigen reaction and potentiation of the compound 48/80 response, 
aroused considerable interest. 
Local anaesthetics of this type are usually esters (e. g. cocaine 
or procaine) and amides (e. g. lignocaine) based on p-amino benzoic acid. 
Conventional drug-receptor theories do not explain their action, which 
involves preventing the generation and conductance of nerve impulses. 
This is believed to occur through an as yet undefined adverse effect on 
the nerve membrane lipid bilayer, which has the result of altering or 
closing the membrane pores through which ions move in the propagation of 
action potentials (Ritchie and Cohen, 1978). 
The concept that conformational changes in the structure of the cell 
membrane may be induced by local anaesthetics has been widely recognised 
(Seeman and Roth, 1972; Rabinovitch and De Stefano, 1976). These agents 
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have been shown to 'fluidize' erythrocyte cell membranes (Goldstein, 
Aronow, and Kalman, 1974), and to cause gel to liquid crystalline phase 
transitions in artificial dipalmitoyl lecithin liposomes (Jain, Wu, and 
Wray, 1975). 
A local anaesthetic such as lignocaine might therefore be expected 
to have important effects on a variety of cell membrane-dependent physio- 
logical functions. This does appear to be the case. For example, it has 
been shown to antagonise histamine induced contraction of guinea pig 
tracheal smooth muscle in vitro (Weiss, Anderson, and O'Brien, 1975). 
This action, unaffected by either ß-adrenergic (propranolol) or cholinergic 
(atropine) blockade, was attributed by the above authors to a stabilizing 
effect on smooth muscle membrane via a reversible interference with 
calcium ion flux. Lignocaine has also been observed to significantly 
reduce both random and chemotactic factor stimulated locomotion in blood 
leucocytes (Moudgil et al., 1977) and activation of lymphocytes in vitro 
(Waterfieid, Hanmarstrom, and Smith, 1976). Of greater relevance to the 
present study is its reported ability to inhibit compoud 48/80 induced 
histamine release from rat peritoneal mast cells (Kazimierczak, Peret, 
and Maslinski, 1976), although in the same type of experiment, the 
closely related substance tetracaine possessed inhibitory activity at low 
doses while enhancing release at higher concentrations. 
In the guinea pig conjunctiva, the contrasting effects of ligno- 
caine on the antigen and compound 48/80 but not histamine responses 
strongly suggested that its site of action is at the mast cell. No 
definite conclusions may be drawn from the data obtained in the present 
study as to the mechanism of action of lignocaine. In the context of 
mediator release from mast cells however, adverse effects on membrane 
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integrity might be expected to affect either the initial cell membrane 
activation step which follows antigen-antibody combination, or the sub- 
sequent intracellular rearrangement of microtubules and granular membranes. 
The lack of any discernable effect of systemic pentabarbitone anaesthesia 
on the conjunctival antigen response is in agreement with the previous 
observation of Parish, Hall, and Coombs (1963), who found that whole 
animal anaesthesia induced with either volatile inhalation anaesthetics 
or pentabarbitone has no effect on systemic guinea pig anaphylaxis. 
The beneficial effects of adreno-corticosteroid therapy in allergic 
conditions are well established. For example, hydrocortisone, prednisone, 
and dexamethasone, have been widely used to provide relief from the 
symptoms of asthma and hay fever (Baldwin, Dworetzky, and Isaacs, 1961; 
Cameron et al., 1973). A new topically applied steroid, beclomethasone, 
has also recently proved effective, without the commonly occurring side 
effect of adrenal suppression (Mygind, 1973; Gibson et al., 1974; 
Morrison-Smith et al., 1975). 
A short term pretreatment of guinea pigs with dexamethasone at 4 and 
24 hours before challenge had no effect on the antigen conjunctival 
response in the present study. A small but significant effect on the 
histamine response was observed with a4 hour dexamethasone pretreatment, 
for which there appears no obvious explanation in view of its inactivity 
against the antigen reaction. Although single doses of dexamethasone 
have been reported as being effective in the guinea pig (Kurihara and 
Shibata, 1975), it is widely thought that treatment with cortisone or 
dexamethasone must be continued over an. extended period of 14-28 days 
before significant beneficial effects (such as a fall in tissue histamine 
levels) will occur (Telford and West, 1960; Hicks, 1965; Kovacs, 1965). 
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Dwyer, Darougar, and Jones (1976) have also previously found the guinea 
pig conjunctival anaphylactic response insensitive. to systemic doses 
of cortisone (25 mg/kg) given at 24 hours and 20 minutes before 
challenge. 
i 
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CHAPTER FOUR 
HISTOLOGICAL STUDIES ON THE 
GUINEA PIG CONJUNCTIVA 
- 159 - 
INTRODUCTION 
The presence in the bloodstream or at specific tissue sites of 
abnormally high numbers of eosinophils, neutrophils, or lymphocytes, 
has long been recognised as characteristic of a wide range of human 
clinical disorders, including immunological hypersensitivity reactions. 
Delayed (Type IV) hypersensitivity reactions in skin are recognis- 
able histologically by a transient appearance of neutrophils (Long, 
Vorwald, and Donaldson, 1931; Angevine and Seastone, 1950), and a sub- 
sequent dense mononuclear infiltration (Dienes and Mallory, 1932; Gell 
and Hinde, 1951; Uhr, 1966; Turk, 1975). A neutrophil infiltration is 
also closely associated with the formation of immune-complexes, and 
complement activation typical of Arthus (Type III) lesions (Ovary, 1958; 
Cochrane, Weigle, and Dixon, 1959; Cochrane and Aiken, 1966). 
r 
Systemic or local eosinophilia is frequently observed in a number 
of clinical conditions including the allergic diseases, skin disorders, 
parasitic infections, and eosinophilic leukaemia. Eosinophils are 
commonly present in bronchial sputum smears from asthmatics, and in 
nasal and conjunctival secretions of patients suffering from allergic 
rhinitis and conjunctivitis (Loveless, 1945; Stromme, 1955; Fontana, 
Spain, and Desanctis, 1956; Morrow-Brown, 1958; Connell, 1968; 
Parish and Pepys, 1968; Smith, Casanova-Roig, and Wells, 1968; Ishizaka 
and Newcomb, 1970; Fujita et al., 1975). 
Although skin testing has been extensively used in clinical 
practice to identify specific allergens, little. was known about the 
histological changes which occur during and following a typical skin 
wheal and flare reaction until comparatively recently. Kline, Cohen, 
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and Rudolph (1932) were the first to observe an eosinophilic and 
neutrophilic infiltration into skin sites of atopic subjects tested with 
ragweed allergen. Development of the 'skin window' technique for the 
study of local cellular infiltration (Rebuck and Crowley, 1955; Hu, 
Fosnaugh, Bryan, and Jacks, 1961) has confirmed an active infiltration 
of eosinophils and neutrophils into human skin test sites over the 24 
hour period following allergen challenge. The neutrophil response 
appears faster in onset, with large numbers of these cells being present 
as early as 30-60 minutes after challenge. Eosinophil accumulation 
commences more slowly, numbers being low at 4 hours, and increasing 
between 12 and 24 hours (Eidinger, Raff, and Rose, 1962; Eidinger, 
Wilkinson, and Rose, 1964; Fowler and Lowell, 1966; Feinberg, Feinberg, 
and Lee, 1967; Atkins, Green, and Zweiman, 1973). 
Local tissue eosinophilia in man and experimental animals is there- 
r 
fore widely recognised as frequently being a direct result of anaphylactic 
reactions. Consequently, eosinophil infiltrations are often most dense 
in those tissues which contain numerous mast cells, and where anaphylactic 
mediators have been released following antigen or compound 48/80 
application. 
In the guinea pig, eosinophils have been found in large numbers in 
the peritoneal exudate after repeated intraperitoneal injections of 
foreign proteins (Litt, 1960a, 1960b), or antigen-antibody complexes 
(Litt, 1961,1962), and as a result of passive peritoneal anaphylaxis 
(Redd and Vaughan, 1955). Eosinophils may also be indirectly involved 
in primary antigen recognition, as they have been observed to accumulate 
in the axillary and popliteal lymph nodes of guinea pigs within 4 hours 
of antigen injection into the footpads (Litt, 1964b). 
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As in man, both eosinophils and neutrophils infiltrate skin sites 
in guinea pigs during the 24 hour period after active or passive cutaneous 
anaphylaxis, whether IgE or IgG1 antibodies are responsible (Kay, 1970a; 
Parish, 1970a, 1972a, 1972b; Muller and Healy, 1973). 
Cellular infiltration has also been previously demonstrated in the 
guinea pig conjunctiva following topical serum antigen challenge. Al- 
though originally observed to comprise a predominantly eosinophilic 
response from 24-48 hours after challenge (Feinberg, unpub. obs. ), more 
recent reports have described a mixed cellular infiltration of both 
eosinophils and neutrophils commencing within 60 minutes of rabbit serum 
challenge, and lasting for 48-72 hours (Dwyer and Darougar, 1971; Dwyer, 
Turk, and Darougar, 1974). 
The purpose of the present work was therefore . to re-investigate 
r 
the nature of the cellular infiltration which follows guinea pig 
conjunctival anaphylaxis, in terms of both distribution and quantification 
of eosinophil and neutrophil response, and to compare antigen-induced 
cellular infiltration with that which follows histamine or compound 
48/80 challenge. 
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MATERIALS AND METHODS 
Conjunctival smears: 
Smears were taken by loop from the conjunctivae of guinea pigs at 
24 hours after topical challenge. The smears were air dried or alcohol 
fixed, before staining with Hansel stain (Lide Laboratories Ltd., St. 
Louis, Missouri, U. S. A. ). This commercial diagnostic preparation was 
found to be a highly effective stain for both eosinophils and 
neutrophils. The smears were then washed in 70% alcohol and permanently 
mounted in Duramount (G. T. Gurr Ltd. ). 
Each smear was assessed for cellular content by differential counts 
of those cells observed in random sweep fields at x 400 magnification. 
A minimum of 200-300 cells were counted per smear. The results are 
expressed for each cell type as a percentage of the total number of cells 
r 
counted on a given smear. Appropriate controls (smears from unchallenged 
or saline challenged. eyes) were incorporated in all experiments. 
Paraffin sections: 
Paraffin sections (7u) were employed to investigate the general 
structure of the guinea pig conjunctiva, the distribution of mast cells, 
and to define and quantify more fully the eosinophilic and neutrophilic 
infiltration initially indicated by conjunctival smears. 
Whole eyes were removed at sacrifice either from normal guinea pigs 
(for structural and mast cell studies), or at various intervals after 
topical conjunctival challenge. The control treatments used in the 
cellular infiltration investigation were of three types: 
(1) 'normal' eyes removed from guinea pigs unused in any previous 
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experimental procedure. 
(2): saline challenged guinea pig conjunctivae. 
(3): 'normal' guinea pigs topically challenged with antigen. 
The whole eyes were fixed according to the cell types to be studied. 
For the general structure and cellular infiltration work, formol-alcohol 
was routinely used (50 ml 10% formalin, 450 ml 90% alcohol, and 25 ml 
glacial acetic acid). Three types of fixative were tested in order to 
find a successful formula for mast cell fixation in guinea pig tissues: 
(i) A mercuric chloride sublimate fixative (5.5g mercuric 
chloride and 2.7g sodium acetate dissolved in 100 ml distilled 
water) originally described by Donaldson et al., (1973). 
(ii) 4% w/v basic lead acetate in 50% ethanol (Parish, 1964). 
(iii) Formol-alcohol fixätive as above. 
After 24-48 hours in fixative, the eyes were transferred to, and 
stored in 70% alcohol until processing. The optical stalk, retina, sclera, 
vitreous body, and lens, were then cut away, and the remaining tissue 
(eyelids, conjunctiva, cornea, and iris) processed and blocked up in 
paraffin wax for sectioning. 
Those sections used for general structure and cellular infiltration 
studies were stained by conventional methods using haematoxylin and eosin. 
Sections fixed for mast cell distribution work were stained with 1% 
Toluidine Blue (G. T. Gurr Ltd. ) using a modification of the technique 
of Parish (1964). Briefly, the sections were deparaffinised and brought 
to 70% alcohol in the usual way, before being stained with 1% Toluidine 
Blue in 70% alcohol for one hour. The sections were then blotted to 
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remove excess stain, washed in 70% alcohol, dehydrated in absolute 
butanol rather than absolute ethanol (2 x1 minute), and cleared in 
xylol before mounting. 
Assessment of Cellular Infiltration: 
The eosinophilic and neutrophilic infiltration into the conjunctival 
tissue was assessed in two ways: 
a 
(1) Tissue mapping of the cellular distribution on each individual 
section, and subsequent estimation of eosinophil and neutrophil 
numbers present using a0 to 3+ scoring system defined as follows: 
SCORE 
0 No polymorphonuclear cells present. 
1 Scattered cells present in the sub-mucosal conjunctival 
tissue. 
Op 
2 Eosinophils or neutrophils regularly distributed in the 
sub-mucosal tissue and mucosal epithelium. 
3 Large numbers of cells observed throughout the sub-mucosal 
tissue and along the mucosal cell layer, particularly in 
the basement membrane region. 
(2) 
_Localized eosinophil and neutrophil counting along the 
length of 
the conjunctival mucosal epithelium, and in the immediate sub- 
mucosal tissue within 0.3 mm of the mucosal basement membrane 
(defined by graticule). 
Sections prepared from guinea pig eyes were cut and stained in 
batches, up to fifty being processed at any one time. They were routinely 
coded at the fixation stage to ensure that assessment was performed 
'blind', whichever of the above two methods was used. 
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The methods of guinea pig immunization, challenge, and reaction 
assessment used were as described in Chapter One. Standard topical 
doses for conjunctival challenge were as follows: 
1. antigen (ovalbumin): 500 pg. 
2. histamine : 250 pg. 
3. compound 48/80 : 7.5 mg. 
p 
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RESULTS 
4.1. Histology of the Guinea Pig Eye. 
Following the removal of the retina, sclera, lens, and vitreous 
body of the eye at the tissue fixation stage, each stained and mounted 
section consisted of the upper and lower eyelids and conjunctivae, the 
cornea, and the iris (including the ciliary body). A schematic half 
section diagram of one eyelid, conjunctiva, and cornea is shown in 
Figure 29. 
The conjunctiva itself consists of two main tissues, the palpebral 
conjunctiva which lines the inner surface of the eyelids, and the 
bulbar conjunctiva which covers the 'white' of the eyeball. The 
conjunctival mucosal cell layer is of typical stratified columnar 
epithelial cells, with superficial flat cuboidal type cells and deeper 
columnar cells making up'a mucosal epithelial layer 3 to 4 cells thick in 
all. At each end of the conjunctival mucosa is an admarginal zone, where 
the stratified columnar epithelial cells of the conjunctival mucosa 
change either into the cornified epidermal cells of the outer eyelid, or 
into the squamous epithelial cells of the cornea. The reflection of the 
palpebral and bulbar conjunctival tissues forms two deep recesses between 
the upper and lower eyelids and the eyeball. These two regions are known 
as the superior and inferior fornices, where the columnar epithelium is 
occasionally observed to thicken slightly. Beneath the outer mucosal 
epithelial cell layer lies a basement membrane, which divides the 
mucosa from the submucosal connective tissue (termed the palpebral 
fascia). 
The funcion of the conjunctiva is to clean, moisten, and protect 
the surface of the eye, using tear fluid secreted from the lachrymal 









FIGURE 29. A half section diagram of the eyelid, conjunctiva and cornea 
of the guinea pig. 
Key: 1. Ciliary process and muscle 
2. Iris 
3. Descamet's membrane and posterior corneal'epithelium 
4. Substantia propria 
5. Bowman's membrane 
6. Squamous epithelial cell layer 
7. Cornea. 
8. Lymph node 
9. Palpebral conjunctiva (stratified columnar epithelium) 
10. Mucosal basement membrane 
11. Epidermis 
12. Hair follicle 
13. Orbicularis muscle 
14. Sub-mucosal tissue (palpebral fascia). 
15. Region of the fornix 
- 168 - 
glands, and mucous from the secretory cells in the conjunctival 
epithelium. Being an externally exposed mucous membrane, the conjunctiva 
is required to serve as a first line of defence against a whole variety 
of environmental hazards, including airborne pollens and other common 
allergens. 
The submucosal connective tissue is provided with a dense capillary 
network and lymphatic system, which in the guinea pig, includes a lymph 
node in the fornix region of one or both eyelids. It is this abundant 
vascular and lymphatic system which accounts for both the rapid absorption 
of antigens or drugs placed in the conjunctival sac, and the intense 
oedema and erythema characteristic of guinea pig conjunctival anaphylaxis 
and human hay fever. 
The cornea is a transparent non-vascular membrane consisting of 
five main types of cell layer! The outer cell layer is composed of 
squamous epithelial cells, 4-5 cells thick, and is a very sensitive tissue. 
It is known to possess free nerve endings of the pain type, which are 
important in the blinking reflex, and in the production of tear fluid. 
The corneal outer squamous epithelium rests on a layer of cells known 
as the Bowmants membrane. The bulk of the cornea is made up of the 
substantia propria, a dense connective tissue which contains both cells 
and extracellular substance. The flattened connective tissue cells lie 
between bundles of collagenic fibres. Wandering lymphoid cells are some- 
times present, especially during inflammation, and are thought to arise 
from the blood vessels of the corneal limbus. The two innermost layers 
of the cornea are the basement membrane (referred to as the Membrane of 
Descamet), and a layer of mesenchymal epithelium lying over the basement 
membrane termed Descamet's epithelium. 
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The iris is a loose, pigmented, and highly vascular tissue, the 
smooth muscle of which controls the diameter of the pupil, and hence the 
amount of light entering the eye. The iris is connected to the ciliary 
body, itself consisting of the ciliary muscle and process, by a tissue 
known as the ciliary margin. The function of the ciliary body is to 
help control the focal length of the lens. 
The outermost epidermal layer of the eyelid or skin is provided with 
many small hairs and sebaceous glands. The follicles of these hairs 
penetrate deeply into the dermis, which contains blood vessels, nerves, 
and fibroblasts, but only rarely reticulo-endothelial cells. The orbi- 
cularis muscle, responsible for the closing of the eyelids, is comprised 
of pale striated fibres situated between the inner conjunctival sub- 
mucosal connective tissue and the outer subcutaneous layers of the 
eyelid. F 
4.2. The distribution of Mast Cells in the Guinea Pig Conjunctiva. 
The method of tissue fixation employed is critical for the study of 
mast cells in many species, and not least in the guinea pig, where the 
mast cell granules are known to possess water soluble tendencies. This 
problem is normally overcome by the use of either high alcohol content 
or lead and mercury salt fixatives. However, the latter type of salt 
fixative did not prove very successful in the present investigation. The 
lead fixative in particular was found to leave a crystalline deposit in 
the tissue which was difficult to remove. The same formol-alcohol 
fixative as employed in the structural and cellular infiltration studies 
eventually gave the most satisfactory results when combined with the 
modified Toluidine Blue staining technique. 
The mast cells identified in the guinea pig conjunctiva (Figure 
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30) were compared with those characteristically found in guinea pig 
subcutaneous connective tissue preparations (Figure 31). The mast cells 
present in both tissues stained metachromatically dark purple due to the 
heparin laden granules present in this cell type. The background 
tissue stained a non-specific pale blue in each case. 
The mast cells observed in subcutaneous connective tissue and 
conjunctival submucosa were similar in appearance, often being irregular 
in shape, and possessing discernable purple granules under the light 
microscope. In the guinea pig conjunctiva, the mast cells were 
distributed regularly, but not in large numbers (perhaps ten to twenty 
cells per section), along the length of the palpebral submucosal tissue. 
Mast cells were not observed particularly lying adjacent to blood 
vessels as occurs in some tissues, and none were found in the deeper 
submucosa or in the subcutaneous tissue of the eyelid. 
F 
4.3. Cellular Infiltration into the Conjunctiva Following 
Topical Challenge. 
4.3.1. Conjunctival smears: 
The smears were taken from the conjunctivae of guinea pigs at 24 
hours after topical challenge with antigen, histamine, or compound 48/80. 
Preliminary experiments confirmed the presence of neutrophils and 
eosinophils in smear material, but the results were inconclusive due to 
a combination of lack of material on some smears, and poor staining 
quality on others. Improvement of the smearing technique with practice, 
together with the introduction of Hansel stain (found to be particularly 
effective for eosinophils), resulted in cell counting data typical of 
that shown in Table 23. 
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Figure 30. Mast cells in the guinea pig conjunctiva. 
Mast cells were present in the submucosal connective 
tissue (sm) of the guinea pig palpebral conjunctiva, 
often close to the mucosal epithelial basement 
membrane (bm). None were observed in the mucosal 
epithelium (me)itself. The section was fixed in 
formol-alcohol, and stained with 1% Toluidine Blue 
(x 400). 
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Figure 31. Mast cells in guinea pig subcutaneous connective tissue. 
Typical irregularly shaped mast cells were observed in 
spreads of guinea pig subcutaneous connective tissue. 
The tissue specimens were spread onto microscope slides, 
fixed in absolute alcohol, and stained with 1% Toluidine 
Blue (x 600). 
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In this particular experiment, four groups of 5 guinea pigs were 
topically challenged with either 0.9% saline (controls), or standard 
doses of ovalbumin, histamine, or compound 48/80. The cell counts 
obtained are shown together with the conjunctival responses (mean t s. e. n. ) 
and number of cells counted, for each treatment group. 
The saline control smears contained predominantly mucosal 
epithelial cells, and a few lymphocytes. Both of these cell types were 
present on all of the smears examined. The control smears also contained 
a small number of neutrophils (3.2%), indicating that these cells are 
normally present in the conjunctiva. No eosinophils were observed on 
any control smears. 
In contrast, the 24 hour smears taken from antigen, histamine, and 
compound 48/80 challenged guinea pig conjunctivae all showed considerable 
numbers of neutrophils, comprising 19.4,8.8, and 12.3% of the cells 
present respectively. These neutrophil cell counts were significantly 
greater than controls in all three cases (p<0.01). A substantial 
eosinophilia was only observed on those smears taken from antigen 
challenged animals (5.4%). A smaller number of eosinophils were present 
on smears from compound 48/80 challenged guinea pigs (1.1%), while this 
cell type was rare following histamine challenge (0.1%). 
It was therefore concluded that substantial numbers of neutrophils 
infiltrate into the conjunctiva as a result of topical challenge with 
antigen, histamine, or compound 48/80. In contrast, large numbers of 
eosinophils were only found following antigen challenge. Smaller numbers 
of eosinophils were present with compound 48/80, whereas none were usually 
observed in those animals challenged with histamine. 
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Table 23. Conjunctival smear counts. 
CHALLENGE n EYE REACTION CELLS COUNTED % EOSINOPHILS % NEUTROPHILS 
SALINE 5 0 301 ± 68 0 3.2 ± 0.8 
OVALBUMIN 5 2.9 ± 0.4 282 ± 47 5.4 ± 1.1* 19.4 ± 3.9* 
HISTAMINE 5 3.2 ± 0.1 304 t 30 0.1 t 0.1 8.8 t 3.4* 
COMPOUND 48/80 5 1.8 t 0.3 225 t 35 1.1 t 0.4 12.3 t 1.8* 
The conjunctival smears were taken 24 hours after topical challenge 
with saline, ovalbumin, histamine, or compound 48/80. The conjunctival 
responses (visually scored) are expressed as group mean i s. e. m. 
The smears were alcohol fixed, stained with Hansel stain, and assessed 
by differential counts of 200-300 cells in random fields. Neutrophils 
were present on smears from all treatments including the controls 
(saline challenge). Eosinophils were only present in significant... 
numbers on the smears taken from ovalbumin challenged guinea pigs. 
* significantly different from controls (p<0.01). 
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4.3.2. Paraffin sections: 
The conjunctival smear technique allows the sampling and assess- 
ment of a limited cell population obtained from the outer conjunctival 
mucosal surface. It can therefore provide only limited information 
about the overall distribution of cells infiltrating the conjunctiva. 
In order to investigate the cellular infiltration more fully, and to 
study any structural changes in the tissues occurring during or 
following conjunctival reaction, paraffin sections were prepared and 
stained with haematoxylin and eosin as described. Eyes were removed 
from guinea pigs at varying periods after conjunctival challenge as 
follows: 1,4,8,16,24, and 48 hours. The presence and distribution 
of both eosinophils and neutrophils at each of these time intervals was 
assessed using both the tissue mapping or selective area counting 
methods. 
V 
At I hour after challenge, oedema is extensive in the submucosal 
connective tissue of the conjunctiva, and was responsible for the slight 
'breaking up' of some sections. The blood vessels of the submucosal 
tissue were also found to be markedly dilated at this time. These 
effects were strictly localized to the submucosal tissue of the conjunctiva 
itself. No oedema or vascular dilation was observed in the subcutaneous 
regions of the outer eyelids. 
Following all three types of challenge, a characteristic and massive 
infiltration of neutrophils commenced as early as } hour after challenge. 
Neutrophils first appeared in and around dilated submucosal blood vessels 
(Figure 32). The number of neutrophils present had increased substantially 
by 4 and 8 hours after challenge, and was generally maximal at 8 or 16 
hours (Figure 33). Infiltration of neutrophils occurred along the 
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0 
0 
Figure 32. Neutrophils observed in and immediately adjacent to a 
dilated conjunctival submucosal blood vessel 30 
minutes after challenge with ovalbumin. Section fixed 
in formol-alcohol and stained with haematoxylin and 
eosin (x 825). 
p 
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TIME AFTER CHALLENGE (HOURS) 
FIGURE 33. The time course of cellular infiltration into the conjunctiva 
following topical challenge. 
Groups of 5-7 guinea pigs were topically challenged with either ovalbumin 
(500 pg), histamine (250"pg) or compound 48/80 (7.5 mg). Histological 
analysis by tissue mapping technique was performed on sections of 
conjunctival tissue obtained from groups sacrificed at each of a series 
of intervals after challenge. All sections were cut from conjunctival 
tissue fixed in formol-alcohol, and stained with haematoxylin and eosin. 
Neutrophils were assessed following ovalbumin (0 - 0), histamine (  - .) 
and compound 48/80 challenge (f - A), and eosinophils following ovalbumin 
challenge (0 - 0). 
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entire length of the conjunctiva in most cases, and at 8 and 16 hours, 
appreciable numbers of these cells had migrated across the submucosa 
towards the mucosal basement membrane, and on into the mucosal epithelium 
itself (Figure 34). A small number of neutrophils appeared to migrate 
into the outer substantia propria of the cornea, but none were seen 
throughout the bulk of this tissue. The neutrophil presence had 
decreased dramatically by 16 and 24 hours on most sections, -with few 
remaining in the conjunctiva by 48 hours after challenge. 
The eosinophil response appeared more selective. These cells were 
only observed in significant numbers following antigen challenge, and 
were found widely distributed throughout the submucosal tissue, often 
in the deeper submucosa (Figure 35). Accumulation of eosinophils in the 
submucosa also took place more slowly. Appreciable numbers were seldom 
evident before 8 hours after challenge, and usually increased at 16,24, 
and 48 hours. Clustering of eosinophils along the mucosal basement 
membrane, and infiltration into the mucosal epithelium (Figure 36) was 
also less commonly observed than with the preceeding neutrophil response. 
In contrast to the picture following antigen challenge, where an 
intense neutrophilia preceeded a more generalised eosinophilia, the 
compound 48/80 induced neutrophilia was followed only by sparse numbers 
of eosinophils. These were again widely distributed along the length of 
the submucosa, and only occasionally accumulated close to the mucosal 
basement membrane. Eosinophils were rare and usually absent following 
histamine challenge. 
Cell counting was performed on preselected areas of the conjunctiva 
in order to define and quantify more accurately the distribution of 
neutrophils at each set period following challenge. Neutrophil counts 
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Figure 34. Infiltration of neutrophils into the guinea pig conjunctiva 
at 8 hours after topical challenge with histamine (250 ug). 
Neutrophils were numerous at this time, widely distributed 
throughout the submucosal tissue, and also present in the 
mucosal epithelial cell layer itself. Section stained 
with haematoxylin and eosin (x 400). 
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Figure 35. Eosinophils present in the submucosal conjunctival 
tissue of a guinea pig challenged with antigen 24 
hours previously. Section fixed in formol-alcohol 
and stained with haematoxylin and eosin (x 600). 
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Figure 36. A group of eosinophils observed in the conjunctival 
mucosal epithelial cell layer of a guinea pig 24 hours 
after topical challenge with antigen. Section stained 
with haematoxylin and eosin (x 1500). 
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in the submucosa were high as early as } hour after challenge, and peaked 
at 4 hours, for each of antigen, histamine, or compound 48/80 challenge 
(Figure 37). Mucosal neutrophil counts did not peak before 8 or 16 hours, 
at which time the overall neutrophil infiltration was also maximal for 
all three types of challenge. 
The pattern of cellular infiltration into the conjunctiva seemed 
therefore to be one of complete contrast between neutrophil and eosinophil 
participation. Neutrophils arrived quickly following all three types of 
conjunctival challenge. They then appeared to migrate away from dilated 
blood vessels into the submucosal tissue, on towards the basement 
membrane, and frequently into the mucosal epithelium itself. The 
eosinophilic infiltration which followed only antigen challenge was 
slower in onset, seldom as dense, and always more widely distributed. 
Sections prepared from cöntrol guinea pig eyes (unchallenged, saline 
challenged, or antigen challenged unimmunized animals) showed no 
significant neutrophil or eosinophil infiltration. In addition, 4 hour 
neutrophil counts on sections prepared from antigen and histamine 
challenged complement (C4) deficient guinea pigs were unchanged from 
those obtained in the above experiments (Table 24). 
4.4. The Effect of Conjunctival Reaction Inhibitors on the 
Cellular Response. 
4.4.1. Triprolidine: 
The cell counting technique was used to investigate the effect of 
triprolidine on the neutrophil infiltration which follows antigen and 
histamine topical challenge. Guinea pigs were treated with triprolidine 
(3.0 mg/kg) by intraperitoneal injection 30 minutes prior to challenge. 
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FIGURE 37. Neutsroghii counts in the mucosal epithelial cell layer and 
inmediate suh ucosal tissue following challenge. 
Neutrophils were counted in the mucosal epithelial cell layer (open symbols) 
and immediate submucosal tissue ar a(closed symbols) following ovalbumin 
(0 / p), histamine (  / O) and compound 48/80 (f /e) challenge. The results 
are expressed as the mean of >5 observations for each challenge treatment 
and time interval. 
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The triprolidine dose chosen had been previously observed to maximally 
inhibit the antigen response, and abolish the histamine reaction 
(Chapter Three). 
The submucosal neutrophil counts from sections taken at 4 hours 
after challenge in triprolidine pretreated guinea pigs decreased to 27% 
(ovalbumin) and 21% (histamine) of controls (Table 24). The mucosal 
counts were similarly reduced to 13% (ovalbumin) and 11% (histamine) of 
expected values. Inhibition of the gross conjunctival reaction with 
triprolidine had therefore also significantly inhibited the neutrophil 
cellular response (p<0.01) which followed each type of challenge. 
4.4.2. Anti-Allergic Agents: 
Paraffin sections prepared from the eyes of guinea pigs challenged 
with antigen in the presence of DSCG and doxantrazole (both 2.5 mg doses) 
were studied using the tissue 
Fmapping technique. In what was only a 
strictly limited study with a few animals, the results were not as clear 
cut as those obtained with triprolidine. This was probably due to the 
less effective and frequently only partial nature of the gross response 
inhibition observed with DSCG and doxantrazole. Nevertheless, the overall 
picture on sections examined at both 4 and 24 hours after challenge 
indicated that when marked inhibition of the antigen response occurred 
with these drugs, a reduction in the subsequent cellular infiltration 
also resulted. In those guinea pigs where the gross response had only 
been partially inhibited, little apparent difference was noted in either 
the density or distribution of the subsequent neutrophilic or eosinophilic 
infiltrations. 
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Table 24. Mucosal and sub-mucosal neutrophil counts in normal, 
complement (C4) deficient, and triprolidine treated 
guinea pigs at four hours after challenge with 
ovalbumin and histamine. 
Protocol 
4 hour 
Neutrophil cell count (mean). 
Challenge n Treatment Mucosal Sub-inucosal 
epithelium tissue 
Saline 12 ) 3.8 3.9 
unimmunized 
Ovalbumin 5) 14.0 12.0 
Ovalbumin 16 ) 170.1 289.1 
immunized 
Histamine 8) 99.4 221.7 
Ovalbumin 4) immunized 
op 
146.8 472.0 
Histamine 4) C4 def. 101.8 296.8 
Ovalbumin 5) immunized 22.6 77.6 
Histamine 5) Triprblidine 11.0 46.6 
Neutrophil cell counting in predefined mucosal and sub-imucosal 
tissue areas was performed as described in Materials and Methods 
section. The cell counts for the ovalbumin immunized, triprolidine 
(3.0 mg/kg) treated guinea pig group were significantly different 
from control immunized values (Student's t-test: p<0.001), while 
those for the complement (C4) deficient group were not. 
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DI SCUSSION 
Perhaps surprisingly, there have been few previous reports 
describing the distribution of mast cells in the conjunctival tissue of 
either man or experimental animals (see Riley, 1959; Selye, 1965). In 
the present study, these cells were observed predominantly in the sub- 
mucosal tissue of the guinea pig conjunctiva in the region of the 
basement membrane. Although previous reports have shown that these cells 
are common in certain areas of the skin of this species, few were present 
in the outer skin of the eyelid. 
In both human and guinea pig lung tissue, mast cells are numerous 
in the mucosa of the trachea, and are frequently evident in the sub- 
mucosal tissue close to the pulmonary blood vessels of the larger bronchi 
(Mota and Vugman, 1956a; Salvato, 1961; Selye, 1965; Brinkman, 1968). 
r 
They are also situated immediately below the epithelial basement membrane 
of the bronchial mucosa in a similar type of tissue area to those observed 
in the guinea pig conjunctiva during the present study (Staub, 1955; 
Richardson et al., 1973). Clearly, mast cells are widely distributed 
throughout the body, and are common in those mucous membrane tissues 
exposed to the external environment, being also found in the submucosal 
tissue of the intestinal tract (Norris et al., 1963; Thompson et al., 
1964) and nasal passage (Boreus, 1960; Ali, 1964). 
In the present investigation, a characteristic neutrophilic 
infiltration was found to follow topical conjunctival challenge with 
antigen, histamine, or compound 48/80. Arriving within 30 minutes of 
challenge, neutrophils were most evident in the mucosal and submucosal 
tissue at between 8 and 16 hours. In contrast, eosinophils were only 
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observed in significant numbers following antigen challenge, over an 
extended period between 8 and 48 hours after conjunctival reaction 
(Figure 33). A smaller number of eosinophils were present on sections 
prepared from compound 48/80 challenged eyes, while few or none resulted 
from histamine challenge. 
The importance of the local neutrophilic and eosinophilic infiltrations 
commonly observed following anaphylactic reactions in tissues such as 
the conjunctiva remains largely obscured by our inadequate knowledge of 
the mechanisms which govern the movement and function of these cell types. 
Three areas of considerable interest in recent years have therefore been 
(i) how is the bone marrow stimulated to increase stem cell production, 
maturation, and release of reticulo-endothelial cells, (ii) when and why 
do local stimuli direct cells to leave the blood and infiltrate specific 
tissue areas, and (iii) what is the function of these cells once they 
r 
are present in inflammatory or anaphylactic reaction sites? 
Neutrophils are known to be highly active phagocytic cells for either 
bacteria or inert foreign particles, a process which is frequently 
accompanied by degranulation (Wilson, Wiley, and Bruno, 1957; Hirsch 
and Cohn, 1960; Sbarra et al., 1961). The lysosomal granules of neutro- 
phils have been shown to contain phosphatases, hydrolytic enzymes, and a 
variety of other bactericidal substances (Cohn and Hirsch, 1960; Horn and 
Spicer, 1964; Horn, Spicer, and Wetzel, 1964; Klebanoff, 1971). They 
have also been reported to actively phagocytose and degrade antigen- 
antibody complexes (Cochrane, Weigle, and Dixon, 1959; Sorkin and Boyden, 
1959; Hensen, 1971), and frequently appear to monitor the persistence and 
severity of an inflammatory reaction, in addition to serving merely as a 
phagocyte. 
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The significant contribution of the neutrophil to the protection 
of the body from bacterial invaders, the phagocytosis of immune complexes, 
and the release of active inflammatory substances, has therefore been 
clearly established. The role of the eosinophil has attracted rather 
greater speculation. 
Archer (1960,1963) demonstrated that the injection of histamine 
into horse skin attracts eosinophils, and suggested that the function 
of these cells might be the inactivation of anaphylactic mediators such 
as histamine, 5-hydroxytryptamine, and bradykinin. Eosinophils have also 
been observed in the skin of human atopic subjects following histamine 
application (Eidinger, Wilkinson,. and Rose, 1964; Atkins, Green, and 
Zweiman, 1973). In contrast, none arise from the intradermal injection 
(Parish and Coombs, 1968) or topical conjunctival instillation (this 
study) of histamine in guinea 
r 
pigs. 
A number of reports in different species have shown that eosinophils 
are able to selectively phagocytose antigen (Roberts, 1966), antigen- 
antibody complexes (Archer and Hirsch, 1963b; Sabesin, 1963; Litt, 1964a; 
Parish, 1970a), bacteria (Cline, Hanifin, and Lehrer, 1968), foreign red 
blood cells in the presence of immune serum (Archer and Bosworth, 1961), 
and mast cell granules following antigen or compound 48/80 induced 
exocytosis (Welsh and Greer, 1959; Mann, 1969). In man, eosinophils from 
ragweed-sensitive patients also possess ragweed antigen E binding activity 
(Hubscher and Eisen, 1971), and take up IgE-ragweed antigen immune 
complexes (Ishikawa, Wicherk, and Arbesman, 1974; Fujita et al., 1975). 
Eosinophil lysosomal granules, the contents of which have been 
detected in phagocytic vacuoles surrounding ingested material, are 
known to possess a high peroxidase core content. Other hydrolytic 
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enzymes present include acid phosphatases, aryl sulphataso, ß-glucuronidase 
and ribonuclease (Archer and Hirsh, 1963a, 1963b; Miller, De tiarven, and 
Palade, 1966; Bainton and Farquhar, 1968a, 1968b; Lessner, Shelton, and 
Himmelhoch, 1972; Gleich, Loegering, and Maldonado, 1973). Eosinophil 
granules also contain histaminase and phospholipase D (Goetzl, 1976), an 
SRS-A destructive activity attributed to aryl sulphatase (Orange, Murphy, 
and Austen, 1974; Wasserman, Goetzl, and Austen, 1975), and anti-histamine 
properties demonstrable on smooth muscle (Vercauteren and Peeters, 1952). 
In addition, Hubscher (1975a, 1975b) has described an eosinophil derived 
mast cell mediator release inhibiting factor, which possibly acts by 
increasing cAMP levels in the mast cell. This factor is a mixture of 
acidic lipids resembling PGE1 and PGE2 in biological activity, and its 
release is blocked by indomethacin (the important effects of PG's on mast 
cell cAMP levels and mediator release are more fully discussed in 
Chapter Three). 
The stimulus for the specific directional locomotion of eosinophils 
and neutrophils into reactive tissue sites such as the conjunctiva has 
been widely attributed to the local biosynthesis of specific chemotactic 
factors. These are either released, or directly activated, during 
anaphylactic and inflammatory reactions. The whole subject of leucocyte 
chemotaxis and its significant role in the inflammatory response has 
been recently reviewed by Wilkinson (1974). Boyden (1962), using an 
in vitro chamber technique, was the first to show that antigen-antibody 
complexes incubated in the presence of immune serum are chemotactic for 
polymorphonuclear leucocytes. Histamine, 5-HT, and SRS-A were not 
chemotactic in the same system (Kay, and Austen, 1971). Further studies 
(Keller and Sorkin, 1965; Kay, Stechschulte, and Austen, 1971) indicated 
that the chemotactic activity observed with immune complexes is serum 
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complement dependent, (immune complexes incubated in the presence of 
heated immune serum appear chemotactically inactive in vitro), rather 
than being a direct effect of the complexes alone. 
At least three components of complement have been shown to possess 
chemotactic activity in vitro for eosinophils and neutrophils. These are 
C3a, a split product of complement activation also possessing anaphylatoxin 
activity, and having a molecular weight of 7-10,000 (Bokisch, Muller- 
Eberhard, and Cochrane, 1969), C5a, also a split product with a molecular 
weight of approximately 15,000 (Snyderman et al., 1969; Kay, Stechschulte, 
and Austen, 1971; Kay, Shin, and Austen, 1973), and C567, a 200,000 
molecular weight complex arising from Cl-C7 activation (Ward, Cochrane, 
and Muller-Eberhard, 1965,1966). 
It is now widely recognised that lymphocytes are also capable of 
releasing substances which possess selective chemotactic activity for 
either eosinophils or neutrophils. These substances belong to a group 
of soluble factors, termed lymphokines, which are released when lympho- 
cytes are incubated in vitro with antigen, antigen-antibody complexes, 
or mitogens such as phytohaemagglutinin (Cohen and Ward, 1971; Pick and 
Turk, 1972; Torisu et al., 1973). However, it is more likely that 
lymphokines are responsible for the increases in blood eosinophil counts 
observed during parasitic infections, rather than the specific local 
infiltrations which follow immediate hypersensitivity reactions. 
An active contribution of complement-derived chemotactic factors to 
the anaphylactic cellular response also appears doubtful. The complement 
(C4) deficient guinea pigs tested in the present study showed normal gross 
reactions and subsequent cellular responses, to antigen and histamine 
conjunctival challenge. Although alternative pathway complement 
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activation, and direct C3 or C5 enzyme cleavage are both possible in C4 
deficient animals, decomplementation with cobra venom factor is also 
reported to leave eosinophil and neutrophil accumulation at IgG1 guinea 
pig passive cutaneous anaphylaxis sites unaffected (Cochrane, Muller- 
Eberhard, and Aikin, 1970; Ellman et al., 1971; Kay and Austen, 1972). 
The precise mechanism of eosinophil chemotaxis following immediate 
hypersensitivity reactions remains to be determined, and is probably 
the result of multiple chemotactic factor activities. Nevertheless, a 
number of recent investigations have shown that a factor selectively 
chemotactic for eosinophils is released from a variety of tissues 
including human blood basophils, human and guinea pig chopped lung, and 
rat peritoneal mast cells, during anaphylactic reactions (Kay and Austen, 
1971; Kay, Stechschulte, and Austen, 1971; Parish, 1972c; Lewis et al., 
1975). This substance, a low molecular weight peptide, exists preformed 
r 
in the tissues, and has been designated eosinophil chemotactic factor of 
anaphylaxis (ECF-A). Its release is antigen dose dependent, and is 
modulated by drugs affecting intracellular CAMP levels in the same way 
as that of histamine or SRS-A (Wasserman et al., 1973; Wasserman, Goetzl, 
and Austen, 1974). The structure of ECF-A has been established as a 
mixture of two tetrapeptides of the amino acid sequences Val-Gly-Ser-Glu 
and Ala-Gly-Ser-Glu (Goetzl and Austen, 1975,1976). 
The infiltration of eosinophils into the conjunctiva of the guinea 
pig following topical challenge with antigen or compound 48/80 may there- 
fore be attributed at least in part to the release of ECF-A from target 
cells. However, if lymphokines and complement derived chemotactic 
factors are not involved in the conjunctival cellular response, the 
stimulus for the initial (15-30 minutes) and sustained (4-16 hours) 
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neutrophilic infiltration remains to be identified. 
Parish (1972a, 1972b), during a series of histological studies on 
IgG1 mediated guinea pig PCA reaction sites, has also described an early 
neutrophilia and a subsequent eosinophilia of slower onset. These 
findings bear a close resemblance to the pattern in the guinea pig 
conjunctiva. He suggested that at the height of an anaphylactic reaction, 
during the phase of capillary dilation and increased permeability, cells 
may migrate into anaphylactic tissues sites in the relative proportions 
in which they are present in the bloodstream. The infiltration of 
additional cells might then be stimulated by the release of specific 
chemotactic factors either during the initial tissue reaction (e. g. ECF-A), 
or as a result of phagocytosis of foreign material and/or immune 
complexes by the first inflammatory cells (i. e. neutrophils) to arrive. 
There is considerable evidence to support the above hypothesis. Not 
only are neutrophils among the first cells to arrive at the inflammatory 
tissue sites characteristic of a number of clinical disorders, but they 
have also been shown to release a'number of agents chemotactic for 
neutrophils and eosinophils. These include PGE1 (Higgs, McCall, and 
Youlten, 1975), thromboxane B2 (Boot, Dawson, and Kitchen, 1976), the 
arachidonic acid lipoxygenase metabolites HPETE and HETE (Vane, 1976; 
Turner, Tainer, and Lynn, 1976), and a neutrophil derived eosinophil 
chemotactic factor (Czarnetzki, Konig, and Lichtenstein, 1976; Konig, 
Czarenetzki, and Lichtenstein, 1976). In the present investigation 
conjunctival challenge with histamine produced a severe conjunctival 
response, followed by a substantial neutrophil infiltration as shown in 
Figures 32 and 34. Both the conjunctival oedema and erythema, and the 
resultant tissue neutrophilia, were abolished by pretreatment with an 
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anti-histamine. Clearly, the two phenomena are closely associated. 
In conclusion, if the infiltration of eosinophils into the 
conjunctiva observed between 8 and 48 hours after challenge is largely 
due to release of ECF-A from mast cells, it should remain unaffected by 
pretreatment of guinea pigs with doses of H1 receptor antagonists such 
as triprolidine. It should also be possible to mimic the response with 
synthetic chemotactic tetrapeptides. On the other hand, if the selective 
chemotaxis of eosinophils into conjunctival tissue is dependent in any 
way on the preceeding neutrophil infiltration, then triprolidine should 
actively inhibit the arrival of both cell types. This remains to be 
investigated. Furthermore, if the biosynthesis of thromboxanes or 
prostaglandins at the local tissue site is important, then although the 
" prostaglandin synthetase inhibitor indomethacin was inactive against the 
gross conjunctival reaction, it too might be expected to inhibit the 
subsequent cellular response. 
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GENERAL DISCUSSION 
The present study was designed to investigate immediate conjunctival 
hypersensitivity in the guinea pig as a potentially useful animal model 
for allergic conjunctivitis in man. In this respect, four important 
criteria on which any conclusions must be based are: 
(1) does the experimentally induced guinea pig conjunctival response 
closely resemble the symptoms characteristic of human allergic 
conjunctivitis? 
(2) are the immunological, pharmacological, and pathological mechanisms 
of both human and guinea pig responses similar in nature? 
(3) is the guinea pig experimental model selectively sensitive to the 
action of drugs which possess proven clinical efficacy, such as 
anti-histamines or disodium cromoglycate? 
(4) is the guinea pig conjunctival model appropriate for the routine 
testing of novel anti-allergic compounds? 
The results described in the text have both confirmed and extended 
the initial observations of Feinberg and Chopra (1966). Topical 
instillation of either serum or protein antigens onto the conjunctival 
tissue of correspondingly immunized guinea pigs consistently resulted in 
evidence of local irritation and lacrimation. This was followed by a 
rapidly developing erythematous and oedematous response which extended 
throughout the bulbar and palpebral conjunctiva. The guinea pig 
conjunctival response therefore bare a close resemblance in this 
respect to the clinical conditions observed in man. 
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It should be remembered that the guinea pig immediate conjunctival 
hypersensitivity reaction is an acute response to a single dose antigen 
challenge. In direct contrast, human allergic conjunctivitis is 
frequently a chronic response to a lower level of continual antigen 
exposure, which may continue over a period of hours or days. Criticism 
regarding duration of response may be equally applied to a number of 
other widely used experimental models of allergy. Most of these models 
are single dose acute reaction tests, including passively sensitized 
human chopped lung or rat peritoneal mast cells in vitro, and antigen 
induced bronchoconstriction or passive cutaneous anaphylaxis in vivo. 
However, in the case of guinea pig conjunctival anaphylaxis, the data 
obtained in Chapter One of this thesis indicated that with a modified 
protocol, a low level response could be developed and maintained for a 
prolonged period. This might more closely resemble the human clinical 
situation. 
A whole range of anti-histamines such as promethazine, mepyramine, 
and triprolidine, given either systemically or topically, have been 
extensively employed in the control of human allergic rhinitis and 
conjunctivitis (Crompton, 1973). The significant protection afforded 
by these drugs serves to re-emphasise the important contribution of 
histamine to the human allergic conjunctival response. The potent 
inhibitory activity of triprolidine against conjunctival anaphylaxis 
in the guinea pig strongly implies that histamine also plays an important 
role in this species. Indeed, of all those pharmacological agents 
tested in the guinea pig conjunctiva, only histamine was observed to 
produce the intense conjunctival erythema and oedema characteristic of 
the antigen reaction. In direct contrast, guinea pig conjunctival 
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sensitivity to 5-HT was poor, even at dose levels considerably higher 
than those at which histamine was active. Moreover, the inhibitory 
effects of B. W. 501C67 andimethysergide on the guinea pig conjunctival 
reaction were only marginally significant, and non-specific in nature. 
Both of these 5-HT antagonists also inhibited the conjunctival response 
to histamine. 
No evidence was obtained to directly implicate the involvement 
of prostaglandins in the guinea pig conjunctival reaction. Intra- 
conjunctival injections of PGE1. PGE2, and PGF2a all proved inactive 
in the guinea pig at dose levels which are known to cause erythema in 
the skin of guinea pigs and rats (Crunkhorn and Willis, 1969; Williams 
and Morley, 1973). Pretreatment of test animals with indomethacin, 
a prostaglandin synthetase inhibitor, also had little effect on the 
severity of the-antigen conjuInctival response. The potentiating 
effect of PGE1 on the conjunctival responses to antigen and histamine 
served only to show that endogenous biosynthesis of PG's, if present, 
might certainly affect the strength of the response. 
From these results it seems certain that histamine makes a 
significant contribution to guinea pig conjunctival anaphylaxis, while 
a major role for 5-HT and PG's appears doubtful. Future studies should 
include investigation of conjunctival sensitivity to other pharma- 
cological mediators which are either established or potential contri- 
butors to allergic and inflammatory reactions. These include SRS-A, 
bradykinin, anaphylatoxins (C3a and C5a), and rabbit aorta contracting 
substance (PGG2, PGH2 and thromboxane A2). 
The severity of the guinea pig conjunctival response to antigen 
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was significantly reduced in the presence of the anti-allergic agents 
DSCG and doxantrazole. Non-specific anti-histamine activity appeared 
to contribute to the inhibitory effect of doxantrazole at the highest 
intravenous and topical doses employed. In contrast, DSCG possessed 
no anti-histamine activity at its effective anti-allergic doses, 
confirming a previous report by Cox et al., (1970). The topical doses 
of these drugs required to inhibit guinea pig conjunctival anaphylaxis 
were high in both cases. However, in the case of anti-allergic drugs 
in general, and DSCG in particular, the challenge system, target tissue, 
and homocytotropic antibody involved, have all been shown to strongly 
influence the doses required for in vivo anti-allergic activity. 
Furthermore, when a drug is applied topically to the guinea pig 
conjunctiva, the effective dose in terms of tissue levels attained is 
hard to estimate, and may only be a fraction of the total dose instilled. 
r 
A large proportion of the drug dose is probably lost through a 
combination of scratching, blinking, Iachrymation, and drainage from 
the conjunctival sac. Nevertheless the doses of DSCG required to 
inhibit guinea pig conjunctival anaphylaxis are broadly comparable to 
those chosen and effective in human clinical use, recently quoted as 
1 drop of a 4% ophthalmic solution 4 times daily (Greenbaum- et al., 
1977; Easty, 1977). 
The potent inhibitory activity of salbutamol against the antigen 
conjunctival response is in agreement with previous reports that 
betat-adrenoceptor stimulants are effective inhibitors of immediate 
hypersensitivity reactions. This activity has been widely attributed 
to the prevention of mediator release through adenyl cyclase stimulation, 
and a resultant increase in mast cell CAMP levels. However, the fact 
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that salbutamol also effectively inhibited the conjunctival response 
to histamine at similar dose levels, indicated that prevention of 
mediator release is not the complete explanation. Two other recent 
reports have also demonstrated the inhibitory activity of beta2-adreno- 
ceptor agonists against the cutaneous response to histamine in man 
(Jorde and Schata, 1976), and the exudation of dye which follows intra- 
peritoneal injection of histamine in rats (Smith, Spicer, and Ross, 
1977). This is presumably a beta-receptor specific direct effect on 
the local vasculature. 
In man, IgE is now recognised as the major contributory homocyto- 
tropic antibody to anaphylactic reactions. In the guinea pig, the 
situation is less clear, with the possibility of two distinct antibody 
classes being involved. As in man, guinea pig IgE is a long term 
sensitizing and heat labile hpmocytotropic antibody. IgGI .. (earl)t on 
the other hand, is a heat stable antibody, and its two subclasses show 
short (4-8 hours) and medium (2-4 days) term sensitizing activities in 
passive transfer experiments. A major problem in the guinea pig is 
therefore the determination of the relative contribution of each of 
these antibodies to a given anaphylactic response. 
As has been the case in several previous studies (Mota and Perini, 
1970; Parish, 1970c; Margni and Hajos, 1973a), the PCA data obtained in 
the present investigation was inconclusive, and the problem remained 
largely unresolved. IgGj antibodies possessing short and medium term 
sensitizing activities were demonstrated in all sera tested by PCA. 
In those guinea pigs topically challenged regularly over an extended 
period, short and medium term PCA, and serum haemagglutinating activities, 
increased substantially. A highly significant correlation was found 
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between the respective 4 hour PCA and HA activities in those sera 
tested, indicating that the same IgG1 antibody populations may be 
responsible for both immunological properties. Long term (8 day) PCA 
activities were low or absent in all of the sera taken from guinea pigs 
immunized with ovalbumin. Haemolytic activity was also absent in all 
sera tested, confirming the previous observation that immunization with 
low doses of protein antigens in saline does not induce the formation 
of haemolytic (IgG2 and IgM) antibodies in guinea pigs (Benacerraf, 
ovary, Bloch, and Franklin, 1963). 
The high serum IgG1 and low IgE serum antibody activities recorded 
in the PCA studies cannot be taken as precluding the involvement of IgE 
in the conjunctival response at mast cell level. For example, tissue 
mast cell bound antibodies are not detected in the PCA test, and other 
studies have shown that IgE blood levels in guinea pigs may peak as 
early as 11-13 days after immunization (Margni and Hajos, 1973a; Taylor 
and Roitt, 1973), i. e. before the serum samples were obtained in the 
present investigation. In addition, the short and medium term PCA 
activities detected did not correlate with the severity of individual 
conjunctival responses in any of the experiments where this possibility 
was considered. Whereas the short and medium term serum PCA activities 
increased progressively with regular topical challenge, the strength of 
the conjunctival responses remained constant. Serum antibody activities 
in the PCA test, therefore, provide at best only a tentative guide to 
the class of mast cell bound homocytotropic antibody upon which 
conjunctival sensitivity to antigen challenge finally depends. On the 
basis of the results obtained in the present investigation, both IgG1 and 
IgE antibodies may contribute to the guinea pig antigen conjunctival 
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response when the animals are immunized using the protocol employed here. 
A characteristic cellular infiltration into the conjunctival 
tissue of guinea pigs was found to follow each of the three types of 
conjunctival reaction investigated. Neutrophils were observed in the 
submucosal conjunctival tissue within 30 minutes of challenge with 
ovalbumin, histamine, or compound 48/80. This rapidly developing 
neutrophilia was maximal at either 8 or 16 hours after challenge in all 
three cases, and receded over the subsequent 12 to 36 hours. In direct 
contrast, infiltration of eosinophils was only substantial following 
challenge with antigen over the period between 16 and 48 hours. Eosino- 
phils were observed in smaller numbers as a result of challenge with 
compound 48/80, but were not generally present following a histamine 
response. In man, the presence of eosinophils in conjunctival scrapings 
is frequently 'taken as indicating the occurrence of an allergic reaction 
in the conjunctiva, and the appearance of these cells is regarded as a 
valuable diagnostic tool. 
From the results described in the text, it is apparent that the 
guinea pig conjunctiva possesses certain advantages over other tissues 
in the investigation of the type, pattern, and mechanism of cellular 
infiltrations which follow hypersensitivity reactions. Firstly, the 
nature of the cellular response to a given stimulus may be studied 
either by the preparation of sequential conjunctival smears, or by 
paraffin sections obtained at predetermined intervals after challenge. 
Secondly, antigens, anaphylactic mediators, or other inflammatory 
substances may be applied topically to the conjunctiva, removing the 
additional complication of local tissue trauma due to an injection. 
The guinea pig conjunctiva has already been used by other workers to 
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study the nature of delayed (. Type IV) hypersensitivity reactions in 
addition to the immediate anaphylactic response (Feinberg, unpub. obs.; 
Dwyer and Darougar, 1971), and should prove ideal for the investigation 
of the chemotactic activity of substances such as ECF-A, C3a and C5a, 
and prostaglandins in vivo. 
CONCLUSION: 
The conjunctival anaphylactic response in the guinea pig certainly 
appears worthy of further consideration as an experimental in ViVo model 
of human allergic conjunctivitis. It involves the correct target tissue, 
the naturally occurring route of antigen challenge, and provides the 
option of systemic or local drug administration. The conjunctival 
response closely resembles that which occurs in man in terms of both 
gross and cellular components, is easily quantifiable, and selectively 
inhibited by the same types of drug. Immediate hypersensitivity in the 
guinea pig conjunctiva therefore appears to satisfy each of the four 
criteria previously considered relevant in the assessment of this in vivo 
allergy model. 
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